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Abstract 
In 2004, the FDA launched the Process Analytical Technology (PAT) initiative to support 
product and process development. Even before this, the biologics manufacturing industry 
was working to implement PAT. While a strong focus of PAT is the implementation of 
new monitoring technologies, there is also a strong emphasis on the use of multivariate 
data analysis (MVDA). Effective implementation and integration of MVDA is of 
particular interest as it can be applied retroactively to historical datasets in addition to 
current datasets. However translation of academic research into industrial ways of 
working can be slowed or prevented by many obstacles, from proposed solutions being 
workable only by the original academic to a need to prove that time invested in developing 
MVDA models and methodologies will result in positive business impacts (e.g. reduction 
of costs or man hours). 
The presented research applied MVDA techniques to datasets from three scales typically 
encountered during investigations of biologics manufacturing processes: a single product, 
dataset; a single product, multi-scale dataset; a multi-product, multi-scale, single platform 
dataset. These datasets were interrogated in multiple approaches and multiple objectives 
(e.g. indictors/causes of productivity variation, comparison of pH measurement 
technologies). Individual project outcomes culminated in the creation of a robust 
statistical toolbox. 
The toolbox captures an array of MVDA techniques from PCA and PLS to decision trees 
employing k-NN. These are supported by frameworks and guidance for implementation 
based on interrogation aims encountered in a contract manufacturing environment. The 
presented frameworks ranged from extraction of indirectly captured information 
(Chapter 4) to meta-analytical strategies (Chapter 6). Software-based tools generated 
during research ranged from translation of high frequency online monitoring data as 
robust summary statistics with intuitive meaning (Appendix A) to tools enabling potential 
reduction in confounding underlying variation in dataset structures through the use of 
alternative progression variables (Chapter 5). Each tool was designed to fit into current 
and future planned ways of working at the sponsor company. 
The presented research demonstrates a range of investigation aims and challenges 
encountered in a contract manufacturing organisation with demonstrated benefits from 
ease of integration into normal work process flows and savings in time and human 
resources.  
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 Introduction 
The only useful function of a statistician is to make predictions 
and thus provide a basis for action. — William Edwards Deming 
In a 1994 press release, Andrew J. Guarriello, then chief operating officer of AT&T 
Power Systems, stated that “the roots of today's Total Quality Management can be traced 
to the work of three AT&T scientists and quality pioneers--Walter Shewhart, W. Edwards 
Deming, and Joseph Juran.” [1] In 1924, Shewhart presented a single page document at 
a meeting at Western Electric, CA, USA. One-third of the page was given over to what 
would now be called a Shewhart control chart. This document is often seen as the start 
of statistical process control (SPC) as a separate field of study blending engineering, 
quality control, and statistics. Further developments by Shewhart created the basis for his 
1931 book Economic Control of Quality of Manufactured Product. Deming and Juran 
became interested in Shewhart’s work and promoted the use of SPC, in particular 
Shewhart’s Plan-Do-Check-Act cycle. 
SPC initially focussed on univariate analysis. However univariate analyses do not allow 
interactions between variables to be easily identified or tested, as observed in Figure 1 
where readings for a sample appear normal when considered in a univariate manner but 
is clearly unusual when considered in a multivariate manner. Identification of such 
multivariable interactions and evaluation of the impact of those interactions can be used 
to improve process robustness [2], efficiency [3], and safety [4]. The tools of SPC have 
expanded to include a wide array of multivariate techniques, including decision trees [5], 
principal component analysis (PCA) [6,7], partial least squares (PLS) [6,7], artificial 
neural networks [8,9], self-organising maps [10,11], structural equation modelling [12], 
and even multivariate adaptations of Shewhart’s original control charts among others. 
Multivariate data analysis (MVDA) techniques had been suggested before Shewhart’s 
work, however the computational power necessary to complete the associated equations 
limited their use when relying on manual computation. As greater computational power 
became available through the development of computers, ever more intensive 
multivariate techniques could be applied to ever larger datasets. In recent years, the speed 
at which analyses can be completed has started to become less of an obstacle than the 
volume, quality, and diversity of data able to be brought together from analysis. 
The variety of data sources and MVDA techniques available for process understanding is 
matched by the range of industries they have been used in and aims achieved. A multiple 
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case study review by Miletic et al. [13] captured four adaptations of PCA and PLS 
algorithms in various degrees of complexity in execution.  The simplest was the use of 
PCA-based control charts to identify when a specific type of fault was about to occur for 
a continuous slab caster, resulting in a 50% reduction of faults over a 6 year period for 
one caster, a reduction of 4 faults for a second caster, and increased operator confidence 
at higher levels of production. This methodology was adapted for a second area of 
operation to track batch evolution of a sulphite pulp digester in real-time. 
More complex methodologies were required in two further examples. An adaptive 
PLS-based automatic control system for the control of chemical reagents in a 
desulphurisation process for a liquid metal required extensive supervision during tuning 
and initial operating period. Investment into this more sophisticated control system 
yielded a 50% reduction in the root mean square error of sulphur content of the final 
output. Additional benefits were reductions in reagent use, most notably a 70% reduction 
in the addition rate for a second reagent and a 25.5% reduction in purchased reagent 
quantities. 
 
Figure 1. Variable 1 and Variable 2 recorded for 25 samples. The highlighted sample appears to 
show normal behaviour when Variable 1 and Variable 2 were viewed separately (A and B), 
however multivariate analysis (C) shows there is an unusual interaction for the highlighted 
sample. 
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The final example concerned a paperboard manufacturing process. The original aim was 
to identify process faults through the application of PCA, similar to the case studies 
detecting faults in continuous caster machines and desulphurisation processes. However, 
multiple grades of paperboard were manufactured using the same machinery, which 
caused severe confounding in the dataset. Due to the large number of paper grades 
produced, it was not economically feasible to create and maintain models for each grade 
of paperboard. Furthermore, this view would be strongly focussed on the final product 
and not the underlying process or machinery. Instead, a partial least squares-discriminant 
analysis (PLS-DA) model was used to identify differences in paper grades. The PLS-DA 
model residuals were then used to create a PCA model for fault detection, as was 
originally intended. The final result was a 60% reduction in processing variability. 
Beyond the academic novelty of re-purposing one model’s residual to create a second 
model, the final case study demonstrated a more holistic approach to process data analysis 
than is typically observed in more academically driven papers. Specifically, the cost of 
maintained use and appropriateness for the intended area of application (here, a flexible, 
multi-product manufacturing platform) is in direct contrast to the more traditional 
academic emphasis on a single, fixed analysis workflow developed for a specific use with 
at best a limited view towards adoption by industries. 
In each of Miletic et al.’s case studies [13], MVDA was applied retroactively to datasets 
and incorporated into pre-existing data flows. Ideally, multivariate statistics can be 
employed from the very start of development to plan a deliberate experimental design 
space. A commonly employed technique is Design of Experiments (DOE), outlined in 
Ronald A. Fisher’s 1935 book of the same name [14] or a derivative thereof. In DOE, a 
scientist selects multiple variables of interest to be tested multiple levels as a series of 
experiments designed to test multivariate interactions. This methodology can be used to 
create a Design Space for a process, e.g. a multidimensional/multivariate combination of 
input variables and process parameters for which quality is assured through product and 
process understanding [15]. 
SPC and MVDA grew to become fundamental tools in a variety of manufacturing 
industries during the 20th century, at the time they were relatively unused by the 
bioprocessing industries, in particular the biopharmaceutical and biologics industries. 
Biologics are a category of medical treatments and therapies derived from living 
organisms. The US Food and Drug Administration (FDA) uses the term biological 
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product, which is defined as “a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, 
blood component or derivative, allergenic product, or analogous product, or 
arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic 
compound), applicable to the prevention, treatment, or cure of a disease or condition of 
human beings.” [16] The European Medicines Agency (EMA) uses the term biological 
medicinal product, defined as “a medicinal product whose active substance is made by 
or derived from a living organism.” [17] 
According to a market survey published in 2014, there were 230 approved biologics on 
the market in 2012 with global sales of US$124.9 billion [18]. While a wide variety of 
products are allowed under the term “biologic”, the majority of biologics are recombinant 
proteins and monoclonal antibodies (Figure 2) with approximately 50% of sales 
attributable to 10 block buster drugs (Figure 3). 
The use of established cell lines allows biologics production processes to benefit from the 
use of platform processes and platform technologies. A platform can be defined as “a set 
of stable components that supports variety and evolvability in a system by constraining 
the linkages among the other components.” [19]. A definition more specific to 
biopharmaceutical manufacturing platforms is “[t]he approach of developing a 
production strategy for a new drug starting from manufacturing processes similar to 
those used by the same applicant to manufacture other drugs of the same type (e.g., as in 
the production of monoclonal antibodies using predefined host cell, cell culture, and 
purification processes, for which there already exists considerable experience)” [15]. 
The use of process platforms allow a contract manufacturing organisation (CMO) to 
benefit from a wide variety of savings both within the company itself and through 
interactions with other companies, e.g. reductions in development times or improved 
resource use efficiencies [20]. Within the company, the use of platform process allow for 
improved efficiency in scale-up of projects and site-transfer/technology transfer of 
projects. These improved efficiencies can also be achieved when transferring a 
technology or product with other, external companies. 
In biologics, two commonly encountered platforms are expression platforms (host cell 
line and expression system) and process platforms (including culture operating conditions 
and feed strategies). 
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Figure 2. Distribution of 230 approved biologics by compound class [18]. Monoclonal antibodies 
make up 21% with other recombinant products making up a further 13% of approvals. 
 
 
Figure 3. Top ten biologics which represent approximately 50% of all global sales of biologics in 
2012 [18]. Six were produced using a CHO cell line, three using an E. coli cell line, and one using 
a hybrid/murine cell line. 
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In a typical protein or monoclonal antibody (mAb) production process, the genetic code 
for the product of interest is inserted into the DNA of a host cell. The cell then produces 
the protein as part of its normal metabolism. Although mammalian cell lines have been a 
part of biopharmaceutical development since the 1900s [21], wide spread usage of 
mammalian cell lines in protein or mAb production was limited by numerous obstacles 
and perceived obstacles, from shear sensitivity of mammalian cells in suspensions [22] 
or complex media requirements [23,24]. Instead, large scale processes for much of the 
20th century were reliant on non-mammalian cell lines [25]. 
The first human recombinant protein licensed was the recombinant insulin Humulin 
(Genentech) in 1982, produced using the bacteria Escherica coli. E. coli was and 
continues to be widely used as E. coli typically grows quickly and robustly in large-scale 
manufacture [26,27]. However despite greater robustness and lower costs when compared 
to mammalian cell lines, fundamental drawbacks regarding product safety and efficacy 
can exist when using bacterial hosts. 
Host cell lines perform post-translational modifications to the expressed protein or mAb, 
and this affects which host cell line can be safely used. A key example is glycosylation, 
the process by which oligosaccharides are attached to asparagine (N-linked), serine (O-
linked), and threonine (O-linked) side chains [28]. Oligosaccharides are often essential 
for recognition of the protein by the patient’s immune system. Post-translational 
modifications or lack thereof can cause a variety of undesired outcomes from decreased 
efficacy [28–30] to side effects caused by patient immune systems attacking a drug as an 
infection [31–35]. For these reasons, the ability to glycosylate proteins in a manner similar 
to glycosylation by human cells can lead a manufacturer to select a mammalian cell line, 
which do glycosylate proteins, over a bacterial cell line, which do not glycosylate 
proteins. 
Two commonly used mammalian cell lines are Chinese hamster ovary (CHO) and murine 
myeloma. Of the top ten biologics in 2012, representing approximately 50% of all global 
sales of biologics for that year, six were produced using a CHO cell line and one was 
produced using a hybrid/murine cell line. [18]. In terms of new drug approvals, CHO and 
murine myeloma accounted for 31% and 11% of approved biologics in 2012 respectively 
[18]. Additional mammalian cells used include human, hybridomas, and baby hamster 
kidney (BHK) (Figure 4). Research continues be conducted to identify, isolate, and 
evaluate mammalian cell lines able to express protein and mAb products with 
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economically viable titres and with appropriate post-translational modifications as 
differences in glycoforms produced by a mammalian host cell and those produced by 
human cells can still lead to undesirable side effects. The murine-derived cetiumab 
(Erbitux®) was shown to trigger anaphylaxis in a subset of patients with pre-existing 
antibodies that attacked a sugar residue seen on products derived from CHO and murine 
hosts which is absent from post-translational modifications by human cells [36].  
Of note are studies that demonstrated that several of the issues which had prevented 
wide-spread use of mammalian cell lines were simply perceived issues. In particular 
several studies stating that mammalian cell lines can survive the shear forces encountered 
in suspension cultures [37–39] stand in stark contrast to older studies [40,41] that 
indicated mammalian cells were not suited to suspension cultures. 
When the genetic information for a mAb is introduced to the host cell, the vector typically 
contains additional genetic information. This additional information may serve to 
promote growth of transfected cells or to improve stable integration of the new genetic 
information into the host cell genome. 
 
 
Figure 4. Distribution of host cells used in industrial biologics based on number of licensed 
biologics using cell line until 2012 [18].  
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A common addition to transfected vectors are genes that add some new metabolic activity, 
such as the ability to synthesise some metabolite A which is crucial to cell survival but 
would normally need to be made available in culture media. These genes allow for 
selective survival of cells based on whether the gene vector was successful transfected 
and integrated into the cell’s DNA. Continuing the previous example, only successfully 
transfected cells would be able to survive in media deficient in metabolite A, assuming 
the cells were provided with the necessary precursors. 
This complexity of interactions from the very beginning of the biologics manufacturing 
system, from drug discovery to cell line and selection system choice to expression, 
isolation, formulation, and storage through to the interaction of final drug with the patient 
makes biologics manufacturing an ideal industry for improvements through MVDA. 
Decision trees have been used to select local optimum operating conditions for cultures 
from tested conditions [42] and combined with the PLS algorithm for use in control 
decisions for cultures [43]. PCA has been used to monitor batch performances, to “finger 
print” media using spectral datasets, and identify genes of interest [44–46]. The field of 
chemometrics in particular has readily adopted MVDA to develop “electronic noses” for 
the detection, classification, and measurement of multiple chemicals by sensors [47]. 
Drivers for manufacturers to adopt MVDA range from improved safety of the end 
product, reductions in manufacturing costs, and reduced time to market. Reduced time to 
market may be achieved through techniques such as DOE decreasing development times. 
However following the release of the Process Analytical Technology (PAT) Initiative by 
the US Food and Drug Administration (FDA) in 2004 [48], time to market may also be 
reduced by using PAT to support submissions to regulators. Two PAT-supported 
biologics approved through the FDA’s expedited process for breakthrough therapies were 
Genentech’s Gazyva™ (obinutuzumab) [49] and Genentech’s Perjeta™ (pertuzamab) 
[50]. 
The FDA’s PAT Initiative guidelines were intended as a way for industry to meet three 
aims [48]: 
1. Improve the scientific basis for establishing regulatory specifications. 
2. Promote continuous improvement. 
3. Improve manufacturing while maintaining or improving current product quality. 
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The main concept behind PAT was that “quality cannot be tested into products; it should 
be built-in or should be by design.” [48] Three key areas are covered by the PAT 
framework: process understanding, analytical principles and tools, and strategies for 
implementation. As a flexible framework, PAT permits the use of many different tools 
and technologies to be used, from the introduction of brand new equipment such as 
spectral readers to the re-examination of existing historical databases with multivariate 
data analysis to knowledge management systems. 
While the PAT Initiative is often spoken in terms of FDA documentation, the PAT 
Initiative is supported by many regulatory bodies around the world, including the 
European Medical Authority (EMA) and the Japanese Pharmaceuticals and Medical 
Devices Agency (PDMA). As part of global harmonisation efforts, the FDA, the EMA, 
and the PDMA co-operated as the International Conference on Harmonization of 
Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) to 
create joint guidance with the aim "[t]o promote a mutual understanding of regional 
harmonisation initiatives in order to facilitate the harmonisation process related to ICH 
Guidelines regionally and globally, and to facilitate the capacity of drug regulatory 
authorities and industry to utilise them" [51]. Three ICH documents particularly relevant 
to the presented work are ICH Q8 “Pharmaceutical Development”, ICH Q9 “Quality Risk 
Management”, and ICH Q10 “Pharmaceutical Quality System” [52]. 
In addition to PAT usage guidelines, these documents include guidance on the use of 
Quality by Design (QbD), a systematic approach to product/process development, 
including life-cycle management [53], and the use of Design Spaces to support regulatory 
decisions. Variation within the Design Space and related effects on the product quality 
are considered to be understood, whereas variation outwith the Design Space is 
considered a change requiring additional regulatory approval and could lead to 
destruction of the product. As an example, a process design space is created and tested 
for a pH range of 6.5 to 7.5 and temperature range 30°C to 35°C with the desired process 
conditions pH 7.0 and 32.5°C as the centre point. The process conditions pH 6.8 and 31°C 
are within that design space and the effects of this change considered understood with 
appropriate actions for based on these effects. However the process conditions pH 6.4 and 
29°C are outwith the design and effects of this change on the product are untested and not 
considered understood. 
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Guidance from regulatory bodies can also be seen as an attempt to avoid repeating the 
failures to introduce MVDA and SPC experienced by other industries. When techniques 
such as Kaizan and Lean Design were first introduced to American manufacturing 
industries, in particular American automotive manufacturing, they were rarely as 
successful as hoped [54]. The poor results were often attributed to poor implementation 
due lack of understanding and appreciation for the tools. When the biopharmaceutical 
industry as a whole began implementing PAT tools and technologies in the 1990s and 
early 2000s, it was with awareness of known obstacles. Several such obstacles highlighted 
by Miletic et al. [13] are: 
 Poor acceptance by shop-floor personnel 
 Lack of know-how in model implementation, maintenance, or interpretation 
 Difficulties developing and tuning monitoring systems for full operating range 
 Handling process drifts and changes to processes over time 
 Lack of provision for on-going operation and system maintenance 
 
In addition to these obstacles, the biopharmaceutical industry faces challenges from the 
complexity of the data generated by the biologics manufacturing process [55,56]. 
However the continuing development of data collection equipment such as the electronic 
noses and the MVDA techniques required to interrogate these datasets continue to provide 
new opportunities to enhance process understanding. It was with these barriers in mind 
that the contents for the statistical toolbox representing a core outcome of the presented 
work were selected and developed for use by the mammalian cell culture research and 
development department of the biopharmaceutical contract manufacturer, Lonza.1 It is 
intended that the toolbox be directly utilised, adapted for use, or act as a foundation for 
the development of a new toolbox by other departments, sites, and industries. 
The toolbox included outcomes from several sub-projects that focussed on different 
questions posed by the host company and explore different aspects of MVDA highlighted 
in this introduction. Each chapter is prefaced with more detailed information on the 
relevant areas of investigation to better contextualise the research and conclusions. 
                                                 
1 An outline of the final toolbox and contained tools and guidelines can be found in §7.5. 
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 Materials and Methods 
Three datasets form the foundation of the research discussed within the thesis. Each 
dataset was formed from a different combination of host cell lines and expression systems 
to produce a variety of protein products (Table 1). This chapter is broken down into four 
sections detailing the materials and methods used to generate the data: 
1. Development and selection of mAb-producing cell lines 
2. Overview of platform processes at Lonza 
3. Description of data collected 
4. Description of data collection methods 
Dataset Host Cell and 
Expression System 
Number of 
Cultures 
Note Identifier 
1 DHFR-CHO 48 Single product Culture ID 
2 GS-NS0 99 Single product AXXX 
3 GS-CHO 185 Multiple products Pro_XXX_XXX 
Table 1. Summary of three datasets used in the course of EngD research. DHFR – dihydrofolate 
reductase deficient. GS – glutamaine synthetase. CHO – Chinese hamster ovary. NS0 – 
non-secreting murine myeloma. 
2.1 mAb-Producing Cell Lines 
Three different cell types were used in the work presented in this thesis: DHFR-CHO, 
GS-CHO, and GS-NS0. These were developed using two selection systems 
(dihydrofolate reductase (DHFR) and glutamine synthetase (GS))and two base host cell 
lines (Chinese hamster ovary (CHO) and non-secreting murine myeloma (NS0)). 
2.1.1 Selection Systems 
Glutamine synthetase (GS) is an enzyme required for the synthesis of the amino acid 
glutamine from glutamate and ammonia [57,58]. If the host cell lacks endogenous GS 
activity, successful transfection with a vector containing the GS enzyme allows the host 
cell to survive through exogenous GS activity in a glutamine-deficient media where 
glutamate and ammonia are available [59]. Culturing in glutamine-deficient media allows 
successfully transfected cells to be isolated because cells not successfully transfected 
would not survive. For cells possessing endogenous GS metabolism, selection pressure 
can be applied through the addition of methionine sulphoxine (MSX) which inhibits GS 
metabolism [60,61]. The GS cell lines in the presented research used Lonza’s GS gene 
expression system, which includes the genetic sequences for the selectable marker (Patent 
W087/04462) and the associated hCMV promoter (Patent W089/011036). 
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A second commonly used selection expression system is based on the enzyme 
dihydrofolate reductase (DHFR). DHFR catalyses the conversion of folic acid to 
tetrahydrofolate, which is required to produce glycine, purines, and thymidylic acid for 
cell growth and proliferation [62]. According to Racher and Birch [59], the main role of 
the DHFR gene is to improve vector amplification when culturing cells in a folic 
acid-deficient media. Selection pressure can be applied during amplification by inhibiting 
endogenous DHFR activity through the addition of the folate analogue methotrexate 
(MTX) [63]. 
2.1.2 Host Cell Lines 
Mammalian cell lines are generally the preferred host cell for monoclonal antibody 
production. This is due to a variety of post-translational modifications mammalian cells 
perform, in particular the glycosylation of proteins. The glycosylation profile of a protein 
plays a role in protein recognition by a patient’s immune system, which in turn can affect 
drug efficacy and the likelihood of side effects [28,64–69]. 
Two industrially important mammalian cell lines are non-secreting murine myeloma 
(NS0) and Chinese hamster ovary (CHO) [70,71]. The NS0 cell line is a non-glutamine 
secreting subclone of the murine myeloma cell line, NS-1, which was isolated and 
identified in 1976 [72,73]. In industry, CHO typically refers to one of several cell lines 
derived from a single clone isolated in 1957 by Dr. Theodore T. Puck [74]. Three 
derivatives frequently encountered in industry are: DUXB11, DG44, CHOK1SV [75]. 
The DUXB11 and DG44 cell lines are DHFR-deficient cell lines developed by Columbia 
University [76]. The CHOK1SV cell line was developed by Lonza [59]. 
DHFR deficiency in CHO cell lines occurs due to either mutation or deletion of the dhfr 
alleles. Unlike the GS expression system, the competitive inhibitor MTX is required 
during cell line selection to isolate successfully transfected cells. 
Both CHOK1SV and NS0 cell lines can be cultured using the GS system [77–79]. In the 
case of CHOK1SV, this is due to the natural GS activity of the CHO cells being greatly 
reduced through gene silencing and the use of the GS inhibitor MSX to improve selection 
[80,81]. The NS0 cell line lacks endogenous GS activity and therefore does not require 
MSX selection [82,83]. However MSX may be used during GS-NS0 cell line selection as 
increased levels of MSX have been associated with increased GS gene copy number in 
GS-NS0 [77]. A 1985 study by Bebbington and Hentschel found that “[t]he amount of 
protein product of transfected genes is often found to be roughly proportional to the 
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number of functional copies of the gene present” [84]. There is some debate as to whether 
this is true only in specific cases as studies have been published both supporting [85] and 
discrediting [80] this theory. MSX is not used in GS-NS0 selection at Lonza unless 
specified by the client. 
2.2 Platform Processes and Technologies 
Three GS-CHO platform processes were offered by Lonza. In each platform process, 
operating conditions for temperature control, pH control, dissolved oxygen tension 
(DOT) control, gassing strategies, feed strategies, and medium compositions are specific 
to the platform version. When comparing GS platform versions 6, 7, and 8 (Table 2), it 
can be seen with increasing version number that platform developments have led to 
nutrient feeds and operating conditions more tailored to culture performance. Key 
developments are the increasing use of variable feed rates (rates based on some measure 
of biological performance, e.g. cell mass) and the use of a planned change in pH setpoint 
at a defined point during a culture in Version 8. If no platform process meets evaluation 
requirements (e.g. low return on investment), a bespoke process may be developed. 
 
Parameter Version 6 Version 7 Version 8 
pH Setpoint Constant Constant Planned change 
pH Control Boundary Wide Narrow Narrow 
DOT 15% 40% 40% 
Medium CM42 
CD-CHO* 
CM54 
CD-CHO* 
CM76 
Proprietary 
Nutrient Feeds SF40 
FCR, FV 
(4 to 5 days) 
SF50 
CF, VR 
FCD 
SF76 
CF, VR 
FCD 
SF41 
CF, VR 
Glucose 
CF, VR 
FCD 
Glucose 
CF, VR 
FCD 
Nutrient Feed Bolus 
Additions 
N/A SF52, SF53, SF54 
Days 5, 8, 11 
SF71, SF72, SF54 
Days 3, 5, 8, 10 
Table 2. Lonza platform processes for GS expression system [86]. *Invitrogen owned. CF – 
Continuous Feed. VR – Variable Rate. FCR – Fixed Continuous Rate. FCD – Full culture 
duration. CR –Continuous Rate. FV – Fixed Volume. BA – Bolus addition  
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Bioreactor design and scales must also be selected in addition to operating conditions. 
The two bioreactors designs offered at Lonza were continuous stirred tank reactors 
(CSTR) and airlift reactors (ALR). Both CSTR and ALR designs have established use in 
biopharmaceutical manufacturing. The primary difference between CSTR and ALR 
designs is how the bioreactor culture is agitated and gassing introduced. In an ALR, a 
vertical baffle divides the interior space with space at the top and bottom to allow 
continuous circulation of the culture. Gases are introduced on one side of the baffle and 
drive both culture circulation and the distribution of gases and nutrients throughout the 
culture. An important point in ALR operation is ensuring the culture volume adequately 
clears the baffle top and bottom to allow thorough mixing. A second important point in 
ALR operation is ensuring the gassing strategy provides an appropriate physical force for 
circulation throughout the culture duration. In a CSTR, agitation is driven by an impeller 
in the bioreactor. The impeller is driven by an external motor and hence agitation strategy 
can be designed independent of gassing strategy. 
The bioreactor scales offered at Lonza considered in the presented research are 10L, 
130L, 2000L, and 5000L. The scale used for a culture reflects the development stage of 
a project. The 10L scale bioreactors were used for research and development activities 
following Good Laboratory Practice (GLP), such as evaluating adaptation of a cell line 
to process platforms or experiments to test the effects of potential deviations. The 130L 
scale bioreactor, also referred to as “pilot scale”, was used to evaluate non-experimental 
culture performance at a larger scale using Good Manufacturing Practice (GMP). The 
2000L and 5000L scale bioreactors were used for full scale production using GMP 
procedures. 
During research and development activities, a cell line might be cultured in both CSTR 
and ALR to determine which provided a more suitable environment for growth or to 
evaluate the effects of using a different design from what had been previously used, e.g. 
Client A wishes to transfer from a CSTR process to an ALR process. Above the 10L 
scale, all higher scales used the design selected at the 10L scale.  
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2.3 Data Collected 
The development of new process platforms is dependent on identifying areas for 
improvement, such as favouring a particular metabolism pathway through altering culture 
temperature. As it is not feasible to monitor all possible variables, online monitoring and 
offline daily monitoring of cultures centred on a core set of variables (briefly outlined in 
Figure 5). The biological relevancy of the core set of variables are described here. Due to 
the variety of methods in which these variables were monitored, variable monitoring 
methods are described in §2.4. 
 
 
Figure 5. A simplified view of the variables monitored through online and offline measurements. 
The sequence of Radiometer PHM220 to Additional Assays shows the typical process a culture 
sample underwent. The biological significance of these variables are described in §2.3. Variable 
measurement methods are described in §2.4.  
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2.3.1 Temperature 
For mammalian cells, the effects of deviation from normal physiological temperature of 
36.5°C are dependent on the magnitude and direction of the deviation, in addition to other 
environmental conditions. For a DHFR-CHO cell-line producing a humanised mAb, a 
temperature shift from 37°C to 31°C at pH 6.8 during the stationary phase of the culture 
gave a 2.3-fold increase in mAb concentration [87]. Similarly, a shift from 37°C to 32°C 
during the stationary phase resulted in a 3-fold increase in the production of a recombinant 
IgG4 mAb by a GS-CHO cell line [88]. 
It is important to note that these effects do not hold true for all cell lines or products as 
shown through two studies by one research group. In the first study, CHO-DHFR- 
producing erythropoietin (EPO) cultured at 33°C showed a 4-fold increase in productivity 
when compared to a 37°C culture [89]. When the same cell line and CMV promoter were 
used to produce anti-4-1BB antibody, low culture temperatures did not result in enhanced 
productivity [90]. Through these two studies, the research group demonstrated that the 
degree of enhanced productivity from lower temperatures (if any) was affected by the 
product itself or the integration site of the vector. 
2.3.2 pH 
Culture pH affects cell growth [91–94], metabolism [95], product quality [96], and 
production rates [97]. Due to the ability of pH to affect biochemical characteristics [87], 
deliberate changes in the pH operating setpoint may be made as part of an experimental 
study or as part of the standard operating platform [98]. 
The behaviour of the cell culture itself can affect pH levels as accumulation of metabolites 
such as lactate can alter culture pH. Furthermore, effects from changes in pH can interfere 
with effects from other variables [87]. As noted above, in one study changing the setpoint 
of a bioreactor from 37°C to 31°C during the stationary phase of the culture resulted in a 
2.3-fold increase in mAb concentration for a CHO-DHFR- cell line [87]. This increase 
was observed at a pH of 6.8 but did not occur at a pH of 7.0. 
2.3.3 Dissolved Oxygen Tension 
Mammalian cell lines, such as CHO and NS0, are aerobic and require oxygen to survive 
[25,41]. While the exact effects of dissolved oxygen tension (DOT) depends on the cell 
line in question [64], it is known that hypoxia can affect growth rate [99–101], 
metabolism [102], and glycosylation of the mAb product [64,99]. Additionally, there is 
evidence that oscillating DOT levels can also affect product glycosylation without 
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obviously affecting growth [103]. By affecting glycosylation patterns, particularly 
without notably affecting growth, control of DOT can pose a major concern to 
biopharmaceutical producers. 
Studies suggest that hyperoxia is better tolerated than hypoxia in certain aspects of 
metabolism [99,104]. However DOT setpoints used at Lonza are typically in the range of 
15% to 40%. These levels are low enough that hyperoxia conditions would likely only 
occur in the event of equipment failure, e.g. a DOT probe giving a false reading. 
2.3.4 Glucose 
Glucose is an important nutrient for mammalian cell metabolism [105–107]. Insufficient 
glucose levels can result in decreased rate of growth [107–109], decreased specific rate 
of productivity [108], and incorrect glycosylation of products [110]. Glucose depletion 
may also cause cell metabolism to shift from lactate production to lactate consumption 
[102]. 
2.3.5 Lactate 
Mammalian cells are known to produce lactate as a part of normal metabolism and in 
response to stress conditions [107,111–113]. Accumulation of lactate may in turn affect 
culture performance, e.g. growth [114] or expression levels [109]. Normal lactate 
metabolism may also be affected when expressing the product of interest. Effects 
including altered lactate consumption [115–117] or increased lactate expression 
[118,119]. 
2.3.6 Glutamine, Glutamate, and NH4+ 
Glutamine is an amino acid which serves a wide variety of functions in cells [77]. These 
include, among others, roles in the synthesis of proteins, pyrimidines, and purines, 
degradation of amino acids, acting as a nitrogen source, and the ability to function as a 
source of carbon and energy [77]. In the absence of glutamine, glutamine can be 
synthesised by the enzyme glutamine synthetase (GS) using glutamate and NH4
+ present 
in the culture medium. 
As stated previously, NS0 cells exhibit very low levels of endogenous GS activity, hence 
exogenous GS activity can be used to identify successfully transfected cells in a 
glutamine-free medium during cell line construction [58,61,85]. As CHO cells exhibit a 
degree of endogenous GS activity, MSX or a similarly competitive inhibitor is used to 
apply selection pressure during cell line construction and isolation [61,120,121]. 
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In addition to acting as substrates for GS, glutamate and NH4
+ serve other functions in 
cell metabolism. Glutamate can be consumed in the synthesis of the Kreb’s cycle 
intermediary compound α-ketoglutarate [122]. NH4+ has been shown to effect protein 
glycosylation patterns [123]. 
2.3.7 Na+ and K+ 
Cell metabolism produces acid equivalents as a by-product, accumulation of which leads 
to acidification of the cytosol [124]. To maintain an appropriate physiological 
intracellular pH, these acid equivalents are transported through the cell membrane by the 
transmembrane enzyme sodium-potassium adenosine triphosphatase (Na+/K+-ATPase) in 
exchange for Na+ ions. 
Na+ and K+ uptake and release by cells is also driven by the activity of Na+/K+-ATPase 
during regulation of intracellular osmotic pressure, cell volume, and signal transduction. 
Na+/K+-ATPase activity is related to cell life cycle stages, in particular the transition 
between the G1 growth phase and the S senescence phase [125]. 
2.3.8 pO2 
Oxygen is an essential input for aerobic metabolism. The partial pressure of oxygen in in 
solution in the culture medium (pO2) is a measure of oxygen in the culture medium 
available for use by cells. It is monitored for the same reasons given for monitoring of 
DOT. 
2.3.9 pCO2 
CO2 is a by-product of several cell metabolism pathways for the production of compounds 
such as pyrimidines, purines, and fatty acids [96,126,127]. pCO2 is the partial pressure of 
dissolved CO2 gas in culture medium. Accumulation of CO2 gas in the culture medium 
causes increased pCO2 levels which can have a range of effects on protein-producing 
mammalian cell cultures depending on product and cell type. These include inhibition of 
cell growth [114], decreased rates of glucose consumption [126], decreased rates of 
lactate production [126], and altered glycosylation [96,128,129]. 
Increased accumulation of CO2 in culture medium is often observed during scale-up of 
bioreactors and may be caused by insufficient stripping of CO2 from the culture (e.g. by 
nitrogen), poor culture mixing, or as a side-effect of controller action if sparging with 
CO2 gas is used as part of pH control [126]. In particular, build-up of CO2 at a constant 
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pH is associated with increased osmolality and subsequent knock-on effects such as 
increased intracellular pH and increased Na+/K+-ATPase activity [127]. 
2.3.10 Culture Osmolality 
Osmolality is the concentration of solutes in a sample measured in osmoles of solute per 
kilogram (Osm/kg) of solvent [130]. This provides information on how much material is 
in a sample, however it does not identify or specify quantities of individual components 
present in the sample. The indiscriminate nature of osmolality, its impact on statistical 
analyses, and a proposed solution are further addressed in Chapter 4. 
The osmolality of a culture can effect a culture in many way including effects on cell 
growth rate [114,131], specific productivity [131], product quality, e.g. affecting product 
glycoform [128] or polysialylisation [96], and cell mechanical properties such as bursting 
force and cell diameter [132]. The extent of these effects vary with cell type and product, 
e.g. greater inhibition of cell growth from elevated osmolality has been observed in 
hybridomas than in CHO cells grown in the same medium [91,113,126,127] and product 
glycoforms may be robust to changes in osmolality, as in the case of CHO-derived tissue 
plasminogen activator [133]. 
Culture osmolality can be altered by a wide range of causes. For example, increased pCO2 
levels can result in increased osmolality [134] as can accumulation of products or 
by-products in the culture medium. 
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2.4 Data Collection Methods 
A wide variety of data are collected when a bioreactor culture is performed. Data can be 
subdivided into three general classes based on origin and data type: meta-data, online 
monitoring data, and daily monitoring data. Four types of probe were used during the 
online monitoring and daily monitoring data collection: resistance temperature detector, 
potentiometric, amperometric, enzyme-immobilised amperometric. 
A resistance temperature detector (RTD) is based on the resistance of a metal element as 
a function of temperature for a given operating range [135]. The metal element is held by 
a glass or ceramic core, and the full assembly is sheathed in a protective housing that 
allows it to be safely inserted into a reactor or bioreactor. Platinum is the most commonly 
used metal due to its high accuracy and resistance to corrosion with the platinum-coiled 
Pt100 probe design found across many industries [136]. 
Potentiometric probes are ion selective probes, where the ion of interest (typically 
hydrogen) is sensed by a probe membrane [137]. This results in a change in the membrane 
potential from which the ion concentration can be determined using the Nernst Equation 
(Eq. 2.1). 
𝐸 = 𝐸𝑜 + 2.303 (
𝑅𝑇
𝑛𝐹
) log 𝑎𝑜 Eq. 2.1 
where 𝐸 is the total potential developed between sensing and reference electrodes (mV), 
𝐸𝑜 is the standard potential of the electrode (mV), 𝑅 is the Universal Gas Constant, 
(8.314 J K−1 mol−1), 𝑇 is the temperature (K), 𝑛 is the moles of ion in the sample, 𝐹 is the 
Faraday constant, and 𝑎𝑜 is the activity of the ion in solution. 
In an amperometric probe, a permeable membrane covers the electrode, allowing the ion 
of interest to pass through the membrane. The ions initiate some reaction that produces 
an electrical current from which the ion concentration can be determined. For example, 
oxygen ions initiate an oxidation-reduction reaction [138]. 
For an amperometric probe with an enzyme immobilised membrane, the immobilised 
enzymes produce measureable by-products in the presence of the substrate of interest and 
any other necessary reagents. For example, conversion of the substrate in the presence of 
oxygen may produce hydrogen peroxide (H2O2) [138]. H2O2 is then oxidised at the anode 
resulting in a change in current charge proportional to the concentration of the substrate 
of interest in the sample. 
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2.4.1 Meta-Data Collection 
Meta-data is a term capturing a wide variety of data and data sources, such as project 
name, culture identifier, media batch numbers, bioreactor station identifier, 
operator/scientist, and version numbers for spreadsheet calculators for feedrates. 
Effective utilisation of meta-data is a challenge due to both the scale of the meta-data 
available in biopharmaceutical process and the manner in which it is captured, i.e. 
predominantly written records or print outs [139]. Even if preserved electronically by 
scanning, the resulting files are often difficult to search as an information databased. 
2.4.2 Online Monitoring Control and Data Collection 
At the 10L scale, online monitoring was achieved by the use of probes inserted into the 
bioreactor and flowrate meters on gas lines into the bioreactor. These probes were 
connected to an Applikon i-Control unit (Applikon Biotechnology, UK). The unit 
recorded values at a five minute intervals. Nutrient feeds were not controlled using this 
system. Instead nutrient feeds were controlled manually using peristaltic pumps and 
electronic balances. Hence nutrient feeds were treated as part of daily monitoring 
activities. 
At larger scales, one probe was used for control with two additional probes connected for 
monitoring. This allowed two-against-one arguments to be used to identify faulty probes, 
in addition to providing redundancy in the event of the control probe failing. Multi-probe 
arrangements could also be used to monitor and identify gradients within the bioreactor 
as replicate probes were located in different positions in the bioreactor, e.g. top, middle, 
and base levels. 
During a bioreactor culture, the signals and readings informing the controller are sampled 
at a set interval, e.g. 5 minutes. The bioreactor’s online monitoring record can be exported 
to .csv files whenever desired, e.g. during a culture or after harvesting. 
2.4.2.1 pH 
Online monitoring and control of pH was achieved through the use of a Mettler-Toledo 
405-DPAS-SC-K8S/425 potentiometric pH probe (Mettler-Toledo, UK). If the recorded 
value was outside an operating deadband (e.g. ±0.02), automatic corrective action was 
taken by the control system through CO2 addition or base addition. 
pH measurements of samples collected during offline monitoring were compared to 
control system readings to identify and correct probe drift. If the discrepancy was > 0.02, 
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an offset was made to the online probe to bring online readings into agreement with the 
offline reading. If the discrepancy was ≤ 0.02, no adjustment was made. 
2.4.2.2 Temperature 
Culture temperature was measured using a Pt100 temperature probe with Lemo connector 
(Electrolab Biotech, UK). At the 10L scale, passive cooling was used with additional heat 
supplied by a thermal/heating pad jacket. At larger scales, heating and cooling 
requirements were met by circulating water through vessel jackets. 
Temperature measurements were made on daily offline samples, however these were not 
used to make external adjustments as part of daily monitoring. If bioreactor temperature 
or temperature control was question, an Almeno temperature probe was used to verify 
culture temperature and determine if corrective action was required. 
2.4.2.3 Dissolved Oxygen Tension 
Culture DOT was monitored using a P52201015 DOT probe (Mettler-Toledo, UK). DOT 
levels were controlled by increasing and decreasing air and oxygen gas flowrates. 
2.4.2.4 Carbon Dioxide, Air, and Oxygen Flowrates 
Carbon dioxide (CO2) gas is an acidic gas that was used to correct pH in cultures when 
pH measured > pH setpoint. 
CO2, air, and oxygen gas flowrates into bioreactors were controlled and monitored using 
flowrate meters. Gas flowrate and composition when exiting the bioreactor were not 
recorded. 
2.4.2.5 Level 
At the 10 L scale, bioreactor fill levels were monitored visually. Above the 10 L scale, 
bioreactor fill levels were monitored using level probes within the bioreactor. 
2.4.3 Daily Monitoring Data Collection 
As part of normal operation, cultures were sampled approximately every 24 hours. At the 
10L scale, samples underwent the sequence described below. At scales larger than 10L, 
a similar sequence was followed with some differences. This differences are noted as 
required. 
2.4.3.1 Bioreactor Conditions 
Bioreactor temperature, bioreactor pH, and bioreactor dissolved oxygen tension (DOT) 
at the time of daily sampling were recorded from the online control unit.  
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2.4.3.2 Radiometer PHM 220 
A Radiometer Analytical PHM220 meter with a Mettler-Toledo potentiometric pH probe 
was used to measure sample temperature and sample pH. The sample pH measurement 
would be compared to the bioreactor pH measurement to determine if the online probe 
required adjustment due to drift. 
2.4.3.3 NOVA Bioprofile 400 
A NOVA Bioprofile 400 was used to measure multiple variables, ranges and accuracies 
for which are presented in Table 3. A second offline pH measurement, referred to as the 
NOVA pH, was made with a potentiometric probe. Enzyme-immobilised membrane 
amperometric probes were used to measure sample concentrations of glucose, lactate, 
glutamine, and glutamate. Ion selective electrodes were used to measure sample 
concentrations of ammonium ions (NH4
+), potassium ions (K+), and sodium ions (Na+). 
Membrane amperometric electrodes were used to measure sample partial pressure of 
oxygen (pO2) and partial pressure of carbon dioxide (pCO2). 
 
 
 
Component Range Accuracy Probe Type 
pH 5.00 to 8.00 ± 0.01% Potentiometric 
Glucose 0.2 to 15.0 g/L ± 5.0% 
Enzyme-immobilised membrane 
amperometric 
Lactate 0.2 to 15.0 g/L ± 5.0% 
Glutamine 0.2 to 6.0 mmol/L ± 5.0% 
Glutamate 0.2 to 6.0 mmol/L ± 5.0% 
NH4+ 0.2 to 25.0 mmol/L ± 5.0% 
Ion selective electrode K+ 1.0 to 25.0 mmol/L ± 3.0% 
Na+ 40 to 220 mmol/L ± 1.5% 
pO2 0 to 800 mmHg ± 5.0% 
Membrane amperometric 
pCO2 3 to 200 mmHg ± 5.0% 
Table 3. Summary of daily monitoring offline sample pH, chemical concentrations, and partial 
pressures measured using a NOVA Bioprofile 400, including ranges, accuracies, and probe 
types [140].  
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2.4.3.4 Vi-CELL™ XR  
Trypan Blue permeates the membranes of non-viable cells but is excluded by the 
membranes of viable cells. When added to a sample, the dye stained only non-viable cells 
[141]. A Vi-CELL™ XR (Beckman Coulter) was used to count viable cell numbers and 
total cell numbers. From this, viable cell concentration (VCC, 106 cells/mL) and total cell 
concentration (TCC, 106 cells/mL) were determined. Viability was then calculated as the 
percentage ratio of viable and total cell counts. 
𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =  
𝑉𝑖𝑎𝑏𝑙𝑒 𝐶𝑒𝑙𝑙 𝐶𝑜𝑢𝑛𝑡
𝑇𝑜𝑡𝑎𝑙 𝐶𝑒𝑙𝑙 𝐶𝑜𝑢𝑛𝑡
 Eq. 2.2 
The integral of viable cell concentration of the sample was calculated as the area beneath 
the viable cell concentration profile with the units 106 cells.h/mL as shown in Figure 6). 
 
 
Figure 6. Viable cell concentration (VCC) for the culture Dataset α ProA_001. The pink 
rectangles and blue triangles indicate the areas used to calculate the integral of viable cell 
concentration (IVC) for a sample.  
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2.4.3.5 NOVA Bioprofile 400 and Osmomat Auto 
Two different methods were used to measure sample osmolality. Each osmolality 
measurement method was treated as producing a different variable. This allowed for 
greater traceability regarding data origin and identification of potential equipment biases 
or errors. 
The first measurement was made using a NOVA Bioprofile 400 using a component 
calculator. A component calculator is an equation estimating a sample’s osmolality based 
on known concentrations of sample components and those compounds’ effects on 
osmolality. The benefit of this method is that it does not typically require additional 
equipment, and it is technically possible to use a component calculator to generate 
osmolality values for an historical dataset. However it is important to note that component 
calculator values are not true osmolality measurements as the calculations can only take 
into account the effect of components that are directly monitored and does not take into 
account unmonitored components. 
The second osmolality measurement was based on freezing point osmometry (FPO) using 
an Osmomat Auto (Gonotec Gmbh, Germany). In FPO, the osmolality of a sample is 
determined by comparing the difference between the freezing point of the sample and the 
freezing point of water as the freezing point of a liquid is depressed when another 
compound is added. FPO is a rapid, inexpensive method appropriate for small sample 
sizes of low viscosity, non-colloidal solutions. For this reason, it is the preferred method 
for most biological applications [142], however an FPO osmolality measurement was not 
part of routine daily monitoring at scales larger than 10 L. 
2.4.3.6 Additional Assays 
Following the above sequence, daily monitoring samples were also submitted for more 
detailed protein assays and metabolite tests, which were not treated as part of the daily 
monitoring data set for the purposes of the presented research.  
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 Statistical Methods 
Multiple statistical tools are employed throughout this thesis. The techniques relevant to 
multiple chapters are presented here. Additional statistical background is presented where 
appropriate for the presented work. 
3.1 Multiple Linear Regression 
A simple form of regression is multivariate linear regression (MLR). Given the inputs 
(𝑥1, 𝑥2, …, 𝑥𝑘), a response (𝑦) can be modelled as: 
?̂? = ?̂?0 + ?̂?1𝑥1 + ?̂?2𝑥2 + ⋯+ ?̂?𝑛𝑥𝑘 Eq. 3.1 
where ŷ is the predicted response, ?̂?0 is a constant, 𝑘 is the number of independent 
variables, and ?̂?1 to ?̂?𝑘 are coefficients for the inputs 𝑥1 to 𝑥𝑘 respectively. The difference 
between a response predicted by a model (?̂?) and the actual measured response (𝑦) is 
termed a model error or residual (𝜀), e.g. for a sample 𝑖 
𝜀𝑖 = 𝑦𝑖 − ?̂?𝑖 Eq. 3.2 
The coefficients are calculated assuming that model residuals are normally distributed 
and the sum of errors minimised. Distribution of residuals can indicate if the model is 
being distorted by outliers or that behaviours in the response data are not captured in the 
developed model, .e.g. heteroscedasticity (skew) in the modelled dataset. 
Residuals can also be used to evaluate the extent to which a model can be generalised by 
using the predictive error sum of squares (PRESS) statistic. The model is fitted against 
every subset of observations excluding a sample 𝑖. Residuals for each subset are 
calculated (𝜀−𝑖), then squared (𝜀−𝑖
2 ). The PRESS statistic is then calculated as: 
𝑃𝑅𝐸𝑆𝑆 = 1 −
∑ 𝜀−𝑖
2𝑛
𝑖=1
∑ (𝑦𝑖 − ?̅?)2
𝑛
𝑖=1
 Eq. 3.3 
where ?̅? is the mean average of all responses. The PRESS statistic is analogous to the 
coefficient of determination of a model with a range of 0 to 1 with 1 indicating perfect 
predictive accuracy for the tested observations. 
3.2 Significance Testing 
The predictive ability of a MLR model may be negatively affected by over-
parameterisation, the inclusion of too many factors in a model. When a model is 
over-parameterised, highly correlated variables compete to convey similar information 
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and noisy variables can reduce model efficiency. Significance testing can be used to 
manage these issues by identifying statistically insignificant variables that can then be 
removed. A two-sided 𝑡 ratio (Eq. 3.4) is used to evaluate the variables in a MLR and is 
the ratio of the variable parameter estimate to the standard deviation of the variable: 
𝑡 = √
𝑅𝑎𝑑𝑗
2 (𝑛 − 𝑘 − 1)
1 − 𝑅𝑎𝑑𝑗
2  Eq. 3.4 
where 𝑛 is the number of samples, 𝑘 is the number of independent terms in the model, 
and 𝑅𝑎𝑑𝑗
2  is the adjusted Pearson’s coefficient of determination. From the 𝑡 score and a 
selected threshold value α (historically 0.05), a two-tailed p value for 𝑡 is calculated as: 
𝑝 = 2 ∗ P (𝑡 > 𝑡
(
𝛼
2,𝑛−𝑘−1)
) Eq. 3.5 
If p<α, then the variable is said to be statistically significant. If p>α, the variable is said 
to be statistically insignificant. The variable with the highest 𝑝 value above the chosen 
threshold, i.e. the least significant variable, is removed and a new model created. This is 
repeated until only statistically significant variables remain. 
Significance testing in this manner is a form of stepwise backward elimination (Table 4) 
as the procedure begins with the full set of variables and with each step, the least 
informative variable is removed [143]. An alternative approach is stepwise forward 
selection (Table 4), where the most informative variable is determined and with each step, 
the next most informative variable is added to the set [143]. Each technique can be time 
consuming, however stepwise backwards elimination is generally both easier to 
implement and inspires greater personal confidence in the resulting model. 
Stepwise Forward Selection Stepwise Backward Elimination 
Initial variable set: 
{} 
 {A1 } 
 {A1, A4} 
 {A1, A4, A6} 
Reduced variable set 
Initial variable set: 
{A1, A2, A3, A4, A5, A6} 
 {A1, A3, A4, A5, A6} 
 {A1, A4, A5, A6} 
 {A1, A4, A6} 
Reduced variable set 
Table 4. Comparison of stepwise forward selection and stepwise backward elimination for 
reduction of a variable set [143]. 
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3.3 Principal Component Analysis 
Principal component analysis (PCA) is a statistical dimensionality reduction tool suitable 
for use on a large dataset 𝑋 composed of n samples and p factors, which may contain 
highly correlated factors. PCA captures variation in the dataset by creating new variables 
termed principal components (PC); these are eigenvectors calculated from the covariance 
matrix of 𝑋 so that for a PCA model using k PCs: 
𝑋 = 𝑇PT + 𝐸 Eq. 3.6 
where 𝑋 is the original nxp data matrix, T the nxp scores matrix, PT the kxp loadings 
matrix, and E an nxp model residuals matrix [144]. 
Each PC is a new multilinear combination of the original variables and orthogonal, i.e. 
uncorrelated with other PCs. PCs capture variance in a cumulative manner, where the first 
PC captures the most variance in a single PC, the second PC the next most variance, and 
so on. Up to n or p PCs can be computed (whichever is smaller), however in practice the 
number of PCs retained in a model will usually be less than this. The number of PCs to 
be retained can be selected from a variety of ways. This may be a simple calculated 
threshold, e.g. a minimum cumulative variance is reached or the number of PCs giving 
the lowest root mean square error (RMSE) for a cross-validation set: 
RMSE = √
1
𝑛
∑ 𝜀𝑖
2
𝑛
𝑖=1
 Eq. 3.7 
When the loadings for PCs are plotted in two-dimensional space, correlated variables will 
cluster together. Negatively correlated variables will be at opposite points across the 
origin; variables with little or no correlation will be orthogonal. Similarly, when scores 
for samples are plotted in two-dimensional space, samples with similar behaviour will 
cluster together while samples with dissimilar behaviour will separate. 
PCA can be performed on both covariance and correlation matrices. Both matrix types 
are essentially the same, in that relationships between variables are evaluated for 
independence, however different models will be returned depending on which matrix is 
used. Covariance is an unbounded, unlimited value. When the covariance matrix of a 
dataset is used, variables with high covariance values are be prioritised over variables 
with low covariance during model creation due to differences in value magnitude. 
Correlation is standardised to the limits [-1.0, 1.0] and so the magnitude of the original 
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values is eliminated as a potential bias. For this reason, correlation matrices were used in 
the presented work. 
An extension of PCA is principal component regression (PCR). Here the scores generated 
in PCA are then regressed against a response Y. A weakness of PCR is that PCA is a 
technique for describing variance in the input dataset, which may have very little to do 
with variance in the response of interest. 
3.4 Partial Least Squares/Projection to Latent Structures 
In PCA, the purpose of the model was to capture variance in an X dataset without linking 
that behaviour to a response Y. While PCA is a valuable tool for dataset exploration, it is 
of limited use when a response of interest exists as the related technique, principal 
component regression (PCR), emphasises capture of the X dataset. 
Partial least squares or projection to latent structures (PLS) are the same iterative 
algorithm whereby variance in an X dataset is captured based on the ability to describe 
variance in a response dataset Y [145,146]. The Non-Linear Iterative Partial Least Squares 
(NIPALS) algorithm uses an outer regression between X and Y (Eq. 3.8) and inner 
regressions for the input dataset X (Eq. 3.9) and the response dataset Y (Eq. 3.10). 
𝑌 = 𝑋𝛽 + 𝜀 Eq. 3.8 
𝑋 = 𝑇 ∗ 𝑃′ + 𝐸 Eq. 3.9 
𝑌 = 𝑈 ∗ 𝑄′ + 𝐹 Eq. 3.10 
where 𝑇 and 𝑈 are score matrices, 𝑃′ and 𝑄′ are loadings matrices, and 𝐸 and 𝐹 are 
error/residuals matrices. This is shown in Figure 8 and the NIPALS algorithm is shown 
in Table 5. 
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Figure 7. Visual representation of PCA architecture. New variables termed principal components 
(PC) are created. These are multivariate linear combinations capturing variance in the original 
dataset. In the PCA model, each sample is now represented by a single score for each PC retained 
plus a multivariate residual, which captures variance not captured in the PCA model. Here two 
PC are retained, therefore each sample has a score for PC 1, a score for PC 2, and a residual. 
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Figure 8. Visual representation of PLSR architecture. For input dataset 𝑋 and response dataset 𝑌 
respectively, 𝑇 and 𝑈 are scores matrices, 𝑃′ and 𝑄′are loadings matrices, and 𝐸 and 𝐹 are 
error/residuals matrices.
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 𝑋 Regression   𝑌 Regression   Single Algorithm for Improved Inner Relationship 
1. Let 𝑡 = some 𝑥𝑗 1. Let 𝑢 = some 𝑦𝑗 1. Let 𝑢 = some 𝑦𝑗  
2. 
𝑝′ =
𝑡′𝑋
𝑡′𝑡
 
2. 
𝑞′ =
𝑢′𝑌
𝑢′𝑢
 
2. 
𝑝′ =
𝑢′𝑋
𝑢′𝑢
 𝑤′ =
𝑢′𝑋
𝑢′𝑢
 
3. Scale 
𝑝′ =
𝑝′
‖𝑝′‖
 
3. Scale 
𝑞′ =
𝑞′
‖𝑞′‖
 
3. Scale 
𝑝′ =
𝑝′
‖𝑝′‖
 
Scale 
𝑤′ =
𝑤′
‖𝑤′‖
 
4. 
𝑡 =
𝑋𝑝
𝑝′𝑝
 
4. 
𝑢 =
𝑌𝑞
𝑞′𝑞
 
4. 
𝑡 =
𝑋𝑝
𝑝′𝑝
 𝑡 =
𝑋𝑤
𝑤′𝑤
 
5. If Step 2 𝑝′ ≠ Step 4 𝑝′, return to Step 2. 
If Step 2 𝑝′ = Step 4 𝑝′, go to Step 6. 
5. If Step 2 𝑞′ ≠ Step 4 𝑞′, return to Step 2. 
If Step 2 𝑞′ = Step 4 𝑞′, go to Step 6. 
5. 
𝑞′ =
𝑡′𝑌
𝑡′𝑡
 
If 𝑌 has only one 
variable, then 
𝑞 = 1 in 
Step 5 to 7. 
6. Repeat Step 1 to 5 on residuals matrix 𝐸. 6. Repeat Step 1 to 5 on residuals matrix 𝐹∗. 6. Scale to unit length 
𝑞′ =
𝑞′
‖𝑞′‖
 
 
7. 
𝑢 =
𝑌𝑞
𝑞′𝑞
 
8. If Step 4 𝑡 ≠ previous Step 4 𝑡, return to Step 2. 
If Step 4 𝑡 = previous Step 4 𝑡, go to Step 9. 
9. Repeat Step 1 to 8 on residuals 𝐸 and 𝐹∗. 
Table 5. Non-Linear Iterative Partial Least Squares (NIPALS) algorithms for outer regressions and combined algorithm for improved capture of the inner relationship 
[146]. In the Single Algorithm, both 𝑡 (some 𝑥𝑗)  and 𝑢 (some 𝑦𝑗) are used to determine individual latent variable loadings(𝑝
′ and 𝑞′) in both the 𝑋 regression and 𝑌 
regression. All three algorithms use convergence as stopping criteria for proceeding to calculate the next latent variable from the residuals matrices 𝐸 and 𝐹∗. 
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Table 6 and Table 7 are presented as a theoretical comparison of regressions using PCR 
and PLS for a dataset X and a response Y. In Table 6, PCA has been applied to the dataset 
X. Considering the X variance captured, it is seen that the 1st PC captures the greatest 
percentage variance (60%), the 2nd PC a smaller percentage (20%), and the 3rd PC smaller 
still (10%). Only three PCs are retained as these captured 90% of X variance which, in 
this example, has been deemed sufficient for proceeding to regression. The scores for this 
model are then regressed on the response Y. Considering then the Y variance captured, it 
is seen that only a 55% of Y variance is captured total, despite 90% of X variance being 
captured. Furthermore, the percentage of Y variance captured does not decrease with PC 
number as occurs for the percentage of X variance captured. 
In Table 7 where PLSR has been employed, the situation is reversed. The 1st LV captures 
on 20% of the X variance but 60% of the Y variance, the 2nd LV 5% of X variance and 
20% of Y variance, and the 3rd LV 30% of X variance and 10% of Y variance. Here a 
total 55% of X variance explains 90% of the Y variance. 
The purpose of this comparison is to clearly demonstrate the difference between 
PCA-based and PLS-based techniques. PCA focuses on X variance regardless of any 
response, whereas PLS focuses on X variance only so far as it explains Y variance. 
 
 X Variance Captured (%) Y Variance Captured (%) 
PC This PC Total This PC Total 
1 60 60 20 20 
2 20 80 5 25 
3 10 90 30 55 
Table 6. Captured X and Y Variance Using PCR. A total of 90% X variance is captured but only 
55% Y variance can be ascribed to this behaviour. 
 
 X Variance Captured (%) Y Variance Captured (%) 
PC This PC Total This PC Total 
1 20 20 60 60 
2 5 25 20 80 
3 30 55 10 90 
Table 7. Captured X and Y Variance Using PLSR. 90% of Y variance can be ascribed to only 
55% of X variance. 
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The PLS algorithm is not restricted to regressions to predict a response dataset response 
dataset Y. If the response dataset is categorical classifications, e.g. pass/fail, 
positive/neutral/negative, the PLS algorithm is used perform discriminant analysis 
(PLS-DA). In PLS-DA, latent variables and variable weightings are calculated to provide 
the greatest level of separation between the response classes. Hence, as in PLSR, a 
structure is imposed on the dataset to capture variance differentiating classes. 
As with PCA, the use of cross-validation analysis is recommended to prevent over-fitting 
of the model. In ‘Leave One Out’ cross-validation, the number of latent variables used is 
based on the PRESS statistic. This is repeated until each sample has been left out and a 
total PRESS is calculated. The ‘best’ model is selected based on the number of latent 
variables that gives the lowest total PRESS. The number of latent variables retained can 
also be based on alternative model performance criteria, e.g. correct classification of 
specific samples in PLS-DA, instead of overall classification accuracy of the dataset. 
A benefit of PLS is that input variables identified by the algorithm as statistically 
significant for the response of interest are given greater weighting than those identified 
as statistically insignificant. This ability can improve signal-to-noise ratios in large 
datasets as statistically insignificant variables can be given effectively zero impact in 
prediction or analyses. 
It is important to question the identified behaviours as the PLS algorithm imposes a 
structure which, in a suitably large dataset, can potentially create spurious models with 
high predictive accuracy. While cross-validation can help reduce the likelihood of such 
model being selected, it is also possible for more nuanced behaviours to be buried beneath 
“obvious” behaviours. PLS is generally recommended as a tool for extracting information 
from highly correlated multivariate dataset where there is a high signal-to-noise ratio 
whether noise is defined as true noise or unnecessary data [147]. 
3.5 Lack-of-Fit Statistics and Outliers 
Lack-of-fit statistics are used to evaluate models produced through modelling algorithms 
such as PCA and PLS. Two key lack of fit statistics used in the presented work were 
Hotelling T2 residual and Q Residuals. 
Hotelling T2 can be thought of as a multivariate version of univariate standardisation as 
it compares the cumulative variance of a sample’s data to the model mean (Eq. 3.11). 
𝑇𝑖
2 = 𝑥𝑖
𝑇𝐏𝚲−1𝐏T𝑥𝑖 Eq. 3.11 
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where 𝑇𝑖
2 is the Hotelling T2 for a sample, 𝑥𝑖 is the sample data, 𝑥𝑖
𝑇is the transpose of 
the sample data, 𝐏 is the loading matrix for input data, 𝐏T is the transpose of the loading 
matrix for input data, and 𝚲 is the diagonal matrix of eigenvalues 𝑑𝑖𝑎𝑔(𝜆1, 𝜆2, … , 𝜆𝑘) for 
the selected number of components or latent variables [148]. An upper control limit 𝑇𝑈𝐶𝐿
2  
is calculated as shown: 
𝑇𝑈𝐶𝐿
2 =
𝑘(𝑛 − 1)
𝑛 − 𝑘
𝐹𝑘,𝑛−𝑘;𝛼 Eq. 3.12 
where 𝑇𝑈𝐶𝐿
2  is the upper control limit value, 𝑘 is the number of variables, 𝑛  is the number 
of observations, 𝐹𝑘,𝑛−𝑘;𝛼 is the Fvalue for the limit [148]. Values above the calculated 
limit represent samples with statistically unusual values when compared to other samples 
in a dataset, however as the limit is calculated using a threshold (𝛼), a percentage of 
samples should always lie on or above the limit. 
As each individual variable’s contribution to a sample’s Hotelling T2 residual is 
calculated, it is possible to identify variables contributing to high Hotelling T2 values. 
Three causes for high Hotelling T2 values encountered during the course of the presented 
research were: 
 Simple decimal error, e.g. a dataset has a mean pH of 6.91 and standard deviation 
0.02. A pH reading of 6.91 (σ = 0) is recorded as 69.1 (σ = 3109.5). 
 A statistically ‘unusual’ but biologically irrelevant outlier, e.g. a dataset has 49 
readings of 36.5°C and one reading of 36.6°C. When mean centred and 
normalised, the single 36.6°C reading has a standardised value of 7 σ.  
 Samples with experimental operating conditions in a dataset comprising 
predominantly samples with ordinary operating conditions. 
 
In the case of decimal error, technically all that is required is dataset cleaning. In the case 
of variables such as pH in a well-controlled process, decimal errors can be confidently 
identified and rectified. Ideally they are anticipated as part of data capture and the error 
can be flagged at the point of data entry (e.g. an error box appears when entered into the 
data monitoring spreadsheet). However decimal errors may not be caught during data 
cleaning and may have a detrimental effect on subsequent models. This is a particular risk 
for variables with a greater range of values or potential range of values such a pCO2 which 
may range from close to 0 mmHg to over 300 mmHg during the course of a culture. 
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The statistically unusual but biologically irrelevant outlier is an issue that can be caused 
by over-cleaned datasets, differences in rounding used between data entries, and biased 
or unrepresentative sampling (e.g. ‘blocking’ effects). The following example is a 
simplification of an issue concerning differences in bioreactor scale (10 L v. 5000 L) and 
temperature control. 
At the 10 L scale, temperature is more quickly and tightly controlled relative to 
temperature control at the 5000 L scale, where there is longer lag attributed to increased 
volume. Essentially, when a scientist records reactor temperatures, it is likely that greater 
variation in temperature will be observed at the 5000 L scale due to the greater lag in 
control. This statistical difference in control response is not necessarily biologically 
relevant. However, once this difference between scales is identified, it must be 
demonstrated that the difference does not impact on, for example, the efficacy of the 
product. Once this is done, there are several options: 
1. If the variable has low significance in the model, remove the variable. 
2. Replace the variable with a more robust measure, e.g. replace offline sampling/ 
daily monitoring temperature measurements with median temperatures calculated 
from online monitoring records. 
3. Introduce more samples of this type to the dataset. In the example, the dataset is 
heavily biased towards capture of 10 L scale control. Reducing the number of 
10 L samples or increasing the number of 5000 L samples would improve the 
balance between the two control schemes. 
4. Rectify identifiable errors in input data if possible. Rounding errors, inconsistency 
in how many significant figures to record, different units used for measurements 
(mmol/L v. mg/L), and decimal points errors can affect the calculated Hotelling 
T2 contributions. 
 
A high Hotelling T2 residual does not necessarily mean a sample is an outlier. A sample 
with a high Hotelling T2 may represent more extreme values, however this does not 
necessarily make the sample an outlier if the correlations identified by the model are 
conserved. Conversely, a low Hotelling T2 does not necessarily preclude a sample from 
being an outlier or non-representative sample. 
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These behavioural outliers can be identified through the use of Q Residuals2 (Eq. 3.13) 
also called the squared prediction error (SPE), where the residuals matrix is used to 
calculate the agreement between a sample’s n-dimensional location and the location 
according to the model. 
𝑄𝑖 = 𝑒𝑖𝑒𝑖
𝑇 Eq. 3.13 
where 𝑄𝑖 is the calculated Q Residual of sample 𝑖, 𝑒𝑖 is the 𝑖
th row vector from the error 
matrix E, and 𝑒𝑖
𝑇 is the transpose of 𝑒𝑖. An upper limit for Q Residuals can be 
approximated using the Jackson-Mudholkar formula (Eq. 3.14). 
𝑄𝑖 = 𝜃1 [1 −
𝜃2ℎ0(1 − ℎ0)
𝜃1
2 +
𝑧𝛼√2𝜃2ℎ0
2
𝜃1
]
1
ℎ0
⁄
 Eq. 3.14 
with 
𝜃𝑖 = ∑ 𝑥𝑗
𝑖 , 𝑖
𝑛
𝑗=𝑘+1
 
Eq. 3.15 
and 
ℎ0 = 1 −
2𝜃1𝜃3
3𝜃2
2  
Eq. 3.16 
where 𝑘 is the number of PCs retained, 𝛼 is the significance level, 𝑥𝑗
𝑖 the value of variable 
𝑗 for sample 𝑖, and 𝑧𝛼 is the standard normal value corresponding to the upper 1-α 
percentile [148]. Q Residual contributions are simply the row vector 𝑒𝑖.When comparing 
Q Residual contributions for two or more samples, one observation (A) can be set as a 
baseline. Relative Q Residual contributions are calculated for the remaining samples by 
subtracting 𝑒𝐴.from the error matrix E. 
High ‘Normal’ values 
Behaviour does not fit model 
Ex. Culture with behaviour not captured 
by model but measurements are within 
univariate limits. 
‘Unusual’ values 
‘Behaviour does not fit model 
Ex. Experimental conditions which affect 
culture in manner that does not obey 
model. 
Q
 R
es
id
u
al
s 
‘Normal’ values 
Behaviour fits model 
Ex. Control cultures and “Golden 
Batches” 
Unusual’ values 
Behaviour fits the model 
Ex. Experimental conditions affecting 
culture in a manner that obeys model. 
Low 
 Low Hotelling T2 Residual High 
Table 8. A simple demonstration of interpreting lack-of-fit statistics for a multivariate model. 
Ideally, Hotelling T2 and Q Residuals for samples lie within or near the lower left quadrant. 
Otherwise this indicates a sample’s data, behaviour, or both are statistically different.  
                                                 
2 This value is also known as DModX. The related limit is referred to as DModXCrit. 
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3.6 Decision Trees 
A decision tree is a classification technique which uses induction to determine key 
variables for partitioning observations into individual classes [143]. There are three key 
items in the structure of a decision tree: 
1. Internal Node—A decision point using a predictor variable value as the decision 
criteria, e.g. “pH>7.0”  
2. Leaf Node—During tree construction, this is the majority sample class. For 
cross-validation and testing dataset, this is the predicted class for a sample. 
3. Branch—Pathway between internal nodes and leaf nodes based on attribute value. 
 
A notable feature of decision trees is that they can be constructed from heterogeneous 
datasets, e.g. continuous, discrete, and categorical data can be analysed as a single dataset. 
An example from industry is the use of decision trees to identify most optimal growth 
conditions for E. coli from parameters including inoculum volume, substrate source, and 
culture conditions [42]. 
 
 
Figure 9. Decision tree to determine growth conditions leading to separation of 85 E. coli cultures 
as “High” or “Low” based on fluorescence using gain ratio [42]. Nodes are number sequential by 
layer and from left to right, e.g. node numbers in third layer would be 4, 5, 6, and 7 for fermentor 
numbers #1, #2, #3, and #4 respectively. In this visualisation, the distribution of the two classes 
can be seen at each internal node and each leaf node. The number of samples at each node is also 
displayed. It can be seen that the first decision criteria (% 𝐴𝑟𝑎𝑏𝑖𝑛𝑜𝑠𝑒 ≤ 0.16) resulted in 
approximately 75% of samples (cultures) being grouped on a single node. This group is of high 
enough purity that further splitting of the sample subset is halted and the node is a leaf node.  
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Multiple algorithms exist for decision tree construction. Information Gain is one of the 
simplest decision tree criteria selection algorithms. The Information Gain algorithm 
calculates the information gained when choosing a decision criteria by comparing the 
expected information (entropy) needed to classify a sample (Eq. 3.17) to the information 
still needed to arrive at exact classification following the split (Eq. 3.18). This is shown 
in Eq. 3.19 to identify the decision criteria partition value of an attribute 𝑥 that yields the 
greatest information gain. 
𝐼𝑛𝑓𝑜(𝑋) = −∑𝑝𝑖 log2 𝑝𝑖
𝑤
𝑖=1
 
 
Eq. 3.17 
𝐼𝑛𝑓𝑜𝑥(𝑋) = ∑
|𝑋𝑗|
|𝑋|
𝑣
𝑗=1
× 𝐼𝑛𝑓𝑜(𝑋𝑗) 
 
Eq. 3.18 
𝐺𝑎𝑖𝑛𝑥(𝑋) =  𝐼𝑛𝑓𝑜(𝑋) − 𝐼𝑛𝑓𝑜𝑥(𝑋) Eq. 3.19 
where 𝑝𝑖 is the non-zero probability that a sample in dataset 𝑋 belongs to a class, 𝑤 is the 
number of distinct classes available, 𝑣 is the decision criteria value, 𝑋𝑗 is the subset of 𝑋 
with samples with attribute value 𝑥𝑖 ≥ 𝑥𝑃𝑎𝑟𝑡𝑖𝑡𝑖𝑜𝑛 𝑉𝑎𝑙𝑢𝑒 , |𝑋| is the purity of 𝑋, and |𝑋𝑗| is 
the purity of 𝑋𝑗 [143]. 
Information Gain is biased towards attributes with many values. Gain Ratio is a variation 
of the Information Gain algorithm modified to reduce this bias through use of a 
normalisation term 𝑆𝑝𝑙𝑖𝑡𝐼𝑛𝑓𝑜𝑥(𝑋) (Eq. 3.21). While bias towards many valued attributes 
is reduced, the Information Gain algorithm is itself biased towards unbalanced splits, i.e. 
selecting decision criteria which isolate a small proportion of the samples to be classified.  
𝐺𝑎𝑖𝑛𝑅𝑎𝑡𝑖𝑜𝑥(𝑋) =
𝐺𝑎𝑖𝑛(𝑋)
𝑆𝑝𝑙𝑖𝑡𝐼𝑛𝑓𝑜𝑥(𝑋)
 Eq. 3.20 
where 
𝑆𝑝𝑙𝑖𝑡𝐼𝑛𝑓𝑜𝑥(𝑋) = −∑
|𝑋𝑗|
|𝑋|
log2
|𝑋𝑗|
|𝑋|
𝑣
𝑗=1
 
Eq. 3.21 
A third common algorithm is the Gini Index which selects decision criteria based on the 
impurity of dataset 𝑋 at the decision node: 
𝐺𝑖𝑛𝑖(𝑋) = 1 − ∑𝑝𝑗
2
𝑤
𝑗=1
 Eq. 3.22 
 52 
 
For a partition based on attribute 𝑥, dataset 𝑋 is split into 𝑋1 and 𝑋2 for which Gini Index 
can be weighted to the Gini Index for the split: 
𝐺𝑖𝑛𝑖𝑥(𝑋) =
|𝑋1|
|𝑋|
𝐺𝑖𝑛𝑖(𝑋1) +
|𝑋2|
|𝑋|
𝐺𝑖𝑛𝑖(𝑋2) Eq. 3.23 
A weakness of decision trees is that classes are determined by judging individual variables 
in a hierarchical manner. This is unlike other multivariate methods, such as PCA and PLS, 
where all variable dimensions are considered simultaneously. When using decision trees, 
a high degree of contextual information can be lost when cherry picking variables based 
on pure partitioning power. A number of related algorithms have been suggested to better 
cope with the lack of attribute independence when selecting decision criteria [149]. In the 
Relief algorithm, which is limited to two classes, 𝑊[𝑥], the quality estimation for all 
attributes 𝑥, is initially set equal to zero. A sample 𝑖 is then selected from a total of 𝑚 
samples. The nearest neighbour of the same class (nearest hit, 𝐻) and the nearest 
neighbour of the different class (nearest miss, 𝑀) are identified using the cumulative 
Manhattan distance across all variables. 𝑊[𝑥] is then updated to take into account the 
difference in values for a variable (𝑥) using the following iterative formula: 
𝑊[𝑥]:= 𝑊[𝑥] −
|𝑥𝑖 − 𝑥𝐻|
max(𝑥1,𝑚) − min(𝑥1,𝑚)
+
|𝑥𝑖 − 𝑥𝑀|
max(𝑥1,𝑚) − min(𝑥1,𝑚)
 Eq. 3.24 
where 𝑥𝑖, 𝑥𝑀, and 𝑥𝐻 are values for variable 𝑥 for sample 𝑖, nearest miss 𝑀, and nearest 
hit 𝐻, and 𝑥1,𝑚 is the full range of values observed for variable𝑥. A new sample is then 
selected and 𝑊[𝑥] is updated again. The number of samples 𝑊[𝑥] is updated against is 
userdefined parameter up to 𝑚. 
The ReliefF algorithm (Eq. 3.25) is an adaptation allowing for more than two classes to 
be considered by taking a proportional average of the differences between the sample 𝑖 
and the nearest miss for each class. This is done using the prior probabilities of classes 
estimated from the training dataset, 𝑃(𝐶). ReliefF also allows an increase in the number 
of nearest neighbours compared to sample 𝑖 to be increased to 𝑘. 
𝑊[𝑥]:= 𝑊[𝑥] + 𝐺 + 𝑍 Eq. 3.25 
Where  
𝐺 = ∑
|𝑥𝑖 − 𝑥𝐻,𝑗|
max(𝑥1,𝑚) − min(𝑥1,𝑚)
𝑚 ∗ 𝑘
𝑘
𝑗=1
 
Eq. 3.26 
and  
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𝑍 = ∑
[
 
 
 
 
𝑃(𝐶)
1 − 𝑃(𝐶𝑙𝑎𝑠𝑠(𝑖))
∗ ∑
|𝑥𝑖 − 𝑥𝑀,𝑗(𝐶)|
max(𝑥1,𝑚) − min(𝑥1,𝑚)
𝑚 ∗ 𝑘
𝑘
𝑗=1
]
 
 
 
 
𝐶≠𝐶𝑙𝑎𝑠𝑠(𝑖)
 Eq. 3.27 
A second expansion of the Relief algorithm called RReliefF allows use of the algorithm 
with regression trees through the incorporation of Bayes probabilities [149]. 
A further method for addressing to the univariate action of decision trees is to transform 
the dataset in question using MVDA techniques prior to applying a decision tree 
algorithm. For example, iterative PLS-decision trees calculate a latent variable to describe 
the differences between classes [150]. The latent variable becomes the first node attribute 
and the samples partitioned accordingly. The error matrix from the first latent variable is 
used to calculate a new latent variable to classify the samples on that node. 
3.7 Summary 
Research focussed on the application of multiple MVDA techniques detailed in this 
chapter. For each case study, technique choice was re-evaluated for suitability for the data 
to be analysed and for study aims. As data originated from an industrial research and 
development environment and analysis outcomes were to feed back into this environment, 
techniques were also selected based on interpretability and communication of results, in 
addition to flexibility and ease of implementation for future use.  
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 Comparison of pH Measurement Technologies and 
Extraction of Indirectly Captured Information 
4.1 Introduction 
The global biopharmaceutical industry’s $90 billion worth [151] is dependent on the 
ability of cells to grow and produce the correct product. A fundamental parameter in cell 
cultures is pH as it affects cell growth [95] and production rates [97], which in turn affects 
culture product yield. pH can also affect product quality [96], potentially leading to 
rejection of the final product due to failure to meet release criteria. These issues could be 
addressed by improved pH understanding and control [152]. However to effectively apply 
a pH strategy, measurement technologies must give reliable and accurate readings. 
The most commonly used sensor for pH measurement is the potentiometric pH electrode 
probe, comprising two electrodes: an indicator electrode with a glass membrane and a 
reference electrode [153]. pH is measured by immersing the probes into a sample to create 
a Galvanic cell with the difference between the electrode voltages denoting the potential. 
Using a modified form of the Nernst Equation, the sample’s pH is then calculated [154]. 
All pH measurement technologies at Lonza for 10L and larger bioreactors used 
potentiometric pH electrode probes for online and offline monitoring. 
An aspect of pH measurement frequently taken for granted is consistency between 
technologies. One possible scenario in industry is that different sites may use different 
technologies when manufacturing the same product. A similar situation may arise in a 
single laboratory when individual scientists prefer one of two available technologies over 
the other. 
In Lonza’s operating procedures, two offline pH measurements were made during daily 
offline monitoring of cultures. The first measurement was made with a Radiometer 
Analytical PHM220 pH meter (Radiometer Analytical, France) connected to a Mettler-
Toledo pH probe (Mettler-Toledo, UK). The second measurement was made using a 
NOVA Biomedical Bioprofile 400 (NOVA Biomedical, MA, USA). It was assumed that 
each available pH measurement technology had an accuracy of ± 0.01 pH units [155] and 
that samples were sufficiently mixed to be considered homogenous at this measurement 
resolution. From this, the maximum allowable difference in readings between the two pH 
measurement technologies on the same sample due to pure instrument error was 
± 0.02 pH units. However in the cell culture robustness study forming the basis of the 
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research presented in this chapter, nearly 60% of differences in pH reading by the two 
offline technologies fell outside the allowable error band (Figure 1). Multivariate data 
analysis (MVDA) was to be used to investigate this undesired area of variation. A notable 
constraint on study was to restrict analysis to a pre-existing dataset generated as part of 
standard cell culture robustness study and thus demonstrate if MVDA could be used to 
extract new information. 
Analysis focussed specifically on potential effects from component concentrations in 
samples or sample temperatures. Effects from sample handling [156], sterilisation 
techniques [157], or variations specific to probe age or individual probes could not be 
considered as these are not captured in standard operation data collection. Offline probes 
were replaced as necessary during the robustness study; hence this study investigates 
differences between multiple random pairings of offline pH probes. 
 
 
 
Figure 10. Histogram of Differences in Offline pH Readings by Two Offline Technologies. 
Dotted lines indicate boundaries for differences due to instrument error (±0.02 pH units). 
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4.2 pH and Temperature 
The pH of a sample is not constant with respect to temperature. Without compensation, 
this temperature-pH relationship results in incorrect readings with the potential for the pH 
controller to force a change on a system which is at the pH setpoint in an extreme situation 
(e.g. technical error with temperature control feedback). This is further complicated as 
the pH-temperature relationship varies based on component concentrations [158]. Thus 
in 1947, when Rosenthal presented equations to be used by medical persons to determine 
the pH of human blood and plasma samples at physiological temperatures after samples 
had cooled to ambient conditions, three equations were required to describe the different 
pH-temperature relationships for whole blood, plasma, and derived plasma [159]. In 
contrast to this, an earlier study by Yoshimura and Fujimoto in 1937 found that blood and 
plasma samples from rabbits were found to have pH-temperature relationships similar 
enough to be addressed with a single equation, where they also note that the loss of CO2 
from the samples would also effect the measured pH [160]. Both studies assumed simple 
linear relationships, e.g. the mean change in plasma pH was calculated to be -0.118 per 
+1°C. While these simple linear relationships were deemed appropriate for the 
temperature range across which compensation was to be applied, pH-temperature 
relationships are not truly linear [161]. 
pH-temperature compensation could be performed manually, however it is more for pH 
measurement technologies have a built-in pH-temperature compensation function. In the 
presented study, a Mettler-Toledo pH probe (Mettler-Toledo, UK) physically paired with 
a temperature probe was connected to a Radiometer Analytical PHM220 pH meter 
(Radiometer Analytical, France). The system was calibrated daily using standards of 
known pH; the temperature of those standards was used to create a pH-temperature 
compensation. When an offline measurement was made, the sample’s temperature was 
also taken and the compensation applied by the pH meter. 
A different method was used by the NOVA Bioprofile 400 [162]. The sample’s 
temperature (T) was entered at the user interface. The sample was then heated to 37 °C. 
The pH of the heated sample was measured then pH-temperature compensation was 
applied using the following equation: 
𝑝𝐻𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 = 𝑝𝐻 + [−0.0147 + 0.0065 ∗ (7.400 − 𝑝𝐻)] ∗ (𝑇 − 37) Eq. 4.1 
The concern with such compensation is the assumption all samples have the same 
pH/temperature relationship. In reality, different chemicals have different pH/temperature 
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relationships [159]. Variation in relative concentrations in a chemical mixture (e.g. 
supernatant) could affect the required pH/temperature compensation for a pH 
measurement technology. This has a long established concern which prompted Rosenthal 
to use his 1947 paper “to call attention to a misconception on the part of some who use 
commercial pH that are equipped with “temperature correction” controls” and that 
“Simply setting the pointer at 38° does not solve the problem of finding pH38 while the 
sample is at room temperature” [159]. Furthermore if two technologies assume different 
pH-temperature compensations, they are likely to give different readings for the same 
sample regardless of additional possible effects. 
4.3 Data 
The data forming the basis of this study were generated from the development of a 
bespoke fed-batch process for DHFR-CHO cell line. As part of the development process, 
a series of control and experimental conditions were tested to evaluate process limits, 
hence the study was termed a process limits evaluation (PLE) study. Data were taken 
from 10 L bioreactor cultures with 25 control cultures operating under normal process 
conditions and 23 experimental cultures operating with deviations introduced to normal 
process conditions.  
The key feature of the process was a deliberate alteration in the setpoint for temperature 
control once a minimum viable cell concentration was reached. The control bioreactor 
cultures were initially maintained at pH 7.0 and 36°C. When a minimum viable cell 
concentration (determined by daily offline sampling) was reached, the pH and 
temperature setpoints were moved to pH 6.91 and 30°C respectively. Three different 
bolus additions were made to each bioreactor culture. Bolus A was added when the pH 
and temperature setpoints were adjusted, bolus B was added on Day 4 of the culture, and 
bolus C was added on Day 7 of the culture. 
For the experimental bioreactor cultures, deliberate deviations from standard operation 
were introduced (summarised in Table 9 and Table 10). These included changes directly 
captured in daily monitoring data, e.g. increased operating temperature, decreased 
operating temperature, omission of the shifts in pH and temperature setpoints. Other 
changes not directly captured in the routine daily monitoring data outlined in Chapter 2 
were collected as meta-data, e.g. use of expired medium, alterations to feedrates, or 
alterations to days on which media bolus feeds were added. 
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The cultures were monitored through daily offline samples as outlined in Chapter 2. In 
addition to cell concentrations and concentrations of key metabolites, measurements for 
pH are made using two offline pH measurement technologies: 
 A Radiometer Analytical PHM220 with a Mettler-Toledo probe 
 A NOVA Bioprofile 400 
A total of 48 fed-batch cultures were cultured for an average of 15 days under the 
aforementioned range of conditions with several cultures reaching harvest criteria 
(severely declined viability and viable cell concentrations) earlier than others due to 
effects from experimental conditions. A total of 785 daily monitoring samples were 
collected and analysed during this time. For each sample, 12 daily sampling 
measurements were recorded. The data were collated into a single 785x12 matrix in Excel 
(Microsoft) and analysed using Minitab 15.  
4.4 Removing Daily Adjustments to Online pH Reading 
Offline pH technologies were calibrated daily. The online pH technology was calibrated 
before use. Daily adjustments to the online pH technology were made by comparing the 
online pH reading to the bench offline reading of a sample. If the difference in pH 
readings was equal to or greater than ± 0.02 pH units, i.e. outside instrument error, then 
the bench offline reading was used to adjust the online probe to give the same reading. If 
the difference in readings was less than ± 0.02 pH units, no adjustment was made. 
It was necessary to know what the online reading would have been if no adjustments had 
been made. This ‘true’ reading could be calculated due to the capture of daily adjustments 
in paper records and then using Eq. 4.4 and Eq. 4.5. 
𝑃𝑖 = 𝑃𝑖−1 + 𝐷𝑝𝐻 Eq. 4.4 
𝐷𝑝𝐻 = 𝑅𝑖 − (𝑅𝑖−1 + 𝐴𝑖−1) Eq. 4.5 
where  
𝑃𝑖 ‘True’ online pH reading for sample i 
𝑅𝑖 Online reading for sample i 
𝐷𝑝𝐻 ‘True’ change in pH 
𝐴𝑖−1 pH adjustment from previous sample i-1 
𝑇𝑖 Day sample taken – rounded down to nearest whole number 
Note: If 𝑇𝑖 = 0, then 𝑃𝑖 = 𝑅𝑖 
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Table 9. Summary of cultures and culture conditions. Control culture initial operating conditions 
36 ˚C and 7.0 pH units. When the viable cell concentration met a designated minimum, the 
temperature was reduced and the pH level lowered. Note on Culture ID: First value refers to round 
number, second value refers to culture number e.g. 3.1 is culture 1 of round 3.  
Culture ID Culture Conditions Comments 
3.1 Control 
 
3.2 Control 
3.3 Control 
3.4 Control 
4.1 Control 
4.2 Control 
5.1 Control 
5.2 Control 
5.3 Low Temp 
5.4 Low Temp 
5.5 Low pH Removed for AS2 dataset – see §4.6 
5.6 Low pH Removed for AS2 dataset –  see §4.6 
5.7 High Temp 
 
5.8 High Temp 
6.1 Control 
6.2 Control 
6.3 Control 
6.4 Control Contaminated – removed from all datasets 
6.5 Control Strong drift by online probe – removed from datasets 
6.6 Control  
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Table 10. Summary of cultures and culture conditions (continued). Control culture initial 
operating conditions 36 ˚C and 7.0 pH units. When the viable cell concentration met a designated 
minimum, the temperature was reduced and the pH level was lowered. Note on Culture ID: First 
value refers to round number, second value refers to culture number e.g. 7.1 is culture 1 of round 
7.  
Culture ID Culture Conditions Comments 
7.1 Control  
7.2 Control 
7.3 Control 
7.4 Control 
7.5 High pH Removed for AS2 dataset –  see §4.6 
7.6 High pH Removed for AS2 dataset –  see §4.6 
7.7 High pH Removed for AS2 dataset –  see §4.6 
7.8 Low pH Removed for AS2 dataset –  see §4.6 
7.9 High Seeding  
7.10 High Seeding 
8.1 Control (T=32) 
8.2 Constant pH 7.0 Removed for AS2 dataset –  see §4.6 
8.3 Low DOT  
8.4 Low DOT 
8.5 High DOT 
8.6 High DOT 
9.1 Control 
9.2 Increased Feed 
9.3 Increased Feed 
9.4 Modified Feed Strategy I Removed for AS2 dataset –  see §4.6 
9.5 Modified Feed Strategy II Removed for AS2 dataset –  see §4.6 
9.6 Modified Feed Strategy III Removed for AS2 dataset –  see §4.6 
C1 Low Generation Number  
C2 Low Generation Number 
C3 Low Generation Number 
A1 High Generation Number 
A2 High Generation Number 
A3 High Generation Number 
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4.5 Missing Data 
Approximately 4% of data were missing (560 points out of a raw data total of 14130). 
The majority of missing data were due to issues with sensors used for variable 
measurement. Missing data could also be attributed to Lonza re-sampling policies, where 
a daily sampling may be repeated but only a subset of the variables monitored via daily 
monitoring are recorded. 
The software used (Minitab 15) automatically excluded samples where variables were 
missing. This meant that as variables were removed through significance testing the 
number of samples used could potentially increase (Table 11). This variation was allowed 
as the maximum number of samples would be used with each iteration of statistical 
significance testing, potentially increasing the strength of the tests. 
4.6 Division of Dataset 
The change in temperature and pH set points provided a natural splitting point in the data. 
The data taken from before the shift and the data taken from after the shift reflect two 
different biochemical states. These different states are referred to here as ‘operating 
conditions’: ‘All,’ ‘Before Shift’ (BS), and ‘After Shift’ (AS). 
A variety of changes were made to bioreactor operating conditions, referred to here as 
‘culture conditions’. Culture conditions included changes in temperature shift, pH shift, 
and other parameters, e.g. not undergoing the step change in temperature or operating a 
higher DOT setpoint as seen in Table 9 and Table 10. 
The dataset AS was further subdivided into ‘After Shift 1’ (AS1) and ‘After Shift 2’ 
(AS2). AS1 contained AS data from all cultures. AS2 contained AS data from cultures 
where reactor conditions were directly captured in the inputs used only. As pH was 
excluded as an input due to concerns over bias, cultures not operating at the control pH 
set point were removed. Cultures using modified feed strategies were also removed. 
In summary, the dataset ‘All’ contained all data from all samples, BS contained data from 
all samples taken before the change in operating conditions, AS1 contained data from all 
samples taken after the change in operating conditions, and AS2 contained data from all 
samples taken after the change in operating conditions but excludes samples where 
experimental conditions were not directly captured in the dataset.  
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Table 11. Effect of Missing Data on Samples Used to Model Response. Shading indicates 
exclusion from model creation. ● indicates a missing value. For I, model creation includes all 
variables A to H, causing the software (Minitab) to exclude samples 1 to 3. F is identified as the 
least statistically significant variable and removed from the model inputs. Sample 3 can now be 
included in the creation of the new model. This is repeated until only variables of the desired 
statistical significance remain in the model. 
  
I Variable A B C D E F G H 
S
am
p
le
 1   ●     ● 
2 ●     ●   
3      ●   
4         
 
Variable F removed as least significant. 
Samples 1 and 2 excluded from new model creation. 
II Variable A B C D E F G H 
S
am
p
le
 1   ●     ● 
2 ●     ●   
3      ●   
4         
 
Variable H removed as least significant. 
Samples 1 and 2 excluded from new model creation. 
III Variable A B C D E F G H 
S
am
p
le
 1   ●     ● 
2 ●     ●   
3      ●   
4         
 
Variable C removed as least significant. 
Sample 2 excluded from new model creation. 
IV Variable A B C D E F G H 
S
am
p
le
 1   ●     ● 
2 ●     ●   
3      ●   
4         
 
Variable A removed as least significant. 
All samples included in new model creation. 
V Variable A B C D E F G H 
S
am
p
le
 1   ●     ● 
2 ●     ●   
3      ●   
4         
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4.7 Development of New Variable: Osmolality Residuals 
During the initial analysis to determine potential causes of differences in pH readings by 
offline pH measurement technologies, it was found that, for the four datasets tested, 
inclusion of osmolality resulted in an increase in the R2 for a testing dataset by between 
0.01 to 0.07 depending on data subset used (Table 12). A similar result was note when 
considering PLSR models to predict the difference between pH readings by the two 
offline technologies, with the R2 for testing datasets improved by between 0.01 to 0.04 
when osmolality was included as a variable (Table 13). This suggested that osmolality 
played a part in the difference in pH readings by different offline pH measurement 
technologies, even though the impact of that part varied. However, further interpretation 
of these results was problematic due to the indiscriminate nature of osmolality. 
Osmolality is the concentration of solutes in a sample measured in osmoles of solute per 
kilogram of solvent [130]. It is an indiscriminate measurement as it does not specify how 
much of any specific component is present, i.e. an osmolality reading of 100 mOsm/kg 
does not specify whether there are 100 mOsm/kg of component A, B, D, or a mixture of 
all three. Due to the comprehensive nature of osmolality, the value contains information 
already captured (e.g. glucose concentration) as well as data not captured (e.g. 
background media components). 
Dataset  Osmolality Model R2 No Osmolality Model R2 ΔR2 
All  0.36 0.29 0.07 
Before Shift  0.35 0.32 0.03 
After Shift 1  0.40 0.39 0.01 
After Shift 2  0.42 0.39 0.03 
Table 12 Effects of excluding osmolality in MLR on cross-validation R2 during initial analysis. 
For each dataset, a MLR model was created using all available variables to predict the difference 
between pH readings by a Mettler-Toledo probe with Radiometer Analytics PHM220 and a 
NOVA Bioprofile 400 (B-N). Another MLR model was created to predict B-N with osmolality 
excluded from the dataset. 
Dataset  Osmolality Model R2 No Osmolality Model R2 ΔR2 
All  0.24 0.22 0.02 
Before Shift  0.24 0.23 0.01 
After Shift 1  0.42 0.38 0.04 
After Shift 2  0.44 0.40 0.04 
Table 13 Effects of excluding osmolality in PLSR on cross-validation R2 during initial analysis. 
For each dataset, a PLSR model was created using all available variables to predict the difference 
between pH readings by a Mettler-Toledo probe with Radiometer Analytics PHM220 and a 
NOVA Bioprofile 400 (B-N). Another PLSR model was created to predict B-N with osmolality 
excluded from the dataset. 
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It was theorised that contributions to osmolality by variables not directly monitored via 
standard daily sampling practices could be extracted if contributions to osmolality by 
those variables that were directly monitored were removed from the osmolality 
measurement. The extracted information could then be used to evaluate the impact of 
indirectly monitored variables in subsequent analyses, specifically the impact on 
differences in pH measurements by offline pH measurement technologies. 
There are multiple ways of measuring osmolality. The two most suited to biological 
samples are freezing point osmometry (FPO) and vapour pressure osmometry (VPO) with 
FPO the industry preferred method [130]. The NOVA Bioprofile 400 is designed to 
measure glucose (Gluc), lactate (Lac), ammonia (NH4
+), sodium (Na+), and potassium 
(K+) concentrations in addition to pH levels. This allows a component calculator to be 
included. The unit performs a simple linear combination using these measurements as 
seen in Eq. 4.2 [140]. 
𝑂𝑠𝑚𝑜𝑙𝑎𝑙𝑖𝑡𝑦 = 1.86([𝑁𝑎+] + [𝐾+] + [𝑁𝐻4
+]) +
[𝐺𝑙𝑢𝑐]
0.18
+
[𝐿𝑎𝑐]
0.09
+ 𝑐 Eq. 4.2 
where 
𝑂𝑠𝑚𝑜𝑙𝑎𝑙𝑖𝑡𝑦 Osmolality calculated (mOsm/kg H2O) 
𝐿𝑎𝑐 Lactate concentration (g/L) 
𝐺𝑙𝑢𝑐 Glucose concentration (g/L) 
𝑁𝐻4
+ Ammonium concentration (g/L) 
𝑁𝑎+ Sodium concentration (mmol/L) 
𝐾+ Potassium concentration (mmol/L) 
𝑐 Calculated constant (mOsm/kg H2O) 
 
There are many components which may be present in a sample which are not measured 
by the NOVA Bioprofile 400. There are also components known to affect osmolality 
which are measured by the unit but not included. For these reasons, the component 
calculator is an unreliable measure of osmolality for a biological system and can only be 
counted as a general estimate. 
4.7.1 Osmolality Model Residuals 
Data collected from daily monitoring included freezing point osmolality (FPO) readings 
where an Osmomat (Gonotec) was used to directly measure sample osmolality. It was 
decided to create a component calculator to model the FPO measurement from the 
remaining daily monitoring data in an attempt to extract information concerning variables 
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not directly measured as part of daily monitoring procedure, e.g. bolus feed shot 
concentrations, metabolites, and media composition. 
Multiple linear regression (MLR) was employed with all known component 
concentrations as input variables and the FPO reading as the response variable. The MLR 
model was refined through the use of statistical significance testing so that only variables 
with a p-value less than 0.05 were included. This was performed in an iterative manner 
removing one variable at a time (Figure 11). The final model (Eq. 4.3) accounted for 
83.6% of variation in osmolality in the dataset. 
 
Figure 11. Component Calculator Creation using MLR and Iterative Statistical Significance 
Testing 
 
𝑂𝑠𝑚𝑜𝑙𝑎𝑙𝑖𝑡𝑦𝑀 = 236 − 0.298𝑝𝑂2 + 0.243𝑝𝐶𝑂2 + 74.4𝐺𝑙𝑛 − 14.6𝐺𝑙𝑢𝑐
+ 254𝑁𝐻4
+ + 0.263𝑁𝑎+ + 4.27𝐾+ + 7.95𝑇𝐶𝐶 
Eq. 4.3 
where 
𝑂𝑠𝑚𝑜𝑙𝑎𝑙𝑖𝑡𝑦𝑀 Osmolality calculated by model (mOsm/kg H2O) 
𝑝𝑂2 Oxygen partial pressure (mmHg) 
𝑝𝐶𝑂2 Carbon dioxide partial pressure (mmHg) 
𝐺𝑙𝑛 Glutamine concentration (g/L) 
𝐺𝑙𝑢𝑐 Glucose concentration (g/L) 
𝑁𝐻4
+ Ammonium concentration (g/L) 
𝑁𝑎+ Sodium concentration (mmol/L) 
𝐾+ Potassium concentration (mmol/L) 
𝑇𝐶𝐶 Total Cell Concentration (106 cells/mL) 
 
The purpose of the developed model was to explain osmolality values based on all 
available variables and therefore not a true a priori model. Several variables were 
included when creating the model for osmolality that would not typically appear in a 
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component calculator, for example viable and total cell concentrations. These were 
included as measurements related to cell growth and condition may act as a suitable 
substitute variable for unmonitored products of cell metabolism affecting sample 
osmolality. Temperature was rejected as a possible variable as FPO readings are made at 
freezing point, not sample temperature. Iterative significance testing with a p < 0.05 led 
to the removal of variables for one of two reasons: 
1. The variable was statistically insignificant in the model. 
2.  Strong correlations between variables caused the variable in question to be rejected 
as statistically insignificant, i.e. multiple variables were competing to provide similar 
information to the model. 
 
Competition between correlated variables is the likely reason for the rejection of lactate 
as statistically significant in the model despite lactate being known to affect osmolality 
as seen in Eq. 4.2. Specifically, in the datasets analysed lactate concentration was 
generally closely correlated with glucose concentration. 
There is a notable difference between the presented model and established osmolality 
theory that requires further explanation. According to theory, the glucose coefficient 
should be positive as an increase in glucose concentration is an increase in the solute 
concentration and hence an increase in osmolality. In Eq. 4.3, the glucose coefficient is 
negative. This difference was due to the model capturing the behaviours observed in the 
dataset, e.g. as a typical culture progressed, osmolality increased while glucose 
concentration decreased. Furthermore, in MLR the sign of a variable does not necessarily 
indicate the direction of the relationship between the variable and the response. 
Coefficient direction can be altered depending on correlation with other variables. 
The differences between the predicted osmolality and the recorded osmolality are the 
residuals (errors) for the model. The use of the osmolality model residuals as a variable 
in place of osmolality is an attempt to allow variation in uncaptured data to be evaluated. 
This could not be done with osmolality due to its high degree of correlation with other 
variables. 
Two forms of evidence are presented to justify the inclusion of the osmolality residuals 
as a new variable. The first is based on a mathematical approach that uses principal 
component analysis (PCA). The second is a more heuristic, logical argument based on 
anticipated behaviour and knowledge of cell culture behaviours. 
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4.7.1.1 Validation of Osmolality Model Residuals using PCA 
Principal component analysis (PCA) is a multivariate data analysis technique where 
dimensionality reduction is achieved through the creation of orthogonal linear 
combinations of variables termed principal components (PC)3. When PC variable 
loadings are plotted in two dimensional space, correlated variables will cluster together. 
Negatively correlated variables will be at opposite points across the origin; variables with 
little or no correlation will be at approximately right angles. 
PCA was performed using daily monitoring data. Figure 12 and Figure 13 display loading 
for PC1 and PC2 when osmolality and osmolality residuals were included as inputs 
respectively. In both Figure 12 and Figure 13 the oxygen-based variables DOT and pO2 
were shown to be negatively correlated with respect to lactate concentration. This 
indicated that the PCA model created provided information that was correct from an 
understanding of the physical system. In Figure 12 it was seen that osmolality’s location 
in the loading plot was in the centre between a loose cluster (Day, pCO2, NH4
+, K+) and 
a second, more tightly defined cluster (Gln, Gluc, TCC, VCC, Na+). This was due to the 
correlation with variables in both clusters in keeping with the relationships shown in Eq. 
4.3. Osmolality also had a strong influence on scores due to high loading values. 
In Figure 13, relative positions between variabes remained largely unchanged from those 
in Figure 12 apart for an inversion of the Y-axis. This inversion is a theoretical issue of 
negligble significance whereby principal components which are not unique can change 
signs. It can be seen that “osmolality residuals” (“Osmo Res”) was located in a position 
of less correlation with the two clusters with reduced influence on score positions through 
reduction in loading values. This is in keeping with the theory that the variable osmolality 
residuals contains information not available in (i.e. uncorrelated with) other variables. 
                                                 
3 See Chapter 3. Statistical Methods for a more detailed description. 
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Figure 12. PCA loading plot for PC1 and PC2 when osmolality is used as a variable. Clustering of variables indicates positive correlations between those variables. 
The position of osmolality indicates positive correlations with multiple variables, however not all those variables are positively correlated with each other.  
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Figure 13. PCA loading plot for PC1 and PC2 when osmolality residuals (“Osmo Res”) is used as variable in place of osmolality. The relative positions of the other 
variables are similar to the relative positions in Figure 12, save for a negligible inversion of the Y axis. 
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4.7.1.2 Validation of Osmolality Model Residuals Through Time Series 
Analysis 
In the feed strategy employed, three chemically distinct bolus feed additions were added 
to the culture following a change in the reactor temperature and pH operating conditions. 
All reactors received bolus A on the day of the change in operating condition, bolus B on 
day 4, and bolus C on day 7. This pattern was identified when osmolality model residuals 
were plotted against elapsed time. Figure 14 and Figure 15 show the osmolality residuals 
against elapsed time for the cultures undergoing the setpoint change in operating 
conditions on day 3 and on day 4 respectively. Bolus additions are indicated with the 
following arrow colours: orange (bolus A), blue (bolus B), green (bolus C). Note that in 
Figure 14 and Figure 15 elapsed time is displayed as the day of the sample and not the 
precise elapsed time in hours. This is to allow a clearer comparison of general trends. 
In the first days of culturing, osmolality residual values decreased in a manner thought to 
indicate consumption of medium by the culture during the exponential growth phase. As 
medium composition was not directly measured, the impact of medium composition on 
osmolality measurements could not be accounted for by the model. Therefore information 
on medium composition information would lie in the model’s residuals. 
The decrease in residuals was seen in all cultures in all days until the addition of bolus A. 
For the reactors shifted on day 3, there is a continued decrease after the addition of bolus 
A with a sharp increase following the addition of bolus B. For cultures shifted on day 4, 
both the continued decrease after bolus A and the sharp increase after bolus B were 
absent. This indicated that the effects of the boluses in the osmolality model cancelled to 
some extent. 
For both sets of cultures, the osmolality residuals decreased following the addition of 
bolus B until day 7 when bolus C was added to cultures. A sharp increase in residual 
values occurred following the addition of bolus C, which is followed by a gradual 
reduction in the osmolality residuals over the remaining days of culture.  
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Figure 14. Osmolality model residuals for 15 cultures with setpoint changes on Day 3. Three 
chemically distinct bolus additions made after daily sampling are indicated with labelled arrows. 
A general decrease in residual values follows the addition of Bolus A. Increases in residual values 
follow the additions of Bolus B and Bolus C. 
 
 
Figure 15. Osmolality model residuals for 24 cultures with setpoint changes on Day 4. Three 
chemically distinct bolus additions made after daily sampling are indicated with arrows. The 
decrease in residual values following the addition of Bolus A (seen in Figure 14) is absent, as is 
the increase that followed Bolus B, indicating the effects of Bolus A and Bolus B on osmolality 
residual have cancelled out. The increase in residual values following Bolus C remains present.  
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4.7.2 Limitations of Osmolality Residuals as a Variable 
Osmolality measurements lack discrimination, i.e. it is not possible to identify which 
components contributed to the measurement nor to what extent. The calculated variable 
osmolality residuals is similarly indiscriminate. 
Osmolality residual values capture a variety of components including Bolus A, bolus B, 
bolus C, culture medium components, and by-products of cell metabolism. The relative 
concentrations of these components contributing to the osmolality residuals are not 
constant. Due to this variation, it may be that osmolality residuals do not have a consistent 
impact, e.g. on the discrepancies in pH readings seen in 7.1. For example, a 40 
mOsm/kg H2O residual caused by bolus A may not affect readings to the same extent as 
a 40 mOsm/kg H2O residual caused by bolus B. Extracting this information was not 
possible. 
Furthermore, the osmolality model presented in Eq. 4.3 was specific to the dataset 
analysed. Due to the number of variable which might influence which are not directly 
captured, e.g. media composition or metabolism by-products, two projects cannot be 
assumed to have the same indirectly captured information. Hence, an osmolality model 
created using one project’s data cannot be assumed transferable to another project. 
It may be possible to create a more generalised model from a dataset with a suitably varied 
background, e.g. a single host cell line expressing different products using a common 
process platform would have variation in the indirectly captured osmolality contributions 
due to product-specific effects on metabolism by-products. While a suitably varied 
dataset was encountered during a process platform investigation using historical data, 
osmolality was not typically included during daily monitoring records at that time. Hence 
it was not possible to test whether a generalised osmolality model could be produced 
during the research period presented in this thesis. 
Finally, osmolality residuals could be a more effective variable if the time between the 
NOVA measurements and the osmometer measurement could be taken into account. For 
example, two samples have the same composition when the NOVA measurements are 
taken. One sample is immediately measured using FPO; the other sample is measured 1 
hour later. The osmolality for the second sample may not be the same as the osmolality 
of the first sample due to changes (e.g. degassing, metabolism) in that hour. In such a 
scenario, variation in time between sampling and osmolality reading may affect the 
consistency of statistical significance of a variable in an osmolality model. 
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4.7.3 Osmolality Model Residuals Conclusions 
Additional knowledge concerning indirectly monitored variables was extracted from the 
pre-existing dataset. This was achieved through the comparison of recorded FPO 
measurements with osmolality values estimated through the use of a component 
calculator constructed from daily monitoring data. The extraction of known contributions 
to osmolality from unknown contributions allows the effects of those unknown 
contribution to be considered in the overall aim of determining possible causes of 
differences in readings by different pH measurement technologies. 
4.8 Modelling Differences in pH Readings by Different Technologies 
For each dataset, All, BS, AS1, and AS2, MLR was used to create a model to predict B-N, 
the difference in pH reading by the two offline pH measurement technologies. The first 
iteration of the model included Elapsed Time (h), temperature, DOT, pO2, pCO2, 
glutamine concentration, glutamate concentration, glucose concentration, lactate 
concentration, NH4
+ concentration, Na+ concentration, K+ concentration, viable cell 
concentration, total cell concentration, and osmolality residuals as model inputs. The 
MLR model was then refined through the use of statistical significance testing so that 
only variables with a p-value less than 0.05 were included. This was performed in an 
iterative manner removing one variable at a time. 
In the same method, models were created to the difference between the Radiometer 
PHM220 offline pH measurement technology reading and the true online pH reading (B-
P) and difference between the NOVA Bioprofile 400 offline pH measurement technology 
reading and the true online pH reading (N-P). 
4.8.1 Results and Discussion 
Variables identified as statistically significant in the final reduced models are indicated 
by shading in Table 14. These models do not explain 100% of the differences between 
the two pH technologies; however they do indicate that sample composition and condition 
can affect agreement in pH readings by two pH measurement technologies. 
A number of variables appear to be statistically significant only for specific combinations 
of dataset and response modelled. For example DOT was only significant for the response 
B-P when the ‘All’ dataset was used. Likewise ammonia was significant for the response 
B-P when either the ‘Before Shift’ (BS) or ‘After Shift 2’ (AS2) sets were used but not 
the ‘All’ set. 
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It is possible to rationalise several of these inconsistencies. First gas-based measurements 
have a tendency to be noisy due to degassing of the sample during handling. The value 
listed when the sample was analysed by the NOVA Bioprofile 400 may not be the same 
as when each pH reading was taken with the bench offline technology or the online 
technology. This could affect the variable’s calculated statistical significance. 
Second, some compounds were not present or were only present in low concentrations in 
the BS dataset. This could affect their statistical significance compared to the later AS2 
or full All datasets. 
Third, when iterative statistical significance testing is used for MLR model reduction, 
correlation between variables can cause variables to be rejected as statistically 
insignificant. As correlated variables provide similar information to the model, it can be 
advantageous to retain only one variable from a group of correlated variables. This 
variable may have an impact on the difference in pH measurement or simply be correlated 
with another variable which does have an impact. 
The following conclusions were drawn from the analysis. The consistent significance of 
“osmolality residuals” indicates that certain components not directly monitored have a 
statistically significant impact on the difference in pH measurements. It is thought that 
osmolality residuals behaviour in the pre-bolus BS data were primarily caused by culture 
medium and that osmolality residuals behaviour in the AS data were primarily due to the 
bolus additions. 
An unanticipated benefit of the calculated variable ‘osmolality residuals’ was a reduction 
in variation in usable sample numbers during iterative model generation. The inclusion 
of ‘osmolality residuals’ effectively acted as a filter, whereby a sample needed to have all 
variables used in the calculation of ‘osmolality residuals’, regardless of whether those 
contributing variables were retained in the subsequent model for predicting differences in 
pH reading. This benefit would only be active so long as ‘osmolality residuals’ is retained 
as statistically significant, the consistent significance of ‘osmolality residuals’ allowed 
greater user confidence in statistical results as sample size variation was reduced. 
A second key variable identified as statistically significant was temperature. Before the 
change in temperature and pH operating setpoint, temperature did not have a statistically 
significant impact on differences in pH readings. After the reactor operating temperature 
was reduced, the effect of temperature was statistically significant. One possible 
explanation for this result is a difference in pH-temperature compensation methods used 
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by the technologies. As the degree of compensation required increases, any difference in 
compensated values will similarly increase. 
Temperature was identified as statistically significant when the bench technology or the 
online technology were compared to the NOVA and the AS2 data is used. This was when 
the effects of different temperature compensations would be most emphasised as the shift 
in operation conditions includes a drop in temperature. Hence the gap between the 
temperature when the online reading (at culture conditions) or bench reading is taken (at 
or below reactor conditions) and the NOVA (37 °C) increases. 
Finally it must be noted that the discrepancies in pH readings between the bench and 
NOVA technologies were more accurately modelled than the discrepancies between the 
online technology and either offline technology. The models comparing offline 
technologies tended to significantly outperform those comparing either offline 
technology to the online technology. 
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Model Set 
Variable 
 ALL   BS   AS2  
B-P B-N N-P B-P B-N N-P B-P B-N N-P 
Constant          
Time          
Temp          
DOT (%)          
pO2          
pCO2          
Gln          
Glu          
Gluc          
Lac          
NH4+          
Na+          
K+          
TCC          
Osmo Res          
Model R2 13.8% 38.9% 15.1% 19.6% 45.8% 39.1% 7.9% 46.5% 13.1% 
Table 14. Variables identified as statistically significant (p < 0.05) when using iterative MLR and significance testing method (indicated by shading). Results are given 
for three dataset (ALL, BS, AS2) and three responses (B-P, B-N, N-P). It was observed that temperature was a significant variable when modelling data taken from 
after a change in operation temperature was introduced. The new variable Osmo Res was significant in all models comparing two  readings by technologies using 
different compensation methodologies (B-N, N-P).
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4.9 Conclusions 
While much of what causes the discrepancies between the competing pH measurement 
technologies is still not understood, it has been shown that pH technologies are not 
necessarily interchangeable. If two different technologies are to be used in conjunction, 
e.g. the NOVA is used for offline measurements and a different pH technology is used 
for online measurements, differences in pH measurement could be caused by pure 
instrument error, drift by the online technology, sample composition and condition, or a 
mixture of all three. Eliminating sample composition and condition as possible causes of 
differences  
It was possible to attribute part of the differences in pH measurement technologies to 
differing sensitivities to sample components. The pH technologies were considered as 
whole units, therefore it is not known if these differing sensitivities are caused by different 
probe designs or some other aspect of the technologies. However as both technologies 
operate on the same principles of potentiometrics, it is thought that the issue lies mainly 
with the built-in compensation methods. 
Based on the project work and results, there are several recommendations to be made with 
regards to pH strategy. 
1. Offline and online monitoring technologies should be as similar as possible, e.g. if a 
NOVA is used for online monitoring, then a NOVA should be used as the primary 
offline monitor and used to make adjustments. 
2. Comparability of pH measurement technologies should be demonstrated across a 
variety of conditions within the culture design space including temperature. 
3. The type of online and offline equipment used in a project should be recorded to 
ensure the same equipment is used at all scales of reactor. 
4. Monitoring the unadjusted or ‘true’ online pH reading and comparing this value to 
the offline technologies may prove useful in identifying faulty or drift-prone probes. 
5. Improved capture and analysis of individual pH probe performance over probe 
lifespan. This applies to both online and offline pH probes. 
6. Using the same technologies for online and offline control throughout a project (i.e. 
initial lab testing to full production) will prevent the introduction of avoidable error. 
This will also aid consistency in corrective actions made by the scientist and the 
control systems. 
.   
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 Productivity Investigation 
5.1 Introduction 
One of the most common hurdles to the introduction and implementation of statistical 
techniques is “Where do I begin?” In highly regulated environments, such as 
biopharmaceutical production, this is closely followed with “What is the correct 
technique?” The issue here is the presumption that there is a single best technique. The 
aim of the presented productivity investigation was to attempt to answer these two 
questions when identifying causes and indicators of poor productivity for a 
mAb-producing cell line (Project A). An additional aim was to design a more general 
approach for using historical data to identify weaknesses specific to the customer project 
and weaknesses general to the process. 
5.2 Project Summary 
Project A used a GS-NS0 cell-line to express a mAb which underwent a series of 
cultivations in 10L air lift reactors (ALR) to determine transferability of the cell-line from 
an external process to a bespoke Lonza process. After 15 cultures at the 10L scale, the 
cell-line was cultured at a 130L pilot scale. The 130L culture failed to reach an acceptable 
titre causing an intensive investigation of different parameters that could have affected 
the culture and three more 130L pilot scale cultures. In total, over 50 production-stage 
cultivations were performed at the Lonza Slough site and formed the main dataset for 
analysis. 
Project A was then transferred to Lonza’s production site in Portsmouth, New Hampshire, 
USA for four cultures at the 5000L scale. Underperformance at this scale and process 
validation requirements led to additional investigations in the US at the 10L scale, 
including a Design of Experiments study testing temperature, pH, DO, and feed 
parameters. A further four 5000L cultivations were performed. In addition to the change 
in physical location, US-sited cultures had modified seeding conditions and altered 
air/oxygen gas feed control parameters. 
In total, Project A comprises data from 99 production-stage cultivations (49 UK, 50 
US)4with  eighty-seven 10L cultures, four 130L cultures, and eight 5000L cultures (Table 
15). 
                                                 
4 Cultivations halted early due to contamination or other known issues were excluded from analysis. 
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Data for Project A were drawn from two sources. 
1. Daily monitoring records created by daily sampling 
2. Online monitoring 
The percentage of data missing cross the 99 cultures was strongly dependent on number 
of days of data considered and variables included, reaching ~25% when all possible days 
and monitored variables were considered. This was due to a variety of reasons including 
equipment such as NOVA Bioprofile 400 sensors not operating correctly during daily 
sampling, data collection for satellite/drop out cultures beginning on Day 4 of the main 
pilot, and not part of normal data collection at all scales (e.g. osmolality). 
5.3 Aims 
The overall aim of the productivity investigation was to test possible combinations of 
analytical options to identify suitable methods robust and adaptable enough to be 
transferred to other investigations. Methods were evaluated on relative ease in 
implementation and interpretability in addition to statistical power. 
Initially, the specific aim of the productivity investigation was to identify key behaviours 
and related decision criteria leading to classification of bioreactor cultures classed as 
“High Producer” and “Low Producer”, with particular focus on the UK-sited cultures 
A001 to A049. As the dataset increased through the addition of the US-sited cultures, the 
investigation was split into three key stages: 
Stage 1. Initial Method Development 
Given the UK cultures A001 to A049 and clear pass/fail criteria, to identify a core 
statistical method with additional consideration of data sources used, handling of data 
missing at random, and the use of data compression. 
Stage 2. Improvements through Manipulation of Dataset Structure 
Given the mixed UK- and US-sited cultures A001 to A099 and using key results from 
Stage 1, to develop a method for understanding causes of variation in Day 11 product 
concentration. The focus during Stage 2 was to improve model robustness through 
choice of progression variable and rigidity of the dataset sampling structure. 
Stage 3. Media Batch Analysis. 
In Stage 1 and Stage 2, media batch numbers were not included as a factor. The 
objective in the third stage was to determine whether variation in the media batches 
used were a contributing factor to variation in productivity.  
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UK-Sited Cultures  US-Sited Cultures 
ID Scale  ID Scale ID Scale  ID Scale 
A001 10 L A026 10 L A0505 5000 L A075 10 L 
A002 10 L A027 10 L A0516 5000 L A076 10 L 
A003 10 L A028 10 L A0527 5000 L A077 10 L 
A004 10 L A029 10 L A0538 5000 L A078 10 L 
A005 10 L A030 10 L A054 10 L A079 10 L 
A006 10 L A031 10 L A055 10 L A080 10 L 
A007 10 L A032 10 L A056 10 L A081 10 L 
A008 10 L A033 10 L A057 10 L A082 10 L 
A009 10 L A034 10 L A058 10 L A083 10 L 
A010 10 L A035 10 L A059 10 L A084 10 L 
A011 10 L A036 10 L A060 10 L A085 10 L 
A012 10 L A037 10 L A061 10 L A086 10 L 
A013 10 L A038 10 L A062 10 L A087 10 L 
A014 10 L A039 10 L A063 10 L A088 10 L 
A015 10 L A0402 130 L A064 10 L A089 10 L 
A0161 130 L A041 10 L A065 10 L A090 10 L 
A017 10 L A042 10 L A066 10 L A091 10 L 
A018 10 L A0433 130 L A067 10 L A092 10 L 
A019 10 L A044 10 L A068 10 L A093 10 L 
A020 10 L A045 10 L A069 10 L A094 10 L 
A021 10 L A0464 130 L A070 10 L A095 10 L 
A022 10 L A047 10 L A071 10 L A0969 5000 L 
A023 10 L A048 10 L A072 10 L A09710 5000 L 
A024 10 L A049 10 L A073 10 L A09811 5000 L 
A025 10 L  A074 10 L A09912 5000 L 
Table 15. Project A cultures analysed in the productivity investigation by location. 1 - First 130 L 
culture. 2 - Second 130 L culture. 3 - Third 130 L culture. 4 - Fourth 130 L culture. 5 - First 
5000 L culture. 6 - Second 5000 L culture. 7 - Third 5000 L culture. 8 - Fourth 5000 L culture. 
9 - Fifth 5000 L culture. 10 - Sixth 5000 L culture. 11 - Seventh 5000 L culture. 12 - Eighth 
5000 L culture. 
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5.4 Stage 1: Initial Method Development 
A variety of core statistical techniques were evaluated for ease of use, ease of 
interpretability, and suitability for data to be analysed. Black box and near black box 
techniques such as self-organising maps (SOM) and artificial neural networks were 
rejected due to difficulty of result and model interpretability. Discriminant analysis was 
rejected as the core statistical technique. This was due to the dataset containing only two 
classifications yet also containing a variety of conditions and potentially multiple paths 
to failure. 
Decision trees were selected as the core statistical technique due to relative ease of 
interpretability and the ability to be applied to heterogeneous datasets. Although decision 
trees are generally not a computationally intensive algorithm when compared to PLS or 
SOM, they are not heavily promoted in statistical software. Four decision tree algorithms 
were considered: Gain Ratio, Gini Index, Information Gain, and ReliefF (see §3.6). 
5.4.1 Stage 1: Data Selection 
Online monitoring data were recorded by dataloggers at 5 minute intervals. For cultures 
reaching 11 days, this resulted in over 3,100 readings per variable monitored per culture. 
In comparison, from inoculation to harvest, variables monitored through daily monitoring 
samples had 12 readings per variable. 
While each individual online monitoring point could be included as a variable, this would 
result in a highly unbalanced dataset when combining online and offline measurements. 
In order to reduce the volume of online monitoring data, new variables were created to 
capture online monitoring data through robust summary statistics termed “informative 
values” (these are discussed in greater detail in Appendix A). At the time of Stage 1 model 
development, Informative Values Version 1.0 was used (see Appendix A). In this version, 
data for each variable monitored online was split into “windows of activity” using offline 
sampling times. The average, standard deviation, gradient, and coefficient of 
determination was then calculated for each window of activity for each variable. 
Each combination of dataset, dataset sources, and cultures dataset displayed in Table 16 
were evaluated. At the request of the industry supervisor, the daily monitoring dataset 
was extended to included ratios and specific rates of change of biological interest. 
Detailed lists of variables in each dataset can be found in the appendices (Table 38 to 
Table 41). 
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5.4.2 Stage 1: Missing Data Handling 
Four general approaches for the handling of missing data considered for use are briefly 
compared in Table 17 and are described in further detail in §5.4.2.1 to §5.4.2.4. Of the 
four approaches, three were employed: Fill In with Average, Rate Estimation, and 
iterative PCA. Two versions of Fill In with Average and Ratio Estimation were created, 
resulting in a total of five methods to be tested. 
 
Dataset Name Dataset Source Cultures in Dataset 
Daily Monitoring Offline sampling All 
Online Monitoring Online monitoring* All 
Daily Monitoring and Online 
Monitoring 
Offline sampling 
Online monitoring* 
All 
Control Offline sampling 
Online monitoring* 
Cultures with non-control 
conditions excluded. 
Daily Monitoring (Online 
Monitoring for Estimation) 
Offline sampling 
Online monitoring** 
All 
Table 16. Summary of Dataset Combinations Tested. The primary difference between datasets 
was whether online monitoring and offline monitoring datasets were concatenated. 
 
 
 
Method Description Statistical Effects Practicality 
Cut Down Remove variables and/or 
samples with missing data. 
Can result in few variables 
and/or few samples remaining. 
Manually 
intensive. 
Fill In with 
Average 
Replace missing data with 
mean of available values. 
Assumes mean as appropriate 
estimate. Reduces data spread. 
Simple to 
implement 
Rate 
Estimation 
Ratios calculated between 
sampling points used to 
estimate values. 
Assumes behaviour 
independent of other variables. 
Extensive set-
up work 
required. 
Iterative 
PCA 
PCA models created until 
estimated values converge. 
Limit to missing data required 
to prevent spread reduction as 
seen in Fill In With Average. 
Proprietary 
software. 
Table 17. Summary of Missing Data Treatments Considered. “Cut Down” was rejected due to 
poor industrialisation potential. Two versions of Fill In with Average and Ratio Estimation were 
created, resulting in a total of five methods to be tested   
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5.4.2.1 Stage 1: Missing Data Handling: Cut Down 
One method for the handing of missing data that is often considered an ‘easy option’ is 
the exclusion of variables with missing values or samples with missing values. As seen 
in Table 18 and Table 19, both of these approaches can vastly reduce data available for 
analysis. A combined approach is used in Table 20 to give the maximum retention of 
recorded data while excluding missing data. 
Furthermore, while these approaches are seen as simple to implement, applying the final 
model to new data can become considerably more complicated if the dataset must be 
manually picked through for variable removal. Initial plans to demonstrate the negative 
effects of this approach on models produced were aborted due to the time-consuming 
manual work needed to apply the approach to datasets. 
  Variable 
  A B C D E F G H 
S
am
p
le
 
1      ● ●  
2 ●       ● 
3  ●       
4         
5    ● ●    
Table 18. Removal of samples with missing data leaves one sample. ● – missing data. Shading – 
excluded sample. 8 values out of 33 remain (25%) 
  Variable 
  A B C D E F G H 
S
am
p
le
 
1      ● ●  
2 ●       ● 
3  ●       
4         
5    ● ●    
Table 19. Removal of variables with missing data leaves one variable. ● – missing data. Shading 
– excluded variable. 5 values out of 33 remain (15.6%) 
  Variable 
  A B C D E F G H 
S
am
p
le
 
1      ● ●  
2 ●       ● 
3  ●       
4         
5    ● ●    
Table 20. Removal of samples and variables to give best exclusion of missing data. ● – missing 
data. Shading – excluded variable. 15 values out of 33 remain (46.9%)  
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5.4.2.2 Stage 1: Missing Data Handling: Fill In With Average 
While it is known that the “Fill In With Average” method of infilling missing data 
artificially reduces variance and variable distributions with potentially significant knock 
on effects on other summary statistics (Table 21), it remains a popular suggestion due 
relative ease of application to a dataset. Two versions of the method were tested to 
demonstrate the effects on a real dataset as a cautionary point of reference if suggested in 
future investigations. 
‘Mean Estimate’ refers to where the mean of a variable was calculated using all available 
values for that variable. In this version, there is no filtering of the dataset to determine 
whether or not a sample’s data is used, hence the calculated mean is influenced by all 
operating conditions represented in the dataset. 
‘Historical Mean’ refers to where the mean of a variable was calculated only from cultures 
operating under normal control conditions. Ideally, use of an average value from control 
cultures only would result in a value representative of ‘normal’ behaviour. 
 
-86 -10 11 67 -91 -22 -14 -60 -74 -7 
-8 89 68 76 -28 67 39 86 76 71 
83 56 21 37 -57 -45 -9 99 38 -31 
-93 29 -82 -52 78 92 71 0 -38 -82 
-11 -96 91 49 22 34 -87 -98 13 -64 
26 23 -70 58 -24 -39 -50 80 22 61 
6 -11 24 -36 61 88 -41 4 96 43 
-62 50 -17 31 63 79 30 90 -63 -70 
95 9 -89 -73 5 -74 -98 82 14 -35 
-30 46 78 25 -65 -78 17 12 18 -63 
Table 21. Dataset of 100 values generated using Microsoft Excel formula 
“=RandBetween(-100,100)” with mean = 4.66 and median = 11.5. 8% of the dataset (indicated 
by shading) is removed at random. The remaining dataset has mean = 3.65 and median = 12. This 
represents changes in mean and median of -22% and 4% respectively with the dataset median 
showing greater robustness to missing data than the dataset mean. If the missing values were 
replaced with the remaining dataset’s mean 3.65, the filled in dataset would have mean = 3.65 
and median = 3.83. When these statistics from the filled in dataset are compared to the original 
dataset, the changes in mean and median are -22% and -67% respectively. Hence the previously 
robust median is significantly altered.  
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5.4.2.3 Stage 1: Missing Data Handling: Rate Estimation 
Rate estimation was the term used to describe a form of interpolation whereby observed 
rates of change of a variable were used to estimate missing data. For this method, a rate 
of change was calculated for each variable for each window of activity (i.e. between two 
consecutive sampling points) for each culture using: 
𝑥𝑛,𝑛+1̇ =
𝑥𝑛+1 − 𝑥𝑛
𝑡𝑛+1 − 𝑡𝑛
 Eq. 6.1 
Where 𝑥𝑛,𝑛+1̇  is the rate of change of a variable across the window of activity defined by 
sampling points 𝑛 and 𝑛 + 1, 𝑥𝑛+1and 𝑥𝑛 the recorded values for the variable of interest 
at those sampling points, and 𝑡𝑛+1and 𝑡𝑛 the time of the samplings points as Elapsed Time 
(h). If either 𝑥𝑛+1or 𝑥𝑛  was missing, no rate was calculated. 
Two mean rates were calculated for each window of activity 𝑛, 𝑛 + 1 (Figure 16). The 
first mean rate was calculated using all available rates of change across all cultures and 
referred to as the ‘Mean Ratio’, 𝑀𝑥𝑛,𝑛+1̇ . The second mean rate was calculated from a 
subset of control cultures and referred to as the ‘Historical Ratio’, 𝐻𝑥𝑛,𝑛+1̇ . Missing 
values were estimated using Eq. 6.2 and Eq. 6.3 to plot the values in Figure 17. 
𝑀𝑥𝑛+1̂ = 𝑀𝑥𝑛,𝑛+1̇ (𝑡𝑛+1 − 𝑡𝑛) + 𝑥𝑛 Eq. 6.2 
𝐻𝑥𝑛+1̂ = 𝐻𝑥𝑛,𝑛+1̇ (𝑡𝑛+1 − 𝑡𝑛) + 𝑥𝑛 Eq. 6.3 
where 𝑀𝑥𝑛+1̂  is the value predicted using the Mean Rate and 𝐻𝑥𝑛+1̂  is the value predicted 
using the Historical Rate. If a missing value was from the point of inoculation (𝑛 = 1), 
then Eq. 6.4 and Eq. 6.5 were used. This was the only instance in which extrapolation 
was permitted. 
𝑀𝑥1̂ = 𝑀𝑥1,2̇ (𝑡1 − 𝑡2) + 𝑥2 Eq. 6.2 
𝐻𝑥1̂ = 𝐻𝑥1,2̇ (𝑡1 − 𝑡2) + 𝑥2 Eq. 6.3 
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Figure 16. Rates of change in pO2 between consecutive sampling points were calculated for each 
culture (---). Note that if any of the data points needed to create the ratio was missing, no value 
could be calculated. A mean average rate for rates of change in pO2 was calculated using all 
available rates (-●-). These mean rates were used to estimate missing values such as those in 
Figure 17. 
 
 
Figure 17. Three cultures with missing values for pO2 were treated using ratio estimation. Dashed 
lines link the estimated values to the directly measured values. Note that estimated points do not 
lie in the same locations that simple linear interpolation would place them.  
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There are three main assumptions that must be made for this form of interpolation. First 
is the assumption that rates of change for a variable are independent of other variables in 
the dataset. Second is the assumption that the relationship is a simple proportionate 
relationship and not more complex, such as a quadratic relationship. A simple example 
of the importance to this assumption is a variable with a parabolic relationship with time. 
Simple linear interpolation may be adequate if (𝑡1, 𝑥1) and (𝑡2, 𝑥2) lie on the same side 
of the vertex, however it is obvious how simple linear interpolation is inappropriate if 
they lie opposite sides of the vertex.  Finally, this form of missing data estimation assumes 
that the behaviour seen in other cultures (from which 𝑀𝑥𝑛+1̂  and 𝐻𝑥𝑛+1̂  are calculated) 
is the same as the behaviour exhibited by the sample in question. 
5.4.2.4 Stage 1: Missing Data Handling: Iterative PCA 
The methods presented thus far have been non-iterative calculations where a single 
replacement value is calculated. Iterative PCA (iPCA) is a form of inferential estimation 
which uses algorithmic modelling to estimate values for missing data based on the 
dataset’s covariance matrix. Missing values are first replaced with the variable mean. A 
PCA model is generated to capture a set percentage of variance. Based on this model, 
new values are substituted for missing data with the new values selected based on 
consistency with the PCA model loadings. A new PCA model is generated and new values 
are substituted. This process is repeated until a suitable level of convergence is reached, 
i.e. the change when substituting new values drops below a threshold. 
According to the Eigenvector Wiki “[u]sing PCA to replace data generally works better 
than using the mean of a variable because it uses the covariance in the data to estimate 
what the missing values should be.” This method of missing data estimation was deemed 
to be of potentially high value as missing data is based on behaviour across all variables.  
This form of missing data estimation was easily implemented as it is a feature of the PLS 
Toolbox (Eigenvector) and performed automatically during model creation. However as 
a software specific method, use of iPCA is dependent on software availability or 
significant time investment for an internally useable version. 
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5.4.3 Stage 1: Decision Tree Algorithm 
Four decision tree algorithms were considered in this investigation: Information Gain, 
Gain Ratio, Gini Index, ReliefF. Detailed descriptions of how these algorithms function 
can be found in Chapter 2. To reiterate key differences according to Han et al. (2011), the 
Information Gain and Gini Index algorithms are biased towards attributes with a greater 
number of possible values when selecting decision criteria. The Gain Ratio algorithm is 
biased to unbalanced splits, e.g. one partition is much smaller than the others. The fourth 
algorithm considered was ReliefF, an adaptation of the Relief algorithm that includes a 
k-nearest neighbour function when selecting decision criteria. While ReliefF is only 
available with the data mining software Orange (University of Ljubljana), it was included 
to demonstrate whether investing in a more specialised algorithm could yield any benefit.  
5.4.4 Stage 1: Data Transformation 
Loss of context is a problem when using decision trees as single attributes are selected 
for decision criteria, particularly in the evaluation of a dataset in an unmodified state, i.e. 
values are as recorded, here referred to as “As Is”. Furthermore, the reliance on a single 
variable reading can lead to spurious decision criteria and, consequently, a lack of 
robustness. The application of PCA as a data transformation step during pre-processing 
was investigated as a means of retaining contextual information and reduce spurious 
decision criteria selection. 
 
 
Figure 18. The two analysis pathways shown differ only in whether the dataset is passed 
directly to a decision tree algorithm or whether the PCA is applied to the dataset as a pre-
processing step with the resulting PC scores then passed to the decision tree algorithm. 
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Following the process shown in Figure 18, PCA models were created for each 
combination of data source and missing data treatment using Eigenvector PLS Toolbox 
with random sampling as cross-validation (10 splits, 5 iterations). The first 10 PC scores 
for each dataset were extracted for decision tree creation. The number of PCs used was 
chosen to ensure a minimum of 90% of dataset variance was transfered to decision tree 
creation while maintaining a standardised method. 
5.5 Stage 1: Method 
The cultures were numbered as Pro_A001 to Pro_A049 and then classified as “High” or 
“Low” producers based on product concentration at harvest. The cut-off value was chosen 
to take into account a customer-defined breakeven point for economic viability (for 
confidentiality, this value cannot be stated). Of the 49 cultures analysed, 38 cultures were 
classed as “High” producers (pass) and 11 cultures were classed as “Low” producers 
(fail). 
Decision trees were created for all possible combinations of options listed in Figure 19 
using exhaustive binarisation for optimal split with leaf-splitting stopping criteria of 95% 
purity and m-estimate post-pruning (m=2). To prevent overfitting of models, 30% of 10L 
cultures were randomly selected as a validation dataset. The four 130L pilot cultures were 
excluded from calibration datasets as a final testing dataset. In total, 120 decision trees 
were evaluated for size, classification accuracy, and interpretability. 
 
 
Figure 19. Summary of method options. Three combinations of data sources (daily monitoring, 
online monitoring, and combined daily monitoring and online monitoring) were treated with five 
different processes of missing data estimation. After missing data estimation, the datasets were 
then passed to four different decision algorithms. This was performed with the data “As Is” (i.e. 
with no additional pre-processing). The analyses were repeated using PCA as a pre-processing 
with the resulting PC scores passed to the decision tree instead. 
Data Source
•Daily Monitoring
•Online 
Monitoring
•Daily Monitoring 
and Online 
Monitoring
Missing Data 
Estimation
•Mean
•Historical Mean
•Rate
•Historical Rate
•iPCA
Decision Tree 
Algorithm
•Information Gain
•Gain Ratio
•Gini Index
•ReliefF
Data 
Transformation
• 'As Is'
•Principal 
Component 
Scores
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5.6 Stage 1: Results and Discussion 
Decision tree results and options were evaluated in two ways. In the first, a main effects 
plot was created with classification accuracy of the testing dataset as the response (Figure 
20). From this it was seen that use of data from daily monitoring samples for all cultures 
generally gave higher classification accuracy. Inclusion of online monitoring data (here 
downsampled using Informative Values 1.0) had little effect on test set classification 
accuracy, however a general decrease was observed when using online monitoring data 
alone. Collating online monitoring and daily monitoring datasets for estimation of 
missing data followed by the use of only from daily monitoring had a negative effect on 
testing accuracy. 
A decrease in test set classification accuracy was seen when cultures with deliberate 
experimental conditions were excluded from the daily monitoring dataset (“Control”). 
This demonstrated the effect of over fitting a model by calibrating using only control 
behaviours, particularly when a range of behaviours are to be considered. Deliberate 
inclusion of non-control conditions allowed multiple paths to failure and success to be 
identified in addition to a decreased likelihood of spurious decision criteria selection. In 
short, robust models cannot be calibrated from “Golden Batches” alone. 
The missing data estimation method with the highest testing accuracy was the iPCA 
method included in the EigenVector PLS Toolbox. This was as expected as iPCA 
estimates values based on both the culture’s behaviour across all variables and the 
behaviour of all other cultures in the dataset across those variables, whereas the other 
methods considered behaviour at a single variable at either a single sampling point or 
between two successive sampling points. Further evidence for this conclusion was the 
minor increase in classification accuracy when online monitoring data were included 
during iPCA estimation but excluded from model creation. 
Similar conclusions to the above were made when method option results were evaluated 
on a case by case basis. In the first evaluation method, there appeared to be little benefit 
in creating a PCA model in order to use PC scores in place of the original dataset in terms 
of pure testing accuracy. However, discussion-based evaluation revealed that use of PC 
scores led to greater understanding of differences between high and low producers. This 
was due to the greater contextual information in decision criteria, i.e. values for splits 
were determined from behaviour across multiple variables and multiple days, not a single 
variable at a single time point (e.g. “Glucose (g/L) on Day 6”).
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Figure 20. Main Effects Plot for Testing Accuracy. Four options were evaluated: data type (referring to datasets used), estimation method for missing 
data, decision tree algorithm, and treatment, i.e. whether data were compressed into PCA scores for decision classification or if data that had not first 
been summarised as PC scores (‘As Is’). *Daily monitoring data from control cultures only. **Online monitoring data including during missing data 
estimation.
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It was noted in both cases that interpretation was made difficult by the mixed 
cause/response nature of some variables (e.g. lactate concentrations) as compared to pure 
cause variables (e.g. temperature). As such, using the more context/information rich PC 
scores could provide a more informed basis for action. 
Based on these results, the developed method was as follows: 
1) Online monitoring data is summarised as informative values. 
2) The informative values dataset and daily offline monitoring datasets are collated. 
3) The collated dataset is unfolded into the profile (short and wide) configuration. 
4) iPCA is used  to estimate missing values. 
5) The dataset is mean centred and scaled to unit variance. 
6) A PCA model is created using random sampling and multiple iterations. 
7) PC scores from the model are extracted as a new dataset. 
8) A decision tree is created to classify cultures based on PC scores using the Gini Index. 
The decision tree with the highest classification accuracy is shown in Figure 21. Analysis 
of loadings for PCs selected as decision criteria allowed overall trends to be analysed. 
Contribution analysis of scores allowed more specific behaviours to be further 
investigated. Applying this approach to the first failure at pilot scale (A016) indicated 
initial seeding conditions and subsequent glutamine behaviour as the main areas of 
deviant behaviour. While a specific cause for the altered glutamine behaviour could not 
be identified from the data analysed, it was suggested that batch-to-batch variation in 
media powders used could be a possible contributing factor. 
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Figure 21. Decision tree with the highest classification accuracy and matching top options 
(DMDLG, PC, iPCA, Gini Index). Pie charts indicate the distribution of high-producing (blue) 
and low-producing (red) cultures at the node. Information written within the node indicates the 
majority class, majority class probability, target class probability, and the total number of 
instances on the node. Note that the values displayed are for the calibration dataset (29 cultures) 
and not the validation dataset.  
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5.7 Stage 2: Improvements through Manipulation of the Dataset Structure 
In stage 1, a basic method for data analysis was suggested and locally optimised for 
available options. While this method met the stated objectives of classifying cultures 
A001 to A049 and identifying key indicators, there were several areas which could be 
further improved. Two areas for improvement addressed using the dataset A001 to A099 
in Stage 2 were: 
 The definition of progress measurement for a fed-batch culture. 
 Rigidity in data collection with respect to culture progress. 
PCA analysis of the mixed UK and US dataset indicated confounding caused by the 
differences in seeding. Due to this confounding and a change in investigation focus, the 
proposed alterations were not evaluated using decision trees and pass/fail criteria. Instead, 
the proposed alterations were evaluated when predicting Day 11 product concentration 
using PLSR.  
5.7.1 Stage 2: Defining Progress and Progression Variables 
Time is so heavily embedded in the concept of progress that it can be found in its 
definition: to improve or develop over a period of time [163]. However, while time must 
pass for progress to occur, should its de facto status as the yardstick for progress go 
unquestioned? When defining progress, should something other than time be plotted on 
the X axis? 
A non-biological example of questioning measures of progress is academic performance 
of students and the question of “Is my child’s intelligence developing normally?” In a 
study on intelligence development in school children [164], it was shown that, for 
intelligences evaluated using verbal and numerical tests, progress was better defined in 
terms of terms of time in education (“psycho-educational age”) than in terms of absolute 
physical age (“biological age”). However, biological age tended to be a more appropriate 
when considering intelligences evaluated using figural tests (see Figure 66 and Table 43 
in Appendix B). 
The cell culture analogy to these measures are the absolute values of viable cell 
concentration and elapsed time (analogous to biological age”) and the calculated integral 
of viable cell concentration, which measures growth since inoculation (analogous to 
psycho-educational age).  
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5.7.1.1 Stage 2: IVC as a Progression Variable 
The integral of viable cell concentration (IVC) was proposed as an alternative progression 
variable for fed-batch and batch cultures, in place of Elapsed Time (h) or Elapsed Day 
(d). Evidence supporting IVC as an alternative progression variables are as follows: 
1. From a conceptual perspective, IVC captures “culture history” in a single value. As 
IVC is calculated by summing the area beneath a viable cell concentration growth 
curve, the change in IVC between sampling points takes into account both the time 
between sampling points and the level of growth between sampling points. Hence 
while time still plays a role in measuring progress, using IVC to measure progress 
would allow for a more biology- and response-based yardstick to be employed. 
 
2. An initial evaluation of correlation between events in air and oxygen profiles against 
different progression variables was performed for cultures A001 to A049. It was 
identified that there was comparable or greater correlation between when IVC was 
used in place of Elapsed Time (Figure 22). A follow up evaluation indicated that, in 
general, these correlations were stronger once experimental, non-control cultures 
were excluded. 
 
3. PLSR models predicting product concentration were created using daily monitoring 
and online monitoring data from A001 to A049 for the following variable sets: 
a. No Progression Variable — “Obvious” progression variables VCC, TCC, 
Elapsed Time (h), and IVC excluded from dataset. 
b. Elapsed Time — VCC, TCC, and IVC excluded from dataset  
c. IVC — VCC, TCC, and Elapsed Time (h) excluded from dataset. 
PLSR were created for each subset using the SIMPLS algorithm with random sampling 
and multiple iterations (10 splits, 10 iterations). The final models were selected based on 
maximum R2 during cross validation. Full listings of the variables used and details of the 
final models can be found in Table 45, Table 46, and Table 47 in Appendix B, 
respectively. Data from US cultures A050 to A099 were then applied as a testing dataset. 
Figure 23 shows the predicted product concentration against the measured product 
concentration for the three models, in addition to the calibration R2, cross-validation R2, 
and the US testing dataset R2. 
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Considering only R2 for UK cultures and UK predictions, it was seen that the highest 
values calculated for R2 were reached in models where IVC was included as a measure 
of progress (Figure 23C) and lowest when no explicit progression variable was included. 
In addition to improved predictive power, increased linearisation of predicted value 
against measured value was noted when IVC was included in the model. 
These improvements in model predictive accuracy and linearisation of residuals were 
preserved when considering data from the US-sited cultures A050 to A099. This was of 
particular note as it indicated that use of IVC as the progression variable could convey 
greater model transferability between sites and scale than Elapsed Time (h). 
 
 
 
 
Figure 22. Correlations between Day 11 [Product] (mg/L) and specific events in air and oxygen 
feed profiles for cultures A001 to A049. It was observed that correlation between events and IVC 
was strongly affected by sample selection, with the dataset including all growth conditions having 
notably lower correlation with air and oxygen profile events than when the dataset was restricted 
to control conditions cultures only. Most notable is the strong correlation between IVC with the 
activation of the oxygen feed for control condition cultures. Also notable is correlation between 
IVC at half of air capped flowrate and the IVC at the air capped flowrate for control condition 
cultures. Note that correlations were multiplied by -1 for ease of viewing.   
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A. Progression Variable: 
“None” 
 
UK Data Prediction 
Cal R2 = 0.76 
 
UK Data Prediction 
CV R2 = 0.71 
 
US Data Prediction 
R2 = 0.77  
 
 
B. Progression Variable: 
Elapsed Time 
 
UK Data Prediction 
Cal R2 = 0.86 
 
UK Data Prediction 
CV R2 = 0.83 
 
US Data Prediction 
R2 = 0.82  
 
 
C. Progression Variable 
IVC 
 
UK Data Prediction 
Cal R2 = 0.97  
 
UK Data Prediction 
CV R2 = 0.95 
 
US Data Prediction 
R2 = 0.94  
 
 
Figure 23. US data (red triangle ▼) applied to models calibrated from UK data (grey square ■). 
The green line shows the ideal 1:1 relationship between measured and predicted product 
concentrations. The red line shows the actual line of correlation between measured and predicted 
product concentrations. Note that values have been hidden due to confidentiality requirements. 
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5.7.2 Stage 2: Dataset Rigidity 
Dataset rigidity is the adherence of sampling to a set interval size. Here, it is considered 
as a measure of a specific form of noise: random underlying temporal variation created 
by variation in sampling intervals for different cultures. In a dataset, this temporal 
variation is captured in addition to the variation of interest. Any model algorithms in 
subsequent analyses must be able to separate the undesired, underlying temporal variation 
from the variation of interest. If this cannot be done to a sufficient level, there is the risk 
of incorrect conclusions being drawn and used to justify further actions. 
5.7.2.1 Hypothetical Example 
Ten cultures grow identically. By chance a culture is always sampled slightly later than 
the other nine cultures. When metabolite and cell growth data are analysed, the culture 
will appear to be more advanced that the other nine by virtue of later sampling times. This 
could be fixed by including the sampling time as a variable in analyses, however this 
could lead to unhelpful results, e.g. time being identified a key predictor for product titre 
instead of viable cell concentration. 
5.7.3 Stage 2: Dataset Realignment 
The suggestion was made that reduction or elimination of the underlying temporal 
variation introduced by variation in sampling time could be achieved through appropriate 
manipulation of the dataset. More specifically, it was suggested that this could be 
achieved through interpolation of sampling data to user-defined values for a progression 
variable. 
For concept clarity, dataset realignment is here described in terms of time as this is easily 
accessible conceptually and forms the basis of typical sampling procedures However, the 
concept of rigidity can be applied to any variable deemed to be the progression variable, 
e.g. IVC. While it would be very difficult to implement a sampling procedure based on 
such an approach5, it may be possible to impose adherence after data are generated. 
It is key to note that imposing rigid structure based on a given variable alters the 
distributions of all other variables (Figure 24.), which may be undesirable or unacceptable 
and potentially have an overall negative effect in subsequent analyses.  
                                                 
5 A possible solution is the use of in-line probes to create alerts when a monitored progression variable 
reaches a pre-determined sampling point value. 
 99 
 
 
Figure 24. Comparison of distributions of values for readings of elapsed time and IVC for cultures 
A001 to A049 when using three different datasets: Natural (e.g. approximately 24 h sampling 
interval), Time Aligned (e.g. rigid 24 h sampling interval), and IVC Aligned (e.g. rigid structure 
imposed using select values for IVC). 
A. Natural Data – showing variation in elapsed time for readings. Note that A016, whose data 
became offset due to both a non-standard interval and multiple data entries, can be visually 
identified as a temporal outlier. 
B. Natural Data – showing variation in IVC for readings. 
C. Time Aligned Dataset – showing lack of variation in elapsed time for readings. 
D. Time Aligned Dataset - showing variation in IVC for readings. 
E. IVC Aligned Dataset – showing variation in elapsed time for readings. 
F. IVC Aligned Dataset - showing lack of variation in IVC for readings. 
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5.7.4 Stage 2: Progression Variable Selection and Alignment Effects  
In Section 5.7.1 the potential benefits of alternative progression variables when analysing 
datasets with variation in sampling timepoints were demonstrated. The next part of the 
investigation focussed on the influence of imposing a rigid progression structure on a 
dataset by forcibly aligning data to specific progression points as outlined in Section 
5.7.2. 
Using A001 to A049 as the calibration dataset, three alignments were considered: 
1. ‘As Is’/unaligned allowing for natural variation in sampling time. 
2. Realignment to user-defined values for Elapsed Time (h). 
3. Realignment to user-defined values for IVC. 
A further hypothesis was that realignment of data to user-defined values for the 
progression variable would allow the progression variable itself to be excluded from 
analysis. Hence a comparison was made between models where the progression variable 
was included and models where the progression variable was excluded. 
As demonstrated in several publications [44,165,166], there are benefits to unfolding or 
reorientation of the dataset to treat each row as representing a single sampling of data 
during a culture (“Day by Day”) or to aggregate serial observations of a culture as a single 
observation spanning the full duration of the culture (“Profile”). A Day by Day versus 
Profile comparison was made to determine whether dataset alignment effects, if any, were 
dependent on dataset orientation. 
An area of concern was the suitability of the developed method for multiple responses of 
interest. In this study, the response of interest was Day 11 product concentration. 
However, future investigations utilising the developed methods may focus on maximising 
viable cell concentration or maintaining culture viability. For this reason, alignment and 
rigidity effects were evaluated for three responses: [Product] (mg/L), Viability (%), and 
Viable Cell Concentration (VCC) (106 cells/mL). 
A final factor investigated was the effect of using only data originating from offline 
monitoring versus using data from both online and offline monitoring. To achieve this, 
informative values for online monitoring were recalculated to match the progression 
points used for realignment. 
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5.7.5 Stage 2: Method 
Daily monitoring data were aggregated into a single dataset. Alignment points were 
selected using mean and median values across samples with numbers rounded to give 
standardised progression between interval points (Table 22 and Table 23). 
In the original dataset of up to 14 samplings per culture, the maximum mean average for 
Elapsed Time (h) and IVC were 288.50 h and 1308.61 (106 cell/mL.h) respectively. As 
can be seen in Figure 25, few cultures reach these levels of progress. Maximum values 
chosen for time and IVC alignment points were 312 h and alignment point was 
1000 x 106 cell/mL.h respectively. 
Time realignment and IVC realignment were applied using the progression values listed 
in Table 22 and Table 23. 
 
 
Figure 25. Percentage of cultures A001 to A049 reaching stated values for progression variables. 
These percentages were used to be determine the number of sampling points, the final timepoint, 
and the maximum IVC values used for realignment of datasets. Online monitoring data were 
translated to the robust statistics version of informative values. Informative values were calculated 
using natural sampling times, user-defined time points (as part of time realignment), and times at 
which user-defined IVC values were reached (as part of IVC realignment). 
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Figure 26. Distribution of values for Elapsed Time (h) at progressive sample readings. It was 
observed that resampling of a culture could notably offset recorded points, as seen in the change 
in progression in the minimum Elapsed Time before and after Day 6. 
 
Original Sampling Point 
 
User-Defined Progression Points 
# Min. Mean Median Max. # Value 
1 0.00 1.38 0.97 4.58 1 0 
2 13.83 25.03 23.42 35.42 2 24 
3 35.18 46.91 45.95 58.08 3 48 
4 59.83 70.03 70.50 79.87 4 72 
5 82.50 95.55 93.08 110.00 5 96 
6 86.92 117.84 117.50 128.58 6 120 
7 103.83 141.75 139.67 153.33 7 144 
8 129.08 165.64 166.00 177.78 8 168 
9 152.58 189.46 188.83 200.60 9 192 
10 178.17 213.90 214.92 225.60 10 216 
11 200.92 236.36 235.63 252.33 11 240 
12 221.00 260.41 260.67 273.13 12 264 
13 229.52 280.50 279.12 301.50 13 288 
14 244.25 288.50 299.83 321.42 14 312 
Table 22. Evaluation of A001 to A099 recorded Elapsed Time (h) for selection of progression 
points. User-defined progression points were selected to give a 24h interval between samples. 
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Figure 27. Distribution of values for IVC ((106 cells/mL).h) at progressive sample readings. It 
was observed that a wide range of values were recorded for each day. This was due to both 
variation in Elapsed Time for the samples and the effects from different growth conditions. 
 
Original Sampling Point  User-Defined Progression Points 
# Min. Mean Median Max. # Value 
1 0.00 0.50 0.33 1.65 1 0 
2 4.05 12.01 10.50 26.25 2 10 
3 13.55 27.92 25.38 64.45 3 50 
4 27.33 56.88 56.73 132.22 4 100 
5 43.70 120.54 111.57 265.62 5 200 
6 62.65 217.28 209.29 485.60 6 300 
7 95.05 375.41 374.80 734.41 7 400 
8 181.66 590.22 568.52 958.95 8 500 
9 327.12 838.31 851.75 1144.19 9 600 
10 580.65 1068.51 1091.39 1277.62 10 700 
11 873.56 1203.21 1213.89 1474.63 11 800 
12 1039.97 1291.53 1295.17 1620.87 12 900 
13 1047.14 1311.23 1310.35 1672.92 13 1000 
14 1247.26 1308.61 1303.85 1374.72  
Table 23. Evaluation of A001 to A099 recorded IVC ((10^6 cells/mL).h) for selection of 
progression points. This was due to both variation in Elapsed Time for the samples and the effects 
from different growth conditions. The user-defined progression points were selected using the 
means and medians of the daily samples as a basic guide to appropriate intervals. 
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Daily monitoring datasets were combined with the appropriate complementary 
informative value datasets in both Profile and Day by Day arrangements. Data were 
imported to Matlab for analysis using the Eigenvector PLS Toolbox. iPCA was used to 
estimate missing values. PLSR models were created for all combinations of the options 
described below using random sampling for cross-validation. Due to differences in data 
sample numbers, Day by Day models used 10 splits with 10 iterations and Profile models 
used 7 splits with 5 iterations. Models were selected based on minimum RMSE during 
cross-validation. Tables fully detailing combinations and details of the models generated 
can be found in Table 48, Table 49, Table 50, and Table 51 in the Appendix B. 
Arrangement 
1. Profile - serial observations of a culture treated as a single sample. 
2. Day by Day - serial observations as multiple samples. 
Data Used 
1. Daily Monitoring - data collected through daily monitoring samples. 
2. Daily Monitoring and Online Monitoring - the Daily Monitoring dataset 
expanded to include data collected through online monitoring of cultures and 
summarised using a subset of Informative Values 7.0. (Table 42 in Appendix B). 
Variables Used 
1. No Obvious Indicators – Elapsed Time and IVC excluded from input dataset. 
2. Elapsed Time – IVC excluded from input dataset. 
3. IVC – Elapsed Time excluded from input dataset. 
Output (Response to be Modelled) 
1. Product Concentration (mg/L) – For models using the Day by Day arrangement, 
this refers to the product concentration recorded for each individual sample. For 
models using the Profile arrangement, this refers to the product concentration 
recorded for the Day 11 sample. 
2. Viability – For models using the Day by Day arrangement, this refers to the 
viability recorded for each individual sample. For models using the Profile 
arrangement, this refer to the viability recorded for the Day 11 sample. 
3. Viable Cell Concentration (VCC) – For models using the Day by Day 
arrangement, this refers to the VCC recorded for each individual sample. For 
models using the Profile arrangement, this refer to the VCC recorded for the Day 
11 sample. 
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During model creation, the response to be modelled was excluded from the input dataset. 
When modelling VCC, Total Cell Concentration was also excluded from the input dataset 
as it was highly correlated with VCC. Detailed results of these models can be found in 
Appendix B (Table 50 and Table 51).  
5.7.6 Stage 2: Results and Discussion 
Effects of model options were evaluated by creating figures to visualise differences 
comparing model performance criteria. Each figure shows a different way of grouping 
results to focus on method options. Evaluations were made with respect to the following 
questions. 
1. Does realignment to standardised progression values offer any real improvement 
in the ability to capture culture behaviours? 
2. Does alignment to standardised progression values eliminate the need for the 
progression variable in the model? 
5.7.6.1 Does realignment to standardised progression values offer any real 
improvement in the ability to capture culture behaviours? 
Two main performance criteria were used to compare models’ behaviour capture 
capabilities. The first was model predictive ability, which was evaluated using 
cross-validation R2 (Figure 28). The second was model robustness, which was evaluated 
using the difference between calibration R2 and cross- validation R2 (Figure 29).  
Figure 28 shows cross-validation R2 for datasets where explicit progression variables 
have been excluded and IVC, Time, or No alignment has been applied to the dataset. Here 
it was observed that models generated from Day by Day arrangements strongly 
outperformed models generated from Profile arrangements. These results were thought to 
be due to a combination of the number of unique variables to be modelled per sample (an 
order of magnitude greater than Day by Day samples) and realignment introducing more 
noise to the dataset than it removed. 
With regards to realignment effects, realignment typically results in higher 
cross-validation R2 for all response modelled using data in the Day by Day arrangement. 
Realignment had a negative impact on cross-validation R2 for all response modelled using 
data in the Profile arrangement. The extent to which alignment choice affected 
cross-validation R2 was dependent on the data used and the modelled response. 
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Similar to the results of Stage 1 analyses, interpretation of models created from Profile 
arranged data was difficult as drill down analyses were complicated by the large number 
of variables from which latent variables were composed. 
Figure 29 shows the difference between calibration R2 and cross-validation R2 for datasets 
where explicit progression variables have been excluded and IVC, Time, or No alignment 
has been applied to the dataset. The difference between calibration R2 and 
cross-validation R2 was used as an indicator of model robustness, with a lower value 
indicating greater model robustness. Similar to Figure 28 observations, it was observed 
that models generated from Day by Day arrangements had greater robustness during 
cross-validation. Again, this was believed to be due to the number of unique variables to 
be modelled. 
Effects on model robustness from realignment could not be as easily generalised as effects 
on model cross-validation R2. For models created from data in the Day by Day 
arrangement, realignment improved model robustness. For models created from data in 
the Profile arrangement, models created from IVC aligned datasets had consistently better 
robustness than time aligned datasets. Models created from un-aligned datasets had better 
robustness than IVC aligned datasets with the exception of models created from both 
Daily Monitoring and Online Monitoring datasets to predict product concentration. 
Similar to cross-validation R2, the extent to which alignment choice affected robustness 
was dependent on the data used and the modelled response. 
The introduction of more noise than was removed when data were aligned to standardised 
progression points was not entirely unexpected. Simple linear interpolation was used for 
realignment, which, as described in Section 5.4.2 on missing data estimation, is not 
typically an accurate representation of variable behaviour. Given the improvements seen 
in Day by Day models, further development of the equations used for alignment may 
yield better results. 
Finally, it was noted in all comparisons that performance and robustness were dependent 
on the response being modelled. Models predicting product concentration and VCC 
consistently outperformed models predicting viability. This was likely due to the 
distributions of the measured response values. Specifically, a typical fed-batch 
bioculture’s viability follows a distinct “hockey stick” shape – viability remains steady 
for the majority of the culture, ideally in the region of ~90% to ~100%. Viability declines 
rapidly in the last days of the culture. This gives a response dataset where the majority of 
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values lie in a limited region (~90% to ~100%) and a minority of values spanning the 
remaining range (0% to 90%). 
5.7.6.2 Does alignment to standardised progression values eliminate the 
need for the progression variable in the model? 
Figure 30 and Figure 31 compare the cross-validation R2 and the difference between 
calibration R2 and cross-validation R2 respectively for models where the dataset has been 
realigned and the progression variable either included or excluded. In both figures it can 
be observed that inclusion or exclusion of the progression variables has few appreciable 
effects on either measure of model performance. Hence as a general rule, once data were 
aligned to standardised progression points, the progression variable could be excluded 
from input data with negligible loss in predictive power. 
5.8 Stage 2: Conclusions 
In Stage 2, it was demonstrated that in general IVC was a more robust 
indicator/progression variable than Elapsed Time when establishing a baseline for culture 
progress. This applied both when progression variables were included in model input 
datasets and when realigning data to standardised progression points. 
For the datasets analysed, realignment to standardised progression points allowed for 
more robust models when considering data in the Day by Day arrangement even when 
the progression variable was excluded from the input dataset. However, realignment to 
standardised progression points led to decreased model robustness for models created 
from datasets in Profile arrangement. This was thought to be due to both the increased 
ratio of variables to samples caused by the Profile arrangement and the introduction of 
noise during the realignment process. Finally, the strength of these effects were dependent 
on the response to be modelled.  
As a general conclusion, no generic “best” method could be identified. Instead it was 
demonstrated that the accuracy and robustness of generated models could be greatly 
altered by manipulating the original dataset in seemingly simple ways. It is recommended 
that multiple perspectives of the dataset are model during initial investigations, 
particularly as applying these manipulations required comparatively little effort after 
manipulation tools were created in Excel. From these multiple models, a number can 
selected based on robustness and interpretability for more in-depth analysis. 
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Figure 28. Evaluating effects of dataset realignment on model predictive accuracy through cross-validation R2 when predicting product concentration (A), viability 
(B), and viable cell concentration (C). Overall, models created using datasets in a Day by Day arrangement had high R2 during cross-validation. Effects of realignment 
were dependent on the response tested and dataset arrangement. In the profile arrangement, no alignment tended to give higher values for R2 during cross-validation.  
  
 
 
  Arrangement Data Used 
1,1 Day by Day Daily Monitoring 
1,2 Day by Day Daily Monitoring and Online Monitoring 
2,1 Profile Daily Monitoring 
2,2 Profile Daily Monitoring and Online Monitoring 
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  Arrangement Data Used 
1,1 Day by Day Daily Monitoring 
1,2 Day by Day Daily Monitoring and Online 
Monitoring 
2,1 Profile Daily Monitoring 
2,2 Profile Daily Monitoring and Online 
Monitoring 
   
Figure 29. Evaluating effects of dataset realignment on model robustness through differences in calibration R2 and cross validation R2 when predicting product 
concentration (A), viability (B), and viable cell concentration (C). Here the lower the difference between R2, the greater the model’s robustness. Overall, models 
created from datasets in the Day by Day arrangement had good robustness.  
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Figure 30. Evaluating effects of inclusion of progression variable in a realigned dataset on model predictive accuracy through cross-validation R2 when predicting 
product concentration (A), viability (B), and viable cell concentration (C). In nearly all cases, inclusion or exclusion of the progression variable does not notably alter 
the cross-validation R2 for models where the cross-validation R2 indicates a functioning model.  
  
 
 
  Arrangement Data Used 
1,1 Day by Day Daily Monitoring 
1,2 Day by Day Daily Monitoring and Online 
Monitoring 
2,1 Profile Daily Monitoring 
2,2 Profile Daily Monitoring and Online 
Monitoring 
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  Arrangement Data Used 
1,1 Day by Day Daily Monitoring 
1,2 Day by Day Daily Monitoring and Online 
Monitoring 
2,1 Profile Daily Monitoring 
2,2 Profile Daily Monitoring and Online 
Monitoring 
   
Figure 31. Evaluating effects of inclusion of progression variable in a realigned dataset on model robustness through differences in calibration R2 and cross-validation 
R2 when predicting product concentration (A), viability (B), and viable cell concentration (C). Here the lower the difference between calibration R2 and cross-validation, 
the greater the model’s robustness. In nearly all cases, inclusion or exclusion of the progression variable does not notably alter the robustness of the model. 
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5.9 Stage 3 Media Analysis 
Due to the lack of a conclusive cause for variation in product titre during Stage 1 and 
Stage 2, the decision was made to focus on the media components used. 
A major area of research in cell culture in the 1990s was the development of 
chemically-defined media and sera, which would eliminate or reduce the issues associated 
with animal-derived sera (Table 24). Chemically defined media and feeds can often be 
considered the most valuable and guarded asset of cell culture companies. However while 
these are thought of as set recipes, variation is still possible, including inherent variation 
in at the smallest measurement scales, e.g. nanomolar concentrations of trace elements. 
This variation may be inconsequential, have negligible effects, or could notably alter 
cellular behaviour. Hence, methods of determining whether variation in the base 
materials’ composition may be a factor in an investigation of cell culture performance are 
a core factor in Quality by Design frameworks. 
 
Advantages 
— Binding and neutralisation of toxins. 
— Protease inhibition. 
— In agitated bioreactors, protection of cells from mechanical damage. 
— Buffer capacity of cell culture mixture improved. 
— Contain growth factors, hormones, and adherence factors. 
Disadvantages 
— Cost. 
— Lot-to-lot variability in composition (and potential impacts therefrom). 
— Negative impacts on both up- and down-stream processing, e.g. foaming in bioreactors or 
inference with columns, and associated increases in operating difficulties and costs. 
— Chemically undefined, e.g. unknown recipe, and undesired constituent chemicals such as 
growth and metabolism inhibitors. 
— Safety risk due to possible infection by viruses and other adventitious agents, such as those 
involved in Bovine spongiform encephalopathy [82]. 
Table 24. Summary of advantages and disadvantages of bovine foetal serum in cell culture media 
[167]. 
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An acknowledged issue in the investigations performed in Stage 1 and Stage 2 was the 
data concerning media and feed compositions were not included during analysis. This due 
to both the categorical nature of the data and simple availability. Media batch numbers 
required transcription from handwritten records, representing a notable delay, particularly 
for an investigation with a large number of cultures where accompanying paper records 
are archived off-site for various reasons. 
A total of 9 media components known to be key components in the process were chosen 
for analysis through identification of clustering. Only cultures A001 to A049 were 
considered for two reasons. First to determine if such analysis could have been used to 
identify and resolve issues before the site transfer was made. Second, media component 
batch numbers could not be accessed for the US-cited cultures A050 to A099. 
5.10 Stage 3: Method 
All available daily monitoring data for cultures A001 to A049 were arranged in the Day 
by Day orientation. As sample temperature and DOT were not recorded as part of daily 
monitoring at the 130 L scale, estimated values were created from online monitoring 
records by calculating the median between sampling timepoints. All remaining samples 
with missing data were eliminated. 
The dataset was mean-centred and scaled to unit variance. A PCA model was generated 
in PLS Toolbox using random sampling (7 splits, 5 iterations). A 6 PC model capturing 
83.54 % of variation was selected. 
Scores plots were created for each combination of scores (e.g. PC3 v. PC6). Additional 
figures were created by plotting a PC’s scores against time. Variations of these figures 
were created by plotting scores from only cultures operating with control conditions 
(Figure 32). Figures were then analysed for clustering by batch number for the 9 media 
components. 
5.11 Stage 3: Results and Discussion 
Several variations on the described method were attempted, e.g. use of PLSR in place of 
PCA, reorientation of the dataset from the Day by Day orientation to Profile orientation. 
Each method failed to improve understanding of product concentration variation for the 
same reason: Only media component batch numbers were recorded, not data pertaining 
to the actual physical differences between batches. 
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This issue was further compounded by the fact that the combinations of media component 
batches used were effectively unique to culture round6. Hence any clustering scene could 
only be attributed to the combination of media component batches used in that round and 
not to a specific component. 
5.12 Stage 3: Conclusions and Recommendations 
While recording of media component batch numbers ensures traceability, it does not 
allow for quantitative comparison of batch chemical composition. Batch number records 
can allow this data to be captured at a later date, however this assumes quantities of the 
component in question are still available and are of an identical state to when used in the 
cultures being investigated, e.g. no effects from aging or storage. 
The use of technologies such as near-infrared spectroscopy to analyse media components 
before use would greatly benefit investigation such as the one presented in this chapter. 
In addition to being a potential screening step to prevent use of media with undesirable 
concentrations, the quantitative data generated by such techniques could be integrated 
into a single dataset with daily monitoring and online monitoring data. This could allow 
direct correlations between specific chemicals within media components to be correlated 
with observed biological behaviour. 
 
Figure 32. PC1 to PC4 scores for cultures operating at control operating conditions. Cultures are 
coloured according SF66 Choline Chloride batch number: ● 019K0066 ■ 070M0192V 
♦ 119K0078 ▲ BCBD3356V. 
                                                 
6 Culture round refers to groups of cultures being performed at the same time, which allows resources such 
as media to be prepared in bulk. 
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5.13 Productivity Investigation Conclusions 
A wide number of statistical techniques and approaches were employed during the 
investigation in to variation in product concentrations at harvest for Project A. The 
productivity investigation comprised three stages. 
In Stage 1 a basic framework was developed, incorporating several MVDA tools. For the 
developed framework, two datasets were available for analysis: online monitoring and 
daily monitoring. Due to differences in sampling frequency, these datasets could not be 
integrated as a single dataset as the online monitoring dataset far outsized the daily 
monitoring dataset. The development of robust summary statistics termed Informative 
Values (see Appendix A) allowed the two dataset to be integrated as a single, balanced 
dataset. In the developed framework, this allowed multidimensional pass/fail boundaries 
to be identified from the most comprehensive dataset possible. 
Even with this reduction of the high frequency online monitoring dataset, the large 
number of total variables to be analysed posed a challenge in subsequent analysis and 
classification of cultures as high or low producing cultures by decision trees. To reduce 
the likelihood of spurious decision criteria selection and the loss of contextual information 
when a single variable is selected as a decision criteria, the integrated dataset was first 
dimensionally reduced using PCA. Scores from the resulting PCA model were then used 
in the subsequent decision tree in place of the unreduced dataset. In developing this 
framework, it was demonstrated that univariate methods for estimating missing data led 
to higher misclassification errors than when the multivariate iterative PCA was used. 
Furthermore, it was demonstrated that a “Golden Batch” approach, whereby models are 
trained using only ‘good’ samples, resulted in less robust classification models when 
applied to data including a range of behaviour. This range of behaviours included both 
deliberate changes to test the effects of potential issues, in addition to samples exhibiting 
unusual behaviours of interest (e.g. control condition cultures with low product 
concentrations at harvest). 
From this work, initial seeding conditions and subsequent glutamine behaviour were 
indicated as the main areas of deviant behaviour for the first pilot scale culture (A016). 
While a specific cause for the altered glutamine behaviour could not be identified from 
the data analysed, it was suggested that batch-to-batch variation in media powders used 
could be a possible contributing factor. 
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In Stage 2, the dataset was expanded to include data from cultures performed at Lonza’s 
US site. An initial attempt to identify variables of interest through PLSR was unsuccessful 
due to a change in seeding protocol between sites. This acted as a confounding variables 
and caused US cultures to appear more mature than UK cultures with respect to time. To 
overcome this source of confounding, the default progression variable (Elapsed Time) 
was questioned as the most appropriate measure of culture progress and maturation. 
Integral of Viable Cell Concentration (IVC) was suggested as an alternative measure of 
progress. For models predicting daily product concentration created from the UK dataset, 
it was shown that models where IVC was used in place of Elapsed Time had lower 
prediction errors and better distribution of residuals. More importantly, models created 
with IVC used as progression variable in place of Elapsed Time had greater robustness 
when UK data were applied as a test dataset. 
During Stage 2, it was shown that inclusion of an explicit progression variable yielded a 
higher cross-validation R2, better residual distribution, and improved robustness to testing 
datasets than exclusion. It was thought that this was due to variation in sampling times 
introducing variation in sample progress value, which had to be accounted for in the 
models. It was theorised that realigning datasets to set progression point values would 
eliminate this underlying variation and hence progression variables could be excluded 
during model creation with little or no effect on model performances. Testing revealed 
that any benefits of realignment were dependent on dataset orientation and the response 
of interest. 
Stage 2 had several learning points pertinent to improved future analyses of projects with 
site-transfers, simple sources of confounding (e.g. altered seeding conditions), or 
variation in sampling times. Specific results from Stage 2 models confirmed previous 
results from Stage 1, however no further understanding concerning variation in product 
concentration at harvest could be extracted. 
The aim of Stage 3 was to investigate whether variation in product concentration at 
harvest could be attributed to variation in media batch composition. Here it was 
demonstrated that batch numbers do not convey any information concerning the chemical 
composition of the batch in question. This situation lends support to on-going PAT 
activities focussed on the introduction of spectral measurement devices such as Raman 
probes as a means of generating more comprehensive understanding of culture 
behaviours.  
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 Multi-Product Platform Process Analysis 
6.1 Introduction 
A general definition of a platform process or platform technology is “a common or 
standard method, equipment, procedure or work practice that may be applied to the 
research, development or manufacture of different products” [20]. Platform 
manufacturing can be defined as the “implementation of standard technologies, systems 
and work practices within manufacturing facilities, and their use for the manufacture of 
different products OR the approach of developing a production strategy for a new drug 
starting from manufacturing process similar to those used by the same manufacturer to 
manufacture other drugs of the same type” [20]. Due to the wide range of interpretations, 
the following definitions are used here: 
Platform Process: A process where major operating parameters such as control system 
setpoints and deadbands, feed strategies, and media are pre-defined for the purpose of 
producing multiple products. 
Platform Manufacturing: “implementation of standard technologies, systems and work 
practices within manufacturing facilities, and their use for the manufacture of different 
products” [20]. 
Platform Research: “the approach of developing a production strategy for a new drug 
starting from manufacturing process similar to those used by the same manufacturer to 
manufacture other drugs of the same type” [20]. 
The use of process platforms allows for standardisation of approaches and tools. 
Consequently, savings in time and money can be made through: 
 Better utilisation of resources including equipment, materials, and personnel.  
 Improved quality and/or greater consistency in product quality (e.g. less wastage 
due to intermediate or final product failing to meet quality criteria). 
These benefits are common to any industry where platform technologies might be 
employed. In particular for pharmaceutical and biopharmaceutical process, there may also 
be time and money savings in regulatory applications if use of a platform process is 
supported by a sufficient level of evidence for platform understanding and robustness. 
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In the production of monoclonal antibodies (mAb) and other protein-based therapeutics 
by mammalian cells, successful transfer of a mAb-producing cell line to the platform 
process may require adaptation by the cell line. When comparing performances on the 
old and new process, such as the transfer of a mAb-producing cell line from one 
company’s own process to a contract manufacturer’s process platform, there may be 
differences observed such as altered harvest titre, differences in metabolism, or alterations 
to the product (e.g. glycan profile affected). These may be desired or undesired. 
In biopharmaceutical production, ideally the process is robust to a wide variety of cell 
lines. Here, any variability is a function of the transfected cell line and potentially 
addressed through minor changes to the process, e.g. inoculating with a higher VCC. If 
undesired behaviours are observed across multiple products sharing a process, it suggests 
a common cause related to the process itself. 
This occurred for a process platform utilised by Lonza. Sudden declines in culture 
viability (~80% to ~0% in 24 h) were observed in multiple projects for different products. 
All projects utilised the GS-CHO cell line with the Version 6 GS-CHO process platform. 
These crashes led to an intensive analysis in 2006 which took many man-months to 
accomplish. 
6.2 The Dataset 
The data used in this investigation originated from 17 customer projects performed using 
Lonza’s GS-CHO Version 6 platform process. The 17 projects were selected in a list 
created by Lonza. The number of cultures included from each project ranged from 1 to 
50 with an overall total of 185 cultures of multiple scale from wave bag to 5000 L. 
6.3 Aims 
The main aim was to identify indicators of sudden declines in culture viability and, if 
possible, determine potential causes. Additional aims were to build upon the strategies 
used in Chapter 6, with particular regards for result interpretability. 
6.4 Obstacles 
Six main obstacles were identified in the dataset that required resolution (Table 25). These 
obstacles are discussed in addition to the suggested resolution that was tested during the 
final presented method. 
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Obstacle Summary of Solution(s) 
1. Distribution of Crashes and 
Data Disparity 
1. Removal of wave bag cultures from dataset. 
2. Analysed data restricted to data collected through 
daily monitoring. 
2. Definition of Crash Rate 1. Standardised tool for classification of samples 
according to maximum rate of decline  
3. Definition of Crash 
According to Culture Stage 
1. Rejustification of dataset to emphasise: 
a. Behaviour since inoculation 
b. Behaviour before crash/harvest 
c. Behaviour at peak VCC 
4. Confounding by Expressed 
Product 
1. Two-step scaling process (intrascaling) applied. 
2. Pro_013 removed from dataset due to use of 
different cell line. 
5. Interpretation of Multivariate 
Serial Observations 
1. Use of purpose built models to identify either Days 
of Interest or Variables of Interest 
2. Use of model hierarchies to better manage 
“information overload”. 
6. Robustness 1. Use of a multiple model confirmatory approach. 
Table 25. Obstacles identified during platform process investigation including suggested 
solutions. 
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6.4.1 Obstacle 1: Distribution of Crashes and Data Disparity 
The distribution of cultures by project and scale is given in Figure 33 and Figure 34. It 
can be seen that there was unequal representation of both projects and scales. As seen in 
Figure 33, the 10 L scale had greatest representation, accounting for 83% of all cultures 
(154 of 185) under consideration. Within the 10 L band (Figure 34), project Pro_014 had 
the greatest representation with 32% of cultures under consideration at that scale (50 out 
of 154) and 27% of all cultures (50 out of 185). 
In addition to difference in distribution of crashes across projects, there was disparity in 
data collection across both scale and time. As noted in Chapter 5, osmolality was not 
recorded as part of daily monitoring at scales above 10L. Below the 10L scale, cultures 
were performed in roller bottles, wave bags, or shake flasks where daily monitoring 
captured only a limited subset of the variables recorded for cultures at scales of 10L and 
above. Furthermore no online monitoring data existed for cultures below the 10L scale. 
Finally, due to the time span considered, pO2 was only recorded for cultures following a 
change in daily sampling data collection. 
6.4.1.1 Resolution 
Wave bag cultures were eliminated due to the limited number of variables monitored 
when compared to scales above wave bag. Between 10 L and 5000 L, reactor design and 
monitored variables are highly conserved with limited differences in variables monitored. 
Due to issues with availability and discoverability7 of online monitoring data, only data 
from daily offline sampling were collated (Table 26). Viable cell concentration (VCC), 
IVC, and total cell concentration (TCC) were collated but excluded from analysis due to 
high correlation with viability (‘obvious indicator’). 
Finally, it was found that Pro_013 had used a GS-NS0 cell line and was hence excluded 
as use of a different host cell line meant a different platform process had been used. 
Temperature Viability Lactate NH4+ pCO2 
pH IVC** Glucose K+ pO2* 
DOT VCC** Glutamate Na+ Osmolality* 
- TCC** Glutamine NH4+ - 
Table 26. Variables available from daily offline sampling. *Excluded due to inconsistent 
collection (e.g. not recorded at all scales). ** Excluded as ‘obvious’ indicator. 
                                                 
7 Discoverability refers to the ease with which data can be found including navigation of file structures, 
access permissions, location maintenance, file extensions (e.g. if file requires specialist software to open), 
and file consistency (e.g. are all data exported as .csv with identical layout). 
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Figure 33. Distribution of Cultures by Scale. The majority of cultures available for analysis were 
performed at the 10L scale. 
 
 
 
Figure 34. Distribution of Cultures by Project at 10 L Scale. There is unequal representation of 
projects with Pro_014 having the greatest number of cultures available for analysis.  
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6.4.2 Obstacle 2: Definition of Crash Rate 
The definition of “crash” provided during an investigation kick-off meeting can be 
paraphrased as “culture viability quickly dropping over the course of 24 hours”. There 
are three main issues with this initial definition. 
First, there is no clear value for acceptable/unacceptable rates of decline. Second, lack of 
clear value raises questions on consistency of results including if all projects 
demonstrated the same rate of decline during a crash. Third, the definition of “crash” did 
not allow for contextual information and only uses values calculated for viability. 
6.4.2.1 Resolution  
Due to the large number of cultures to be analysed and a relatively quantifiable definition 
of pass/fail behaviour as decline in viability over twenty-four hours, it was considered 
neccessary to create a simple algorithm to assign classes in place of manually classifying 
cultures by viewing viability profiles. This had the benefit of removing subjective 
classification of pass/fail, adding an additional level of robustness to the process. 
Once created, this algorithm allowed multiple limits for pass/fail classification to be 
easily assigned by changing cut-off limit value. Hence, each culture was classified as pass 
or fail for the following maximum decline in 24 hours: 
10% 20% 30% 40% 50% 60% 
There was no clear limit for pass/fail classification of cultures based on maximum 
calculated 24h decline in viability. A spectrum of pass/fail limits existed (Figure 35). At 
the more extreme limits considered (10% and 60%), there was very low representation of 
pass or fail cultures respectively. It was decided to test all limits (10% to 60%) to identify 
if identified indicators were consistent across all limits or if identified indicators were 
dependent on the pass/fail limit. 
It was noted that in several cases, repeat cultures (i.e. two cultures of a single product 
with the same media, feeds, and stated operating conditions) did not have the same 
pass/fail profile. Closer examination revealed that this was generally due to the maximum 
decline in viability in 24 hours for the two cultures lying very near a classification limits, 
e.g. Pro_001_002 (-40.26%) and Pro_001_003 (-38.33%) at -40% or Pro_014_005 
(-19.92%) and Pro_014_006 (-21.34%) at -20%. 
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Figure 35. Percentage of cultures in dataset failing at decreasing limits for maximum calculated 
rate of viability decline in 24 h (excluding Pro_013, n = 174). Bars are coloured to show relative 
representation of projects. It can be observed that there is not equal representation of cultures at 
any of the maximum viability decline limits. 
 
6.4.3 Obstacle 3: Definition of Crash According to Culture Stage 
When data were collected, serial observations were arranged in what is considered a 
typical order: the first observation after inoculation is n=1, the second observation after 
inoculation is n=2, etc. As the number of observations for multiple cultures can be 
different due to crashes and/or meeting harvest criteria at different times, this can leave a 
‘rag’ of missing data on the harvest side of a dataset (Table 27A). 
This de facto arrangement complicates analysis in two ways. The first complication is 
how the ‘rag’ of missing data is dealt with, particularly as this data is not missing at 
random. The second complication is that this arrangement biases both model and 
interpretation to focus on behaviour since inoculation. However, behaviour before 
crash/harvest was the focus in this investigation. 
6.4.3.1 Resolution 
During the productivity investigation, efforts were made to remove variability in the 
chosen progression variable, i.e. to make the dataset sampling structure rigid. This was 
achieved by interpolation of data to set values for the progression variables. Set values 
were selected based on variable distribution to minimise the magnitude of adjustment 
made. In summary, dataset justification is a value-based manipulation of the dataset. 
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In contrast, dataset justification is a structure-based manipulation of the dataset. The 
purpose is to manipulate the behaviours identified during MVDA by altering the dataset 
structure to emphasise specific aspects. 
In this investigation two rearrangements were considered. To improve model focus on 
behaviour preceding crash/harvest, data were arranged as shown in Table 27B so that the 
observations were counted n-1, n-2, n-3, etc. 
The second rearrangement distributed the data according to maximum recorded VCC 
(Table 27C). Here, data are arranged so that the maximum VCC occurs in the same 
observation/column and the data ‘rag’ can be on either side of the dataset or distributed 
across both. Theoretically, this should bias model focus towards behaviour concerning 
this specific event. 
A) Inoculation Justified 
Culture 
Viable Cell Concentration (N= First Observation) 
N N+1 N+2 N+3 N+4 N+5 N+6 N+7 N+9 
A 2 25.4 50.7 74.6 89.9 99.7 96.5 90  
B 0.2 24.9 50.4 73.4 84.8 99.1 97.4 92.5 75.4 
C 1 25 50.1 75.7 84.3 93.2 97.1 100 78.7 
D 0.6 24.7 49.8 73.2 86.9 98.1 95.6   
E 1 25.3 50.8 72 82.9 95.4 99.9 91.4  
          
B) Harvest Justified 
Culture 
Viable Cell Concentration (N = Final Observation) 
N-8 N-7 N-6 N-5 N-4 N-3 N-2 N-1 N 
A  2 25.4 50.7 74.6 89.9 99.7 96.5 90 
B 0.2 24.9 50.4 73.4 84.8 99.1 97.4 92.5 75.4 
C 1 25 50.1 75.7 84.3 93.2 97.1 100 78.7 
D   0.6 24.7 49.8 73.2 86.9 98.1 95.6 
E  1 25.3 50.8 72 82.9 95.4 99.9 91.4 
          
C) Peak Viable Cell Concentration Centred 
Culture 
Viable Cell Concentration (N = Observation with Maximum VCC) 
N-6 N-5 N-4 N-3 N-2 N-1 N N+1 N+2 
A  2 25.4 50.7 74.6 89.9 99.7 96.5 90 
B  0.2 24.9 50.4 73.4 84.8 99.1 97.4 92.5 
C 25 50.1 75.7 84.3 93.2 97.1 100 78.7  
D  0.6 24.7 49.8 73.2 86.9 98.1 95.6  
E 1 25.3 50.8 72 82.9 95.4 99.9 91.4  
Table 27. Effects of Dataset Justification on Location of Missing Data. Darker shading indicates 
missing data. Lighter shading indicates the peak value for viable cell concentration recorded. 
Note: data artificially generated for demonstration of concept.  
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6.4.4 Obstacle 4: Confounding by Expressed Product 
Confounding is when some variable, termed a confounder, acts a source of variability that 
interferes with or masks more subtle variation in a dataset. While the analysed data were 
generated from a single platform process, the data was also generated from the production 
of several different mAbs and mAb fragments. As the product being expressed can affect 
host cell metabolism in both a variety of ways and extents, confounding posed an 
obstacle. 
Several methods for removing confounding have been suggested. One of particular note 
is the use of PLS-DA to first classify samples according to a known confounder (e.g. 
product type) to “draw out” the confounded information, giving a “deconfounded” 
residual matrix that can then be analysed [13]. 
While these techniques exist, they are dependent on the data to be analysed and may 
require significant input from an end user either in performing methods manually or in 
development and validation of software to perform such actions. Furthermore, they 
require strong understanding of the techniques to be confidently communicated with 
others. While this last point is a non-technical limitation in the purest of terms, the ability 
to confidently communicate statistical techniques employed during an analysis are 
important when discussing analyses with colleagues, clients, and regulatory authorities. 
Effective implementation of simpler tools is of more benefit to achieving Quality by 
Design than attempting complex, high-powered methods which are poorly understood.  
6.4.4.1 Solution 
The key to the implemented solution was that the statistical methods to be employed used 
the correlations between variables and not the recorded values themselves. Hence it was 
the explicit aim of any confounding reduction method applied was to allow the correlation 
structures of the product-specific subsets to be compared. 
The suggested solution was to employ a two-step scaling method (Figure 36) where the 
multiproduct dataset is first split into single product subsets. Each single product subset 
is scaled using the desired scaling method(s). The scaled single product subsets are then 
recollated into a single dataset, which can then be further treated as desired. 
A trial test of intrascaling during initial exploration of the dataset using PCA indicated 
that this approach could reduce confounding with little to no appreciable impact on 
captured variance (Figure 37). 
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Figure 36. Simple Schematic of Intrascaling Process. The multiproject dataset is split into single 
project subsets (1). The single project subsets are scaled using a desired method (2). The scaled 
subsets are recollated into a single dataset (3). The recollated dataset is scaled using a desired 
method (4). 
 
 
Figure 37. PCA scores plots generated using different scaling methods. Each point represents Day 
1 to Day 12 for one culture. Shape and colour indicate project of origin. As cultures appeared to 
be more strongly cluster by project in A than in B, clustering in A was thought to be more heavily 
influenced by project-specific differences, whereas clustering in B was thought to be more 
strongly governed by culture behaviour irrespective of project. 
A. Dataset mean-centred and scaled to unit variance. Total X variance captured: 25.33% 
(PC1 14.58%, PC2 10.75%). 
B. Intrascaled dataset. Total X-variance captured: 26.22% (PC1 17.09, PC2 9.13%). 
1 2 3 4 
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A second option based on this approach was initially considered. In the second option, 
variables that should not be affected by product types or vector integration site are 
excluded from the first scaling step. These variables are scaled only once the single 
project subsets are recollated into a single dataset. Variables excluded from the first 
scaling step include pH, DOT, and temperature. In this way, variation in behaviours 
related to hardware or control systems are preserved between projects. 
The first option where all variables undergo the two-step scaling process was referred to 
as Intrascale A. The second option where only a subset of variables undergo the two-step 
scaling process was referred to as Intrascale B. Only Intrascale A was tested in the 
presented investigation. 
6.4.5 Obstacle 5: Interpretation of Multivariate Serial Observations 
An observation during the Chapter 5 investigation into variation in product concentration 
for a single product dataset was that interpretation was complicated by the number of 
variables to be considered, particularly when data were in the Profile arrangement. 
6.4.5.1 Solution 
Multilevel or hierarchical modelling is a form of regression where regression coefficients 
are a function of submodels representing another level of the data. For example, a 
top-level model predicting a child’s academic performance may use regression 
coefficients calculated from socio-economic data. 
According to Gelman [168], hierarchical modelling is an improvement over regression 
“to varying degrees; for prediction multilevel modelling can be essential, for data 
reduction it can be useful, and for causal inference it can be helpful”. It is for these last 
two points – data reduction and improved causal inference – that hierarchical modelling 
was used as a template for the presented solution. 
The presented solution is not a true hierarchical model as top-level model regression 
coefficients are not a function of a lower level of data. Instead, the presented solution is 
a hierarchy of models, where results from intermediary models feed into a top level model 
(Figure 38 and Figure 39). 
The key similarity between hierarchical modelling and the model hierarchies developed 
was that the focus of the top-level model could be altered by altering the focus of the 
intermediary model, e.g. if the intermediary models focussed on behaviour on by 
observation number (Figure 38), then contribution analysis of the top-level model would 
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indicate days of particular interest. Similarly, if the intermediary models focussed on 
individual variable behaviour over the course of the culture (Figure 39), then contribution 
analysis of the top-level model would indicate variables of particular interest. 
6.4.6 Obstacle 6: Robustness 
Due to the breadth of behaviour to be considered including multiple products, no 
definitive pass/fail limit, and variation in “when” crashes occurred, robustness of models 
and results was a concern. 
6.4.6.1 Solution 
Instead of attempting to create a single model to capture behaviour and identify indicators 
of crashes, it was instead decided to create several simpler models and perform a 
meta-analysis from the results. By altering model focus as described in §6.4.3 
(rejustification of dataset) and §6.4.5 (model hierarchies to emphasise days or variables 
of interest), the overall aim of meta-analysis was robustness through consistency of 
results. This meta-analysis approach also included multiple limits for pass/fail 
classification (§6.4.2). 
 
Figure 38. Model hierarchy structure producing a top level model focusing on Observation/Days 
of Interest. 
 
 
Figure 39. Model hierarchy structure producing a top level model focusing on Variables of 
Interest.  
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6.5 Method 
A meta-analysis approach was created using the three analysis patterns described below 
and the variables listed in Table 26. The resulting models were compared for both 
consistency and discrepancy across the different data pre-treatment, statistical methods, 
and decline rate/classification limits tested. Models determined to be of particular interest 
then underwent more detailed results analysis. The time needed to complete the 
investigation would also be compared to a previous investigation undertaken by Lonza 
6.5.1 Analysis Pattern 1 
In Analysis Pattern 1 (Figure 40) data were arranged in Profile arrangement (1 row = all 
samples for 1 culture) and then Inoculation Justified, Harvest Justified, or Max VCC 
Centred. The dataset was scaled using two-step intrascaling or mean-centred and scaled 
to unit variance. Missing data were estimated using iterative PCA. A PCA model was 
created using random sampling (10 splits, 5 iterations). The number of PCs retained was 
made on minimum RMSE during cross-validation. Scores were used to classify cultures 
as pass or fail using PLS-DA and decision trees (Gini Index) for each maximum decline 
limit 10% to 60%. 
 
Figure 40. Analysis Pattern 1  
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6.5.2 Analysis Pattern 2 
Analysis Pattern 2 was designed to identify specific variables of interest and followed the 
sequence shown in Figure 41. 
Data were arranged in Profile arrangement (1 row = all samples for 1 culture) and the 
dataset then justified. The justified dataset was scaled using intrascaling or mean-centred 
and scaled to unit variance. Missing data were estimated using iterative PCA. The dataset 
was then subdivided into subsets by variable type (e.g. glucose). For each variable subset, 
a PCA model was created using random sampling (10 splits, 5 iterations). 
Scores for PC1 and PC2 were extracted for each variable model and collated into a single 
dataset. This dataset was the used to classify cultures as pass or fail using PLS-DA and 
decision trees (Gini Index) for each maximum decline limit 10% to 60%. 
 
Figure 41. Analysis Pattern 2 - This analysis pattern was intended to identify specific variables of 
interest by first summarising data by variable type.  
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6.5.3 Analysis Pattern 3 
Analysis Pattern 3 was designed to identify specific days or observations of interest and 
followed the sequence shown in Figure 42. Data were arranged in the Day by Day 
arrangement (1 row = 1 sample for 1 culture). The dataset was scaled using two-step 
intrascaling or mean-centred and scaled to unit variance. Missing data were estimated 
using iterative PCA. A PCA model was created using random sampling (10 splits, 5 
iterations). PC1 and PC2 scores were extracted and arranged into Profile arrangement, 
i.e. cultures were now described as Day 1 PC1, Day 1 PC2, Day 2 PC1, etc.  
The Profile scores dataset was then used to classify cultures as pass or fail using PLS-DA 
and decision trees (Gini Index) for each maximum decline limit 10% to 60%. 
 
 
Figure 42. Analysis Pattern 3 – This analysis pattern was intended to identify specific days and 
observations of interest by first summarising data in ~24 blocks of information.  
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6.6 Results and Discussion 
The developed method was assessed against an historical investigation of the same dataset 
conducted several years prior in keeping with soft aims related to ease of implementation 
and interpretation of results. This previous investigation had primarily relied on univariate 
or qualitative analysis and was human-resource intensive, requiring hundreds of man 
hours and department-wide involvement. 
The method and results presented in this chapter were completed in approximately 200 
man hours by a single person. Personal records allot ~50% of this time to data collation 
and cleaning (100 hours), ~30% to development of tools for dataset justification and 
intrascaling (60 hours), and ~20% to model creation and result interpretation (40 hours). 
The results of the meta-analysis were then presented to scientists involved in the previous 
investigation for comparison to previous results. Hence the final developed framework 
and supporting tools offer significant time savings in future large scale investigations. 
For the top level meta-analysis, comparisons between models were restricted to the 
criteria noted in Table 28. The following areas were then addressed in a general manner: 
 Decline limit choice 
 Scaling option 
 Statistical method used 
 Analysis pattern used 
Based on this top level evaluation was made, a select number of models were chosen for 
more in-depth analysis with particular regards to the following areas: 
 Result interpretability 
 Days of interest 
 Variables of interest 
Statistical Method Recorded Results 
Decision Tree Top node decision criteria 
Tree size (number of nodes) 
Misclassification (%) 
PLS-DA X variance captured (% 
Y variance captured (%) 
Misclassification (%) 
Table 28. Results recorded for meta-analysis. These values can be found in Table 54 to Table 57 
in Appendix B. 
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A main effects plot was generated to identify general trends associated with 
misclassification values (Figure 43). These general trends can be summarised as: 
1. Lower misclassification of cultures was more strongly associated with the use of 
decision trees for classification than with the use of PLS-DA. 
2. Models tended to have lower misclassification error rates when decline limits of 
30%/d or 40%/d were used. 
3. Models were relatively insensitive to analysis pattern choice. 
4. Models were relatively insensitive to dataset justification choice. 
Regarding scaling, further analysis showed effects from choice in scaling were dependent 
on whether PLS-DA or decision trees were used. It was seen that for PLS-DA-based 
models there was a general split in misclassification based on scaling (Figure 43). 
PLS-DA models built from intrascaled datasets had higher rates of misclassification than 
models built from datasets to which Autoscaling (mean-centred and scaled to unit 
variance) had been applied. However, this clear split based on scaling was not observed 
for decision tree-based models. As PLS-DA models retain all variables while decision 
trees retain only decision criteria, decision trees are potentially more robust when the ratio 
of cultures used for model training versus the number of variables is low. 
 
Figure 43. Main effects plot for identifying general outcomes based on misclassification. 
Regarding dataset justification, harvest justification offered minor improvements in classification 
accuracy when the maximum decline in viability used for pass/fail classification was greater than 
20%/d. 
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As seen in Figure 35, pass/fail distribution and culture numbers were not equally 
distributed across projects. Hence the lower rate of misclassification observed when 
Autoscaling was used may be in part due to identification of projects with higher failure 
rates rather than identification of fail behaviour. This possibility was further supported by 
the different effects the scaling methods had on clustering when PCA was applied during 
initial data exploration (Figure 37). 
As the meta-analysis was set out in a similar manner as Design of Experiments, Minitab 
was used for response surface analysis to identify an optimal model for minimising 
misclassification. The suggested optimal model was: 
 Viability Decline Limit: 45.3535 5/d 
 Analysis Pattern:  Analysis Pattern 3 
 Scaling:   Intrascale A 
 Statistical Method:  Decision Tree 
 Justification:   Peak VCC Centred 
This was interesting as it rejected the general correlation of Autoscaling with lower 
misclassification errors. From the Minitab optimiser results (Figure 44) was seen that 
there was in fact little difference in predicted model accuracy whether Intrascaling or 
Autoscaling was applied to the dataset. 
 
Figure 44. Minitab optimiser results using response surface model. The greater the height of an 
option, the higher the misclassification error by a model using that option with all other options 
remaining unchanged. Hence model misclassification is notably insensitive to choice of dataset 
justification, relatively insensitive to choice of Analysis Pattern or scaling applied, notably 
sensitive to decline limit, and highly sensitive to classification method used. 
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Figure 45. Four comparisons of misclassification of cultures. In A, series are coloured by analysis pattern used. In B, series are coloured by dataset justification. In C, 
series are coloured by whether PLS-DA or decision trees were used for classification. In D, series are coloured by scaling used.
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6.6.1 Analysis Pattern 1 Results and Conclusions 
An in-depth analysis was performed using Analysis Pattern 1 on inoculation justified, 
intrascaled data to classify cultures according to a 30%/d decline limit. Two classification 
methods were applied this dataset: PC-decision trees and PLS-DA. 
When using PLS-DA for classification, the model statistic ‘Variable Importance in 
Projection’ (VIP) to be used to identify variables of interest. A variable’s VIP scores is 
an indicator of the variable’s importance in a PLS projection. Variables with VIP 
scores > 1 are considered to be important in the model. 
Figure 46 and Figure 47 show VIP scores from an Analysis Pattern 1 PLS-DA model 
classifying inoculation justified, intrascaled data according to a 30% decline limit. It can 
be seen that even when variables are grouped by variable type (Figure 46) or reading 
number (Figure 47), it is difficult to identify specific variables or days of interest due to 
the large number of variables declared important based on VIP number. While this result 
gives a very comprehensive overview of differences correlated with pass and fail 
classification suitable for less- or un-time-constrained analysis, it is data rich but 
information poor from an operating/manufacturing standpoint. 
Similar interpretability issues were encountered when applying similar drill down 
analysis to models created using PC-decision trees, despite the observed improvement in 
classification accuracy. 
6.6.2 Analysis Pattern 1 Conclusions 
Differences in multiple monitored variables were observed between pass and fail cultures 
in the final samplings for those cultures. According to VIP plots from PLS-DA models, 
these differences typically manifested from the fourth or fifth sample onwards. However, 
further analysis would require intensive analysis by a biologist to separate variables of 
interest (e.g. glucose) from time periods of interest (e.g. activity between Days 3 and 4). 
From these results, it was concluded that use of PCA-decision trees could be used to 
efficiently classify culture behaviour, however data were not in an easily interpretable 
form for onward analysis. 
  
 137 
 
 
Figure 46. VIP scores from an Analysis Pattern 1 PLS-DA model classifying inoculation justified, 
intrascaled data according to a 30% decline limit grouped by variable type. 
 
 
 
Figure 47. VIP scores from an Analysis Pattern 1 PLS-DA model classifying inoculation justified, 
intrascaled data according to a 30% decline limit grouped by reading. 
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6.6.3 Analysis Pattern 2 Results 
The decision criteria for the top node of decision trees created using Analysis Pattern 2 
and Analysis Pattern 3 were recorded. This information was then used to evaluate the 
most frequently selected decision criteria. Frequency evaluation was not extended to the 
lower levels of the decision trees for the results shown, however this a strong area for 
follow on investigation. 
Table 29 and Table 30 display the frequencies of top node decision criteria for decision 
trees generated using Analysis Pattern 2, which was designed to identify key variables of 
interest. These frequencies were then broken down according to justification and scaling 
applied to the dataset during analysis to give pH PC1 as the top variable of interest (top 
decision criteria for 56% of decision trees) followed by Lactate PC1 (14%) and Glutamine 
PC2 (11%).  
 
All 
Inoculation 
Justified 
Harvest 
Justified 
Peak VCC 
Centred 
Top Node Count % Count % Count % Count % 
pH PC1 20 56% 7 39% 6 33% 7 39% 
pCO2 PC2 1 3%   1 6%   
Gln PC1 2 6%     2 11% 
Gln PC2 4 11% 1 6% 3 17%   
Gluc PC1 1 3% 1 6%     
Lac PC1 5 14% 2 11% 1 6% 2 11% 
Na PC1 2 6% 1 6% 1 6%   
K PC1 1 3%     1 6% 
Table 29. Decision criteria for top node in decision trees using Analysis Pattern 2 with respect to 
dataset justification. Shading indicates that the variable was not a top node decision criteria for 
the dataset justification listed. 
 
 All Autoscale Intrascale A 
Top Node Count % Count % Count % 
pH PC1 20 56% 10 56% 10 56% 
pCO2 PC2 1 3% 1 6%   
Gln PC1 2 6% 1 6% 1 6% 
Gln PC2 4 11% 1 6% 3 17% 
Gluc PC1 1 3% 1 6%   
Lac PC1 5 14% 3 17% 2 11% 
Na PC1 2 6%   2 11% 
K PC1 1 3% 1 6%   
Table 30. Decision criteria for top node in decision trees using Analysis Pattern 2 with respect to 
scaling method applied. Shading indicates that the variable was not a top node decision criteria 
for the scaling method listed.  
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For the process analysed, lactate and glutamine were not controlled variables and were 
therefore pure indicators/symptoms of culture behaviour. pH was technically a controlled 
parameter, however due to the wide deadband used by the process, pH was also a possible 
indicator of natural cell behaviour within the deadband. 
When considering nodes below the top node, in particular for decision trees beginning 
with pH PC1 as the top node decision criteria, decision criteria on the majority pass path 
were predominantly metabolite-based (e.g. K+). Decision criteria on the majority fail path 
were predominantly control-based (e.g. pH or temperature) or closely tied to control 
strategies (e.g. pCO2). 
A detailed analysis was performed using the decision tree created from intrascaled, 
inoculation justified data using a pass/fail maximum viability decline limit of 40%/d 
(Figure 48). Culture progressions through the decision tree were determined and the PC 
scores from which decision criteria were selected were plotted. The original data from 
which the intermediary model were created were then located for the cultures at the 
decision node and classed as pass or fail, as determined by the decision rules. These data 
were then summarised as mean, mean + 2 standard deviations, and mean – 2 standard 
deviations for both pass and fail subset for each sampling point (n=1 to n=12). These 
calculated values were plotted against sampling point to visualise the general trends in 
the data. Figures presented in this chapter are limited to those immediately relevant to the 
presented results. The full set of figures can be found in Appendix B. 
From Figure 48 it was seen that two primary failure pathways existed (Table 31). It should 
be noted both pathways were primarily described by PC1 values (i.e. main behaviour for 
the variable in question) and a limited number of variables. 
Pathway 1 Pathway 2 
Node Decision Criteria Node Decision Criteria 
1 pH PC1 <= -0.408 1 pH PC1 <= -0.408 
2 pCO2 PC1 > -2.301 2 pCO2 PC1 > -2.301 
5 Na PC1 > 3.052 5 Na PC1 <= 3.052 
 9 pH PC2 > -0.755 
13 Temperature PC1 > 0.178 
19 Temperature PC1 <= 0.695 
Table 31. Main failure pathways for decision tree classifying intrascaled, inoculation justified 
dataset to a 40%/d viability decline limit. 
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Figure 48. Decision tree classifying inoculation justified, intrascaled data according to a 40%/d viability decline limit. Each node displays the majority class (pass/fail) 
for samples at the node, the percentage of samples with that class, and the total number of samples on the node on the left-side of the coloured box. Pass/fail distribution 
at the node is also indicated by a pie chart on the right-side of the coloured box (red = pass, blue = fail). If the node is a decision node, then the decision criteria variable 
is listed in the bottom of the box. If the node is a leaf node, then the final class is listed at the bottom of the box. The values used for the decision criteria are displayed 
above the subsequent child node. Nodes are coloured by the percentage of fail samples at the node, i.e. the top node is coloured darkest blue as it holds 100% of fail 
cultures whereas leaf node with only pass cultures is completely white. The thickness of lines between nodes indicates the number of samples following that path. 
 141 
 
The decision criteria at Node 1 was pH PC1. Plotting pass/fail subsets as shown in Figure 
49, it was seen that two basic pH behaviours existed. In the ‘pass’ behaviour, the mean 
pH declines from ~7.00 to ~6.85 sometime between the fourth and fifth readings (i.e. 
between Day 3 and Day 4). The mean pH then gradually returns to the previous mean of 
~7.00. In the ‘fail’ behaviour, mean H behaviour is similar to pass behaviour until the 
fourth reading. The mean ‘fail’ pH also declines to 6.85, however the recovery to a mean 
of ~7.00 was not observed. Both pH behaviours were within the permitted operating 
conditions, hence the differences in behaviour have originated from the cell culture 
behaviour, interactions between cell culture behaviour and the feed strategy, or a 
combination of the two. 
 
 
Figure 49. Pass/fail pH behaviour for cultures at Node 1. Note that pass/fail refers to the class 
applied by the decision tree at this node and not the final classification according to the decision 
tree rules or the class determined using the simple profile classifier. In B, the ±2σ have been 
removed to improve identification of mean trends.  
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The decision criteria at Node 2 was pCO2 PC1. Plotting pass/fail subsets as shown in 
Figure 50, there appeared to be divergences in pCO2 behaviour beginning at Reading5 
(Day 4). At this point onwards, fail cultures had on average slightly higher pCO2 readings. 
More notably, it was observed that there was greater variance in each pCO2 reading for 
fail cultures than for pass cultures. These observations were interpreted as indicating 
pCO2 level stability as an indicator of pass/fail behaviour and possible contributor to 
undesired behaviours. 
 
 
 
 
Figure 50. Pass/fail pCO2 behaviour for cultures at Node 2. Note that pass/fail refers to the class 
applied by the decision tree at this node and not the final classification according to the decision 
tree rules or the class determined using the simple profile classifier. Also note the negative values 
plotted were due to the calculated standard deviation. In B, the ±2σ have been removed to improve 
identification of mean trends.  
 143 
 
The decision criteria at Node 5 was Na PC1 Plotting pass/fail subsets as shown in Figure 
51, no immediately obvious differences in Na+ profiles could be seen. However it was 
observed that cultures classed as fail at this node typically had higher recorded values for 
Na+ than cultures classed as pass at this node. This general divergence was observed as 
beginning after Reading 4 (Day 3). 
 
 
 
 
Figure 51. Pass/fail Na+ behaviour for cultures at Node 5. Note that pass/fail refers to the class 
applied by the decision tree at this node and not the final classification according to the decision 
tree rules or the class determined using the simple profile classifier. In B, the ±2σ have been 
removed to improve identification of mean trends.  
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The decision criteria at Node 9 was pH PC2. Plotting pass/fail subsets as shown in Figure 
52, it was observed that the primary difference between mean pass behaviour and mean 
fail behaviour was the rate of pH decline. Results at this node were considered a 
refinement of the behaviours generalised at Node 1. 
 
 
 
 
Figure 52. Pass/fail pH behaviour for cultures at Node 9. Note that pass/fail refers to the class 
applied by the decision tree at this node and not the final classification according to the decision 
tree rules or the class determined using the simple profile classifier. In B, the ±2σ have been 
removed to improve identification of mean trends.  
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The decision criteria at Node 12 was Temperature PC2. No appreciable practical 
differences were observed when plotting the original data for the cultures (Figure 53) with 
one exception (Pro_016_005). It was suggested that the dataset had become so reduced 
in terms of variance that spurious decision criteria were beginning to be selected. This 
suggestion was supported by the fact that temperature data recorded in daily monitoring 
had very limited variance (~ 0). This can be seen in Figure 53 where nearly all recordings 
for all cultures were 36.5 °C. As discussed in Chapter 5 and Chapter 6, “too perfect” 
datasets heavily exaggerate the slightest differences when scaled. Hence, the selection of 
temperature as a decision criteria was taken as an indicator that all useful information had 
been extracted from the decision tree and that further interrogation could be halted. 
 
 
 
Figure 53. Original temperature measurements for cultures at decision node 12. In A, cultures 
were classed as “pass”. In B, cultures were class as “fail”. In both A and B, the majority of 
temperature readings were 36.5 °C.  
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6.6.4 Analysis Pattern 2 Conclusions 
pH behaviour was top node decision criteria in the majority of decision trees generated. 
Decision trees could then be generalised as a “pass” path described by metabolite 
concentrations and a “fail” path described by control-related measurements. 
The strongest generalised pass/fail behaviours were observed for pH. Key differences 
between pass behaviour and fail behaviour were the magnitude of the decline in pH 
readings typically observed by Days 4 and 5 and whether the pH returned to pre-decline 
values or whether pH readings remained lowered. 
Detailed analysis of the decision tree classifying the intrascaled, inoculation justified 
dataset according to a pass/fail limit of a 40%/d calculated decline in viability revealed 
several strongly interrelated variables as being of interest: pH, pCO2, Na
+ concentration. 
Two main potential causes of viability crashes were identified as areas for improvement: 
 pH strategy – Adjustment of pH controller deadband to force pH readings nearer 
to the observed “pass” culture pH behaviour. 
 Gassing strategies related to pCO2 control.  
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6.6.5 Analysis Pattern 3 Results 
Table 32 displays the frequency of top node decision criteria for decision trees generated 
using Analysis Pattern 3, which was designed to identify key days of interest. As Analysis 
Pattern 3 did not use justification, comparison between top node decision criteria was 
limited to dataset scaling process applied where the most frequent variables selected for 
top node decision criteria were Day 1 PC1 and Day 2 PC1. 
From this trend, it appeared that behaviour very early in a culture’s residence was 
correlated with the final pass/fail class and that behaviour on or just prior to these readings 
could be either related to the cause or a strong indicator of the cause of failure. 
To determine the state of the cultures on Day 1 and Day 2 relative to the culture behaviour 
across all readings, contribution analysis was performed on the PCA models used to 
generate the scores summarising daily samples. The types of figures used to conduct this 
analysis are shown in a series of figures in Figure 54. 
Figure 54A was the score plot of the PCA model created using intrascaled data in the day 
by day arrangement, where each point represents the data from one daily sample from a 
single culture. When a decision tree was generated to classify samples according to a 
30%/d decline limit, the Day 2 PC1 score was selected as the top node decision criteria. 
Hence, scores in Figure 54A were limited to those related to Day 2 samplings. 
Figure 54B shows the loading plot of the PCA model from which it was seen that the 
relative positioning of metabolites appeared to be in keeping with known GS-CHO 
metabolism behaviour during a typical 12-15 culture. While there was comparatively low 
variation in DOT (%) or temperature, as was expected for cultures running according a 
set process, pH and pCO2 showed higher degree of variation. 
 All Autoscale Intrascale A 
Top Node Count % Count % Count % 
Day 1 PC1 4 33% 4 67%   
Day 2 PC1 4 33% 1 17% 3 50% 
Day 6 PC1  1 8% 1 17%   
Day 7 PC1  1 8%   1 17% 
Day 9 PC1  1 8%   1 17% 
Day 10 PC1  1 8%   1 17% 
Table 32. Decision criteria for top node in decision trees using Analysis Pattern 3. Shading 
indicates that the variable was not a top node decision criteria for the scaling method listed.
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Figure 54. Figures used for contribution analysis of Day 2 readings to compare pass and fail 
cultures according to a 30%/d decline limit. The following graphs were generated using Analysis 
Pattern 3 with intrascaled data: 
A. Score plot showing scores for Day 2 only. Point colour and shape indicated project. 
B. Loadings for model. 
C. Hotelling T2 contributions for samples classed as fail. Gaps in variable number were due 
to variables excluded from analysis (e.g. osmolality, VCC). 
D. Hotelling T2 contributions for samples classed as pass. Gaps in variable number were due 
to variables excluded from analysis (e.g. osmolality, VCC). 
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Figure 54C and Figure 54D show Hotelling’s T2 contributions for two sets of Day 2 
sample scores. Hotelling’s T2 contributions show the relative contribution by a value for 
a variable to a sample point’s position within a multidimensional model. For the dataset 
under consideration, each point shows the relative contribution compared not only to 
other cultures for that daily sample but also the point compared to sampling pints 
throughout the cultures’ span. 
In Figure 54C, the contributions describe Day 2 samples scores for cultures classed as fail 
by the top node decision criteria (N.B. this is not necessarily the final class assigned by 
the decision tree). In Figure 54D, the contributions describe Day 2 samples scores for 
cultures classed as pass by the top node decision criteria. When these figures were 
compared, it was seen that contributions from pH, DOT, pCO2, and glutamate were 
notably different, effectively opposite values in terms of negative/positive. A difference 
in the magnitudes of contributions by lactate and NH4+ was also noted. 
As stated previously, these contributions were relative to all readings for all cultures in 
the dataset. Hence differences in Hotelling’s T2 contribution were also affected by how 
measurements for Day 2 compared to culture behaviour before and after Day 2. 
Essentially, scaled readings would capture if pH readings were relatively constant 
throughout the culture span, if decline and recovery (as seen in Figure 49) occurred, etc. 
These comparisons were further emphasised by the use of intrascaling. 
6.6.6 Analysis Pattern 3 Conclusions 
pH, DOT, and pCO2 were key indicators related to control strategies. Additionally 
cultures classed as fail by the top node showed lower concentrations of lactate, glutamate, 
and NH4
+ than cultures classed as pass by the top node. These results were in keeping 
with conclusions from Analysis Pattern 2. 
6.7 Final Results and Discussion 
The lack of ease of interpretation for Analysis Pattern 1 stands in contrast to the ease of 
interpretation when separate models were used to identify and interpret variables and days 
of interest (Analysis Pattern 2 and Analysis Pattern 3 respectively). Here it was shown 
that, for the dataset in question, the development of several “simple” models focussed on 
only two dimensions of a three-dimensional dataset (culture x sample x time) was of 
greater use than the development of a single, fully comprehensive model using a more 
complex statistical method (e.g. PLS-DA). 
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The conclusions from the above analyses were presented to key figures in the original 
investigation by Lonza. The conclusions from the presented investigation were in keeping 
with conclusions from the historic investigation used to develop an improved platform 
process, primarily that adjustment of the pH control strategy to enforce behaviours similar 
to that more typical of ‘pass’ cultures. After a key turning point in pH behaviours, analysis 
became complicated by complex interactions between indicators and feed strategies. 
Therefore process development activities would need to take a minimum two-stage 
approach to first address pH behaviours and to afterwards address feed strategies. 
While the presented investigation did not reveal any significantly new information 
compared to the historic investigation, it was shown that appropriate use of multivariate 
data analysis could allow similar conclusions to drawn with both reduced time and 
personnel requirements. 
6.8 Conclusions 
It was demonstrated, that with appropriate modifications to the method developed in 
Chapter 6, a meta-analysis approach of developing many models from a core dataset 
resulted in stronger identification and understanding of captured behaviours than would 
have been achieved by relying on a single model. In doing so, it was also demonstrated 
that the major perceived obstacle to conducting a meta-analysis was time required was 
untrue. 
By developing technically simple spreadsheets, a number of analytical options for 
restructuring and pre-processing the core dataset were tested for a low cost when 
compared to the time need to develop a single model in terms of additional man hours. 
While harvest justification showed only minor improvements in classification accuracy 
for the presented investigation, it was shown that rejustification of the dataset to better 
reflect the response in question could be easily applied and tested. 
Finally, it was demonstrated that the use of intrascaling reduced project-specific 
confounding in a manner appropriate for the dataset used and the investigation conducted. 
Specifically, in this investigation ensuring platform process behaviours were captured in 
place of project-specific behaviours was prioritised over pure classification accuracy. The 
two-step scaling process can be recommended as a tool for the following purposes: 
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1) Reduction of low levels confounding as demonstrated in the presented 
investigation. 
 
2) Identification of high levels of confounding, i.e. confounding remains after 
intrascaling applied as the scaling step indicating a more powerful method is 
required, e.g. confounding reduction through the use of PLS-DA with subsequent 
analysis performed using PLS-DA residuals matrix [13]. 
 
3) Identification of whether confounding has any appreciable impact on analysis, i.e. 
confounding effects on data not appreciably related to response of interest. 
6.8.1 Recommendation 1 
Aspects of the developed meta-analysis framework can applied in a variety of ways for 
process development. For example, a “generic” model is developed for a process platform 
(e.g. CHO V8.0) from a multiproduct dataset. New projects using the host cell line and 
platform process are analysed using this model for a various reasons: 
1. To provide an initial model for performance monitoring until sufficient data is 
available to create a project-specific model. 
2. To identify past projects/products with similar behaviour and identify potential 
sensitivities or issues. 
6.8.2 Recommendation 2 
As the development time for models was shown to be minimal compared to time needed 
to collate and vet data, a meta-analysis/multiple model confirmatory approach is 
recommended as a normal action during investigations, at least during initial data 
exploration and model development.  
6.8.3 Recommendation 3 
In light of the growing adoption of electronic laboratory notebooks and recommendations 
1 and 2, it may be of benefit to develop models to evaluate data at the point of capture. A 
‘dashboard’ of models (generic process and/or product-specific) using the data could be 
displayed. With appropriate development, these models could be used to tracking culture 
progress or monitor known indicators of undesirable future behaviours. Furthermore, as 
data would be directly entered and potentially evaluated one sample at a time, this could 
reduce the time needed to vet data during a large scale analysis as common entry errors 
(e.g. decimal point errors) would be more likely to be spotted near the point of entry  
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 Conclusions 
The research presented demonstrated multiple applications of multivariate data analysis 
(MVDA) to address four main projects. The conclusions and recommendations presented 
here prioritise the methods used, statistical tools generated. Additional space was also 
given to how the works performed met soft research aims, e.g. demonstrating how to link 
multiple statistical techniques in a cradle to grave (data generation to implementable 
result) workflow, considerations for adapting workflows based on available data and 
investigation aims, etc. Key project-specific results of analysis are reiterated, however for 
greater detail of project-specific results, readers are advised to consults the relevant 
chapter. 
7.1 Comparison of pH Measurement Technologies and Extraction of Indirectly 
Captured Information 
During the comparison of pH measurement technologies (Chapter 4), it was shown that 
it was possible to extract indirectly captured information from a pre-existing dataset. 
More specifically, the indirectly captured information were contributions to osmolality 
measurements by unidentified compounds, here termed osmolality residuals. It was 
recommended that osmolality be recorded at all scales to allow the extraction of this 
information and thus improve comparisons between scales. 
Osmolality residuals were calculated through the creation of a multiple linear regression 
(MLR) model that was refined using statistical significance testing. Use of this newly 
created variable was backed by observations of data behaviour through use of time series 
analysis and principal component analysis (PCA). Use of MLR and statistical significance 
testing was then used to demonstrate a different purpose: the identification of variables 
correlated with differences in pH readings by different pH measurement technologies. 
Hence, the application of three MVDA methods was demonstrated: MLR, statistical 
significance testing, and PCA. This met soft aims by demonstrating flexibility of MVDA 
methods in both dataset preparation and final analysis. 
The hard aim of the pH measurement technology comparison was the identification of 
variables correlated with differences in pH readings between the offline pH measurement 
technologies. Results indicated that samples’ chemical compositions and physical 
condition (e.g. temperature) were correlated with differences in pH readings by different 
pH measurement technologies. 
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From this conclusion, it was recommended the company ensure consistency in pH 
measurement technology type used for activities across sites and between scales, e.g. if 
NOVA Bioprofile 400 units are used for offline pH measurement during R&D at 10L at 
one site, use NOVA Bioprofile 400 units for offline pH measurement at different scales 
and/or different sites. 
Similarly, the company should ensure consistency in pH measurement technology type 
used across activities, e.g. if possible, ensure online and offline pH measurement units 
use similar technologies, e.g. both online and offline pH measurements are made using 
Radiometer pH probes with temperature compensation methods. 
7.2 Productivity Investigation 
An investigation into variation in product concentration for a single product project was 
described in Chapter 5. The investigation was broken into three distinct stages. 
In the first stage, the dataset comprised 10L and 130L cultures performed at the Slough, 
UK site. From this dataset, a general method based on decision tree was created. During 
method creation, a variety of available options for data sources, missing data estimation, 
data pre-processing, and decision tree algorithms were tested. 
In addition to identifying the “best” options to employ in terms of lowest misclassification 
error, it was shown that a choice in one area could cause knock on effects in other areas 
and in turn effect the accuracy of the overall method. The specific example was the use 
of iterative PCA for estimation of missing data when the dataset was restricted to data 
from daily monitoring of cultures or when the dataset was extended to include data from 
both daily monitoring and online monitoring of cultures. It was suggested that this was 
due to both greater availability of information to the model and improved estimation of 
missing data when using iterative PCA to estimate missing data. 
In the second stage, the dataset was expanded to include cultures from 5000L and 10L 
cultures from a US site, which used an altered seeding criteria and altered harvest criteria. 
As these alterations prevented the use of the initially developed method of decision trees, 
it was suggested partial-least squares regression models to predict product concentration 
could be used to identify behaviours correlated with productivity instead. 
The alterations in seeding criteria introduced a source of confounding; the US-sited 
cultures appeared to be more “mature” with respect to Elapsed Time (h) due to higher cell 
concentrations for transferred inoculum and associated metabolite differences. It was 
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suggested that this confounding could be reduced by realigning data from time-based 
sampling points (e.g. every approximately every 24 hours) to sampling-based on set 
values for the integral of viable cell concentration (IVC). To test this hypothesis, new 
datasets were created based on rigid sampling points for time and IVC by simple 
interpolation recorded data. 
It was found that use of IVC in place of Elapsed Time (h) lead to improved predictive 
accuracy and better distribution of residuals for PLSR models predicting daily product 
concentration from that day’s associated data. Use of IVC in place of Elapsed Time (h) 
also provided greater robustness when data generated from US cultures with altered 
seeding criteria were applied to models generated from UK culture data. However these 
improvements did not necessarily occur when analysing the dataset in profile orientation 
(e.g. 1 sample = all data for 1 culture) or when using a different response of interest (e.g. 
viability). These findings demonstrate additional considerations that must be taken into 
account each time an interrogation is made of a dataset, in particular if multiple 
interrogations are being made of a single dataset. 
It was also shown that interpolating the dataset to realign sample to set progression values 
(e.g. 0.0 h, 24.0 h, 48.0 h, etc.) allowed the progression variable itself to be eliminated 
from the model with minimal negative effects on model accuracy and robustness. This 
was in keeping with expectations as there would be no variance between samples for these 
variables following realignment and hence no additional information to be captured by 
including the progression variable. This also demonstrated that the underlying 
temporal/progressional variation in the dataset had been effectively removed. 
In the third and final stage, it was suggested that the underlying cause of variation in 
product concentration may have been linked to the batches of media used in the course of 
the study. In collating batch numbers for all UK cultures, it was shown that combinations 
of batch numbers for media components were effectively unique to each round of cultures 
performed. Hence, it was not possible to confidently tie any individual media component 
or specific lot of media component to undesirable behaviour. Even if specific components 
or lots could have been pinpointed as the underlying causes, it would not have been 
possible to identify the differences in composition leading to undesirable behaviours as 
lot compositions were not recorded, only lot number. 
The hard aim of the productivity investigation was the identification of variables and 
factors correlated with variation in product concentration at harvest. Soft aims also existed 
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related to guidance on handling investigations and datasets of this nature, as well 
identification of areas requiring or benefiting from further attention. Additionally, a 
variety of tools were generated in the course of the work. 
In Stage 1, several different means for handling missing data were employed. In addition 
to providing reasons for or against their use from a theoretical viewpoint, the presented 
work also demonstrated the real effects of using the methods for handling missing data. 
While the results were as expected, demonstrating knock-on effects during analysis, such 
as filling in missing values with variable means artificially reducing data spread and in 
turn leading to decreased classification accuracy by PC-decision trees, was within the soft 
aims of the EngD. 
Stage 1 of the productivity investigation provided the drivers for the development of 
informative values for capturing behaviours in online monitoring and subsequently the 
development of the Excel-based tool EPIC-CAT. The work presented in Stage 1 
demonstrated that the initial Informative Values 1.0 met two of the stated criteria: 
1) Capturing behaviours in online monitoring data in a manner suitable for follow 
on use in MVDA 
2) Allowing integration with data from daily sampling. 
However Informative Values 1.0 (see Appendix A) did not meet the desired level of 
intuitive interpretability. Further development was deemed an appropriate use of time as 
informative values had been demonstrated as a useful variable set. This led to the most 
current version of informative values, Informative Values 7.0, which were used during 
Stage 2. 
In Stage 2, another Excel-based tool was created for realignment of datasets to a variable 
of choice. Use of this tool was restricted to realignment to specific values for elapsed time 
or IVC, however the tool allows realignment to any variable which changes in a roughly 
proportional manner with time. For example, it is unlikely that the current version of the 
tool would be able to realign a typical fed-batch dataset according to lactate as this can 
follow an increase-decrease relationship with time caused by a period of accumulation in 
the culture followed by a period of consumption by cells. Further development could 
allow some analogous version to be applied. 
In Stage 3 a key knowledge gap in the collected data was identified. It was shown that for 
this investigation batch numbers for raw materials were of little statistical use and 
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provided a strong example of a case where the use of spectral devices such as Raman 
probes might provide valuable information concerning raw material quality. 
The capture and use of such spectral data is of growing interest in the biopharmaceutical 
industry. While the presented work did not deal with spectral data, key learning points 
could be carried over. As an example, in spectral data analysis, wavelengths or wave 
numbers are typically treated as variables measuring emission or absorption of light, 
depending of spectroscopy type. Many thousands of wavenumbers are recorded for a 
single sample leading to situations similar to those seen in Chapter 5 with high frequency 
data from online monitoring. Two approaches demonstrated in this thesis could be 
considered: 
1. Summarising spectral data as sets of key values, analogous to informative values. 
2. Compression of the spectral dataset using PCA and using the resulting scores in 
subsequent analyses, as demonstrated with the use of PC-decision trees. 
7.3 Multi-Product Platform Process Analysis 
Chapter 6 described an investigation conducted on multiple projects using a common host 
cell and process platform (GS-CHO Version 6) to identify variables correlated with 
crashes in culture viability. In regards to this hard aim, pH control and behaviour were 
identified as the top variable of interest. pCO2 control was highlighted as an additional 
area for process improvement with Na+ concentration as an additional indicator of 
interest. 
General softer outcomes were identified concerning overall trends in the dataset and the 
way in which the analysis was perform. General trends included identifying a range for 
the ‘best’ pass/fail decline limits for the dataset, i.e. misclassification errors for models 
were lower when limits of 30%/d and 40%/d were used. Model optimisation using 
response surface methodology to minimise misclassification error indicated a local 
optimum decline limit of 45%/d. 
Outcomes concerning the method of analysis included improvements to interpretability 
by employing model hierarchies (e.g. Analysis Pattern 2 and Analysis Pattern 3) and the 
creation of a confounding reduction method appropriate for the desired use and future 
implementation. Furthermore, it was demonstrated that classification methods should not 
be selected based on perceived statistical power alone. This was shown by both the lower 
misclassification error and increased interpretability for models using decision trees 
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algorithms when compared to models using PLS-DA, which would generally be regarded 
as the more statistically powerful. 
During the platform process analysis, a variety of different tools and techniques were 
employed. The key obstacle faced was the sheer scale of the dataset to be considered as 
it stretched back several years and covered a wide variety of products with uneven 
distribution of culture numbers, scales, and instances of crash behaviour. Indeed, the first 
task undertaken was a quantitative definition of crash/non-crash behaviour to allow 
efficient classification of the cultures in an acceptable time frame.  
The scale of the dataset was addressed through the use of a many models meta-analysis 
which also serves as a response to the question posed at the start of Chapter 6, “Where do 
I begin?” The use of many models allowed general trends captured in the dataset to be 
identified and thence direct more focussed analyses based on those trends. 
One example of the benefits of the meta-analysis approach was the use of multiple 
pass/fail limits for decline in viability over a 24 hour period to identify a ‘natural’ pass/fail 
division in the dataset. A second example of the benefits of the meta-analysis approach 
was the use of two different scaling approaches (Autoscale and Intrascale A) with three 
primary benefits. 
1. When Autoscale was applied to the dataset, project-specific variance was allowed 
to influence the resulting multi-project model. This provided the person 
performing the analysis an opportunity to identify projects with behaviours 
notably dissimilar to other projects in the dataset. 
2. The use of Intrascale A allowed the influence of project-specific variance in a 
multi-project dataset to be reduced. 
3. Use of both scaling methods as part of a meta-analysis approach enabled 
determination of whether any confounding by product/project observed during an 
initial exploratory PCA affected classification accuracy. 
Finally, the greatest hurdles to implementing a meta-analysis approach to test various 
options for data realignment, justification, scaling, etc. were identified as the initial 
collation of the dataset and data checking. These activities were measured in weeks, 
whereas the creation of several spreadsheet-based tools allowed many different options 
to be applied in seconds, generation of the multiple models was a matter of minutes, and 
initial conclusions were available within hours. 
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7.4 Informative Values 
The aim of the research presented in Appendix A was improved analysis of high 
frequency datasets generated through online monitoring of cell cultures. Initially this was 
specifically for the purpose of the productivity investigation described in Chapter 6. Due 
to the high potential of the high frequency online monitoring dataset, it was decided to 
further build on the initial, project-specific work to create a robust tool designed for use 
with any high frequency online monitoring data. 
Common obstacles in the use of online monitoring datasets in biopharmaceutical process 
are reliance on qualitative, univariate comparisons of monitored parameters and reliance 
on personal experiences. While techniques such as PCA and PLS-DA can be applied can 
be applied directly to online monitoring datasets, interpretation of results can become 
difficult due to both the high number of observations and the lack of similarly 
high-frequency variables of interest (e.g. product concentration). Typically these 
variables of interest or variables closely correlated with such variables of interest (e.g. 
cell growth may be closely correlated with product concentration) are included in offline 
monitoring dataset. However integration of online monitoring and offline monitoring 
dataset by simple extension of the dataset analysed is rarely possible as online monitoring 
data usually overwhelms offline monitoring data due to sampling frequency. 
From these circumstances, the hard research aim was defined as the downsampling of the 
high frequency online monitoring dataset in a manner that captured behaviours in a 
quantitative form meeting the following criteria: 
a) Appropriate for follow-on use in MVDA. 
b) Retained a high degree of intuitive interpretability by scientists. 
c) Allowed integration with offline sampling datasets. 
These three criteria were met through the creation of a set of robust summary statistics 
termed informative values. The use of informative values allowed the use of PCA to 
identify unusual behaviours in online monitoring behaviours. These ranged from one-off 
events (e.g. temporary disconnection of a temperature probe) to differences in movement 
around temperature setpoint between reactors of the same scale. 
Due to the summary statistics selected to make up informative values, these behaviours 
were communicated in a simple and efficient manner with a high degree of intuitive 
interpretability. In the case of the temperature probe disconnection, for the culture in 
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question in one 24 hour block the area below median temperature (ABMTemp) and the total 
area away from the median temperature (TAAMTemp) for temperature were notably high. 
However the area above median temperature (AAMTemp) and median absolute distance 
(MADTemp) were within expected ranges for the 24 hours in question. Informative values 
for all other 24 hour blocks appeared within expected ranges. From this, it was known 
that an event had occurred with the following conditions: 
1. The event was restricted to the 24 hours in question 
2. The event did not last long enough to affect the median temperature or the median 
absolute distance around the median temperature within that 24 hour block. 
3. The event increased area away from the median temperature in one direction only. 
From these simple conclusions, it was determined that the recorded temperature 
measurement had dropped drastically for a short time. Referring back to the original data 
for the 24 hours under consideration, it was revealed that an error had occurred with the 
temperature probe and null readings were recorded. 
The ability to integrate online monitoring and offline monitoring datasets following 
translation to informative values was demonstrated in the work presented in Chapter 5. 
There was seen that models generated from datasets integrating online monitoring data 
(as informative values) and offline monitoring data resulted in lower misclassification 
error by decision trees when classifying cultures as high producing or low producing. It 
was suggested that this was due to both greater availability of information to the model 
and improved estimation of missing data when using iterative PCA to estimate missing 
data. 
Translation of high frequency online monitoring datasets into informative values initially 
required approximately 30 minutes per culture. By the conclusion of the research 
described in Chapter 5, processing time had reduced to approximately 30 seconds per 
culture. This was achieved through the development of the first purpose-built tool created 
from presented research, the Excel-based “Efficient Process Capture - Calculation and 
Alignment Tool” (EPIC-CAT). 
7.5 Final Conclusions 
During the course of the industry placement and through attendance at both academic and 
industry conferences, a wide variety of attitudes towards MVDA were encountered. 
These ranged from dismissal of MVDA techniques as unnecessary, somehow fallacious 
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representations of systems, or unsuitable for use outside laboratory conditions to strong 
devotion to a single statistical method or framework. A third extreme encountered was 
that a model can be created but that model must be perfect, entirely accurate, and the only 
model created. 
These attitudes place a great deal of emphasis on pure predictive/classification accuracy 
and less on practical use of a model as a tool available to scientists. Furthermore, they 
centre on idealised scenarios, both that the model is appropriate for all interrogations 
being made of the dataset and that enough time is afforded to create such perfected 
models. There is also a tendency to rely on a single, inflexible process of analysis. The 
sum effect of these attitudes can lead to a general reluctance to apply MVDA until some 
form of crisis occurs. 
 
Toolbox Division Tool Type 
Main Chapter 
(Related) 
1 – Core Technique Core Technique Selection Guide D (3, 4, 5, 6) 
2 – Dataset Adjustment 
Tools 
Dataset Adjustment Tool Guide D (5, 6) 
Standardised Data Collection S 6 
Dataset Collation S 5 
Dataset Reorientation S 5 
Dataset Realignment S 5 
Dataset Re-Justification S 6 
Data Intrascaling S 6 
Data Source, Sample, and Variable 
Selection Guide 
D (3, 4, 5, 6) 
Missing Data Handling D 5 (6) 
3 – Complementary 
Tools 
EPIC-CAT S  Appendix A (5) 
EPIC-CAT Collator S  Appendix A (5) 
Osmolality Residuals Guide D 4 
Simple Profile Classifier S 6 
4 – Frameworks Result Interpretation Guide D (4, 5, 6) 
Analysis Schemas F (4, 5, 6) 
Table 33. Summary of statistical toolbox contents. The toolbox is split into four main divisions 
containing written documents (D), process flow documents (F), and spreadsheet-based tools (S). 
Where appropriate, the chapter from which the item originated is listed. Additional chapters where 
the item was used are indicated. If no specific chapter is indicated, the item was based upon the 
research body as a whole.  
 161 
 
The presented research approached the application and implementation of MVDA in 
biopharmaceutical processes as the creation of a robust statistical toolbox (Table 33). This 
toolbox included not only the tools, but also guidance on how to use tools, warnings of 
how not to use tools, and flexible frameworks demonstrating how multiple statistical tools 
could be chained together based on user requirements. 
In the four projects described, a variety of ways of using pre-existing historical datasets 
and new datasets generated from current standard data monitoring has been demonstrated. 
These included: 
1. Comparison of discrepancies in readings by supposedly interchangeable 
technologies. 
2. Extraction of indirectly captured information. 
3. Translation of a high frequency dataset for improved user interpretability and 
integration with a lower frequency dataset. 
4. Demonstration of effects of options for missing data estimation on both dataset 
spread and during subsequent MVDA. 
5. Evidence for an alternative measure of culture progression in place of time 
6. A means of removing underlying variability in a dataset from variation in a chosen 
progression variable (e.g. time or IVC). 
7. Identification of a knowledge gap and how that gap may be resolved including 
integration into the presented MVDA frameworks. 
8. A means of removing a well-known, if not necessarily well-understood, source of 
confounding to allow analysis of an underlying shared process. 
9. Evidence of potential benefits in re-justifying physical structuring of samples to 
better reflect model purpose/responses. 
10. Demonstration of a meta-analytical approach to define general trends and 
improved problem definition. 
Demonstration of the benefits of employing multiple ‘simpler’ models with good user 
interpretability in place of a single, more comprehensive model with lower 
As all necessary data were generated through normal company activities, the only 
additional company resources required were a workspace and access to the scientists 
involved in data generation, who represented the intended future users of the research 
outcomes. 
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In short, it has been shown that many areas for improvement in biopharmaceutical 
processes can be addressed by allowing an appropriate investment of time and freedom 
to fail in order to explore which statistical methods do or do not work, where they work, 
and to develop supplementary tools to enable use of statistical methods as a normal action. 
It is hoped that the frameworks and tools developed and demonstrated in this thesis will 
be used to further support the implementation of the PAT Initiative and statistical process 
control in the biologics and other related industries
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Appendix A. Downsampling of Online Monitoring Data as Informative 
Values 
A.1 Introduction 
A key concern in the production of therapeutic proteins such as monoclonal antibodies 
(mAb) is whether the product has the correct critical quality attributes (CQA) [169–174]. 
For a glycosylated product such as a mAb, glycoform profiles are among the CQAs 
regulatory agencies require biopharmaceutical companies to characterise and maintain 
[175,176]. To ensure CQAs and acceptable levels of growth and productivity are met, 
critical process parameters are monitored to allow identification of potential issues [177]. 
It is easy to state that a bioreactor will operate at 36.5 °C with a pH of 6.92 and dissolved 
oxygen tension (DOT) of 40 %. However achieving and maintaining stated conditions 
can be a complex challenge with typical control systems reliant on high frequency online 
monitoring. Similarly challenging is making full use of the high frequency data generated. 
A common practice is to overlay data from different bioreactors on a single figure. This 
style of comparison is inadequate as it is potentially highly qualitative and subjective, and 
does not meaningfully tie information from online monitoring data to biological data from 
offline sampling. 
The FDA PAT initiative is often used to justify introducing newer, more comprehensive 
measurement equipment (e.g. non-analyte-specific spectra capture with Raman probes). 
However the initiative also promotes the use of new measurement techniques to 
understand the impact of process controls on performance. This includes techniques for 
improved interrogation of data from earlier technologies. One area of interest is moving 
beyond statistical process control and “In control/out of control” alarm limits to linking 
bioreactor control system behaviour to cell culture biological behaviour. 
A wide variety of statistical techniques have been applied to online monitoring data for 
this purpose, including self-organizing maps [178,179], data similarity measures 
[180,181], and ensemble methods [182]. The listed techniques focus heavily on direct 
application to high frequency data and lack easy interpretability or intuitive meaning for 
users who are not statistical experts or are not afforded the luxury of time required for an 
exhaustive drill down. While academically interesting and promising for future 
implementation, the majority of these techniques are not amenable to immediate or 
effective implementation in industry 
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Online monitoring data analysis, in particular the analysis of data from online monitoring 
of bioreactors, is highly reliant on contextual information. For many users, an analysis 
that identifies the 1000th pH reading out of several thousand (e.g. ~3 minutes out of many 
days) as a variable of interest is not informative and lacks intuitive meaning. 
It was theorised that interpretation could be improved if the data were summarised as 
intermediary statistics termed “informative values” and subsequent analyses were 
performed using these informative values. Informative values are defined as calculated 
variables that quantitatively summarise online monitoring data behaviours across 
meaning full windows of activity, such as between offline sampling points. Most 
importantly, informative values representing the original data hold intuitive meaning for 
the end-user. These informative values can then be used in subsequent analyses in place 
of the original online monitoring data. 
The aim of the presented study was to create these informative values. Furthermore, the 
informative values were also required to be robust to transfer between processes and 
scales as well as to imperfections from non-ideal, real processing data. 
Principal component analysis (PCA) [144] was used to demonstrate that the selected 
informative values effectively captured online behaviours when applied to a 
manufacturing dataset [183]. 
A.2 Materials 
The data used to develop the presented research were taken from the online monitoring 
of mAb-producing cell cultures grown in 10 L and 130 L air lift reactors at the Lonza 
Slough site. The dataset included monitoring for a wide variety of conditions. A more 
detailed description of the dataset can be found in Chapter 6. An additional, artificially 
generated dataset (cultures P001 to P100) was created for demonstration purposes. This 
was because a variety of behaviours may occur over the course of a culture; the second 
dataset was to more clearly demonstrate individual behaviours. 
Online monitoring of pH, temperature, and DOT was achieved by the use of probes 
inserted into bioreactors. Online monitoring of air flowrate, O2 flowrate, and carbon 
dioxide flowrate was achieved by flowrate meters on lines into the bioreactors. Probes 
and flowmeters were connected to control units which recorded values at a set interval. 
Variables were classed according to variable purpose. Temperature, pH, and DOT were 
classed as steady state because control systems were designed to keep these variables at 
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defined setpoints. Flowrates for air, O2, and CO2 were classed as dynamic. Values for 
these variables were dependent on biological behaviour and were used to control several 
steady state variables. The main behaviours of interest for steady state profiles are 
adherence to setpoint, magnitude of movement around setpoint, and drift. Two further 
behaviours encountered were perturbations and shifts (changes) in setpoint (Figure 55). 
Perturbations were periods of up to four hours where readings remained outside 
acceptable noise limits in a given direction. A variety of causes for perturbations exist 
from incorrect controller action to probe connection issues. However, the focus in this 
study was capture and identification of perturbations through the use of informative 
values. 
 
 
 
Figure 55. Artificially generated online monitoring data of pH for four theoretical cultures 
showing various behaviours and noise. P001: ideal, setpoint ± 0.005. P021: high perturbation, 
setpoint ± 0.005. P031: high perturbation, setpoint ± 0.010. P041: shift in setpoint, setpoint ± 
0.005.  
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DOT was controlled using air, O2, and N2 feeds. Online DOT behaviours could typically 
be split into four sections: 
1. An initial low noise period following inoculation. 
2. When the cell mass consumes more O2 than the airfeed can supply, an O2 feed is 
activated, leading to a period of increasing noise lasting until O2 demand peaks. 
3. A period of decreasing noise as O2 demand and hence O2 flowrate lessen. 
4. A final period of low noise where O2 demands are by the air feed only. 
A.3 Analysis of High Frequency Data in Native State 
Two analyses were performed to determine whether the use of summary statistics could 
provide improvements in either model performance (e.g. X variance captured by model) 
or model interpretation by a user. The first analysis was performed using data in its native, 
high frequency state. The second analysis was performed using summary statistics 
generated from the original dataset. 
A.3.1 Method 
Online monitoring data from 49 cultures performed in 10 L and 130 L bioreactors at 
Lonza’s Slough site were collated into a single, longitudinal dataset. In this orientation, 
there was a single observation per culture representing all data for all sampling points 
(Table 34). Analysed data were restricted to 1916 samplings per variable per culture 
(~160 h) and 11 cultures were removed, including all 130 L cultures, due to reach this 
criteria. Additionally, due to data loss and data validity issues related to transfer of data 
from datalogger to computer, CO2 flowrate was removed as a variable. 
Variable pH Temperature (°C) DOT (%) 
Sample  1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 
A xA,1,1 … … … xA,1,5 xA,2,1 … … … xA,2,5 xA,3,1 … … … xA,3,5 
B xB,1,1 … … … xB,1,5 xB,2,1 … … … xB,2,5 xB,3,1 … … … xB,3,5 
C xC,1,1 … … … xC,1,5 xC,2,1 … … … xC,2,5 xC,3,1 … … … xC,3,5 
D xD,1,1 … … … xD,1,5 xD,2,1 … … … xD,2,5 xD,3,1 … … … xD,3,5 
E xE,1,1 … … … xE,1,5 xE,2,1 … … … xE,2,5 xE,3,1 … … … xE,3,5 
Table 34. A longitudinal arrangement of a three-dimensional dataset (culture x sample [time] x 
variable). The data have been arranged so that an observation comprises all the data for a culture 
A to E. This data is then grouped by variable pH (1), temperature (2), DOT (3). Within in the 
single variable grouping, data are ordered chronologically by sample number, 1 to 5. The 
hierarchy of the arrangement is captured in the subscripts for values, xCulture,Variable,Sample. An 
alternative arrangement could by to first group by sample numbers and then order data by 
variable, e.g. pH (1), temperature (2), DOT (3). This would be captured in subscripts as 
xCulture,Sample,Variable.  
 178 
 
Data were imported to Matlab for analysis with the Eigenvector PLS-Toolbox. Data were 
mean-centred and scaled to unit variance. A PCA model was created using random 
sampling (10 splits, 5 iterations) for cross-validation. A two PC model was retained, 
which captured 36.11% of variance in the dataset. 
A.3.2 Results and Discussion 
Model analysis was performed by first understanding the systematic behaviours captured 
through model loadings and then by performing a comparative drill down analysis on two 
cultures. 
Figure 56 shows model loadings for PC1 and PC2. Loadings were coloured according to 
variable type (temperature, DOT, pH, air flowrate, O2 flowrate). Clear structures were 
observed for both PC1 and PC2 loadings for the dynamic variables air flowrate and O2 
flowrate. These structures showed that the previous discussed dynamic behaviours were 
captured by the model. 
It was also observed that PC1 and PC2 loadings for pH appeared to be sharply split into 
loadings > 0 and loadings < 0. This was interpreted as the model capturing changes in pH 
setpoint several cultures in the dataset underwent. PC1 and PC2 loadings for temperature 
and DOT variables were interpreted as the model capturing movement around the 
temperature and DOT setpoints. It is key to note that this movement could not be 
determined as random or systematic at this level of model interrogation. 
Cultures A006 and A047 were selected for the comparative drill down analysis. A006 
and A047 were selected based on their positions on the model score plot (Figure 17A) 
posed a greater analytical challenge because differences in behaviour would be more 
nuanced than statistically more obvious differences captured in PC1 behaviours (e.g. 
differences in setpoints). Furthermore while A047 was within 95% limits for Q Residual 
and Hotelling T2 (Figure 17B), A006 was outside the Q Residual limit. 
Q Residual contribution analysis (Figure 17C) indicated that the greatest difference in 
contributions was due to difference in pH behaviour. This was due to the change in pH 
setpoint for A006. This was in keeping with Q Residuals as comparison of a culture’s 
behaviour to the mean behaviour of the model as the A006 pH setpoint change was not 
typical of the dataset. 
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Figure 56. Loading plots for a PC model created from online monitoring data in its native state. 
The variables can be split into five distinct ‘variable blocks’ roughly every 2000 variable 
numbers: temperature (1 to ~2,000), pH (~2,000 to ~4,000), DOT (~4,000 to ~6,000), air (~6,000 
to ~8,000), O2 (~8,000 to ~10,000). Across the three loadings plots shown, interpretation of the 
captured model was problematic due to the high number of variables. In all three loadings plots, 
air and O2 were observed to have a strongly conserved behaviour during the course of a culture, 
whereas behaviours for the setpoint controlled variables temperature and DOT appeared to 
capture movement around the setpoint. Behaviour for the setpoint controlled variable pH captured 
that several cultures underwent a change in setpoint while the majority cultures did not. 
A) Loadings plot for PC1 (22.68%) and PC2 (13.43%). 
B) Loadings plot for PC2 (13.43%). 
C) Loadings plot for PC1 (22.68%).  
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Figure 57. Drill down analysis of cultures A006 and A047 in a PC model created from online 
monitoring data in its native state. 
A) Score plot for PC1 (22.68%) and PC2 (13.43%) with 95% Hotelling’s T2 interval (--). 
 
B) Plot of cultures Q residual (63.89%) against Hotelling T2 (36.11%). 
 
C) Comparison of Q residual contributions for A006 (blue) and A047 (red). The variables can 
be split into five distinct ‘variable blocks’ roughly every 2000 variable numbers: temperature 
(1 to ~2,000), pH (~2,000 to ~4,000), DOT (~4,000 to ~6,000), air (~6,000 to ~8,000), O2 
(~8,000 to ~10,000). A clear difference was observed for the pH block due to the change in 
pH setpoint for A006 while the greatest contributions to Q residuals for both A006 and A047 
come from the DOT block. 
 
D) The recorded values for DOT for variable numbers 4551 to 4559 indicated greater noise in 
DOT for A006 (blue) than A047 (red). However it must be stated that the range of DOT 
values compared here are 12 to 17 for A006 and 14 to 15 for A0047. While statistically 
distinctive, this result was of little practical use, in part due to lack of context.  
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Differences in contributions from air and O2 flowrate variables was also observed. An 
overlay comparison of the original air and O2 data (Figure 18) showed three primary 
differences in air and O2 behaviour. 
1. A006 and A047 had difference caps for maximum air flowrate into the bioreactor, 
~2.5 L/min and ~2.0 L/min respectively. 
2. A006 reached the air flowrate cap approximately 40 hours earlier than A047. 
3. A006 generally showed greater noise in both air and O2 flowrates than A047 
across the ~160 hours under consideration. 
It should be noted that these conclusions required a return to side-by-side analysis of 
online monitoring data. 
It was also observed that both culture A006 and A047 had high Q Residual contributions 
from captured DOT behaviours. Drill down analysis to the original values in the dataset 
(Figure 17D) showed that the cultures appeared to have greater movement around the 
DOT setpoint than the majority of cultures. Selecting several consecutive readings for 
DOT indicated a greater range of movement was experience by A006 than A047. 
While it was estimated that A006 experienced three times more movement around DOT 
setpoint than A047 based on these values, this conclusion suffered from being poorly 
defined and semi-quantitative. As with the comparison of air and O2 flowrate behaviours, 
the stated conclusion required a drill down to the original values from online monitoring, 
then re-interpreting the original values up through the model. 
Overall, it was possible to create a PCA model from online monitoring data in its native 
state. However interpretation of the resulting model was problematic due to both a 
potentially overwhelming number of variables and a lack of intuitive meaning or context 
available without resorting to a drill down analysis to the original data measurements. 
This made effective communication of results difficult. Although some differences could 
be stated quantitatively, there was a strong reliance on qualitative descriptions.  
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Figure 58. Air flowrate and O2 flowrate for cultures A006 and A047. There were three main 
differences between gas profiles for the cultures: 
1. A006 shows greater noise than A047 in both gas feeds. 
2. A006 had a high air flowrate cap (~2.5 L/min) than for A047 (~2.0 L/min). 
3. A006 reached the air flowrate cap approximately 40 hours before A047. 
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A.4 Analysis of High Frequency Data as Informative Values 
In the previous analysis, data were analysed in their native high frequency state. A second 
analysis was then performed where the data were summarised as informative values and 
models were created from the resulting informative values instead. 
Informative values were developed along two main lines based on variable behaviour 
type: Steady State and Dynamic. The ability of the selected informative values to capture 
variable behaviour in a manner with high intuitive meaning and interpretability for a 
human user was then tested using three datasets: 
A.4.1 Informative Values for ‘Steady State’ Variables 
The conversion of online monitoring data to informative values underwent several 
iterations (Table 35) to meet requirements for ease of calculation, ease of interpretation, 
robustness, and quality of information. 
Initially, the same informative values were used to describe both maintained setpoint and 
dynamic profiles. Data were split into windows of activity 𝑇𝑛,𝑘 according to offline 
sampling times 𝑇1 (inoculation) to 𝑇𝐿 (last offline sampling considered). For each window 
𝑇𝑛,𝑘, the mean and standard deviation were calculated for each variable. For daily 
calculations, 𝑇𝑛,𝑘 =  𝑇𝑛,𝑛+1. For calculations over all days, 𝑇𝑛,𝑘 = 𝑇1,𝐿. 
Two key issues were identified with these initial informative values. One, results could 
be unusable, e.g. divide by zero results. Two, calculated values were sensitive to noise, 
outliers (e.g. values resulting from disconnection of a probe), and spiking from chemical 
additions not indicative of reactor behaviour as a whole. 
For example, a window of activity contains 59 readings of pH 6.89 and a single spike to 
pH 7.38 due to a concentrated bolus addition. The mean is 6.90 and standard deviation 
0.06. If the desired setpoint is 6.90 with average movement of ±0.02, the mean does not 
reflect that the pH was consistently below setpoint and the range of noise appears to be 
three times the desired range. 
If the data were to be summarised by a human, the spike would be dismissed from 
estimation of the average. Yet the human would still retain the information that a spike 
occurred. The developed informative values needed to replicate this split into overall 
information and special detail information.  
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Iteration Values for Steady State Variables Values for Dynamic Variables 
1.0 Between Sampling Points: 
 Mean Average  
 Standard Deviation 
 Slope 
 Coefficient of Determination 
Between Sampling Points : 
 Mean Average  
 Standard Deviation 
 Slope 
 Coefficient of Determination 
2.0 Between Sampling Points: 
 Mean Average  
 Standard Deviation 
 Slope 
 Coefficient of Determination 
Key Event Times for Air 
Key Event Times for O2 
3.0 Between Sampling Points: 
 Median 
 Median Absolute Distance 
Key Event Times for Air 
Key Event Times for O2 
4.0 Between Sampling Points: 
 Median 
 Median Absolute Distance 
Key Event Times for Air 
Key Event Times for O2 
 
Between Sampling Points: 
 Volume of Air 
 Volumes of O2 
5.0 Between Sampling Points: 
 Median 
 Median Absolute Distance 
Key Event Times for Air 
Key Event Times for O2 
 
Between Sampling Points: 
 Volume of Air 
 Volumes of O2 
6.0 Between Sampling Points: 
 Median 
 Median Absolute Distance 
 Area Above Median 
 Area Below Median 
 Total Area Away from Median 
Key Event Times for Air 
Key Event Times for O2 
 
Between Sampling Points: 
 Volume of Air 
 Volumes of O2 
7.0 Between Sampling Points: 
 Median 
 Median Absolute Distance 
 Area Above Median 
 Area Below Median 
 Total Area Away from Median 
Key Event Times for Air 
Key Event Times for O2 
Key Event Times for CO2 
 
Between Sampling Points: 
 Volume of Air 
 Volumes of O2 
 Volumes of CO2 
Table 35. Development of informative values from first iteration to final seventh iteration. 
  
 185 
 
To address the issues of sensitivity, the overall behaviours of steady state profiles were 
summarised using robust statistics [184,185]. These have been shown to handle 
asymmetric profiles, such as spiking, in a robust manner [186]. Mean was replaced with 
robust equivalent median (𝑚𝑛,𝑘), calculated: 
𝑚𝑛,𝑘 = median
𝑖=n,…,𝑘
(𝑥𝑖) Eq. 5.1 
Standard deviation was replaced by median absolute deviation (MAD), which is 
calculated: 
𝑀𝐴𝐷𝑛,𝑘 = 1.483median
𝑖=1,…,𝑗
|𝑥𝑖 − 𝑚𝑛,𝑘| Eq. 5.2 
where 𝑥𝑖 is the 𝑖th measurement in the window 𝑇𝑛,𝑘, 𝑥𝑗 is the last measurement in the 
window 𝑇𝑛,𝑘, and 1.483 is a correction factor to make MAD unbiased at normal 
distribution [185]. 
To capture special detail behaviour, the informative value set was expanded to include 
calculations for the area between the measured value and the median. It was possible to 
consider areas above and below the median, and the total area away from the median. 
These areas were calculated using a simple algorithm, whereby when using Eq. 5.3 to 
calculate the area above median (𝐴𝐴𝑀𝑛,𝑘) for a window of activity containing online 
measurements 𝑖 to 𝑗, samples with 𝑥𝑖 − 𝑚𝑛,𝑘 < 0 were replaced with 0. Similarly, when 
calculating area below median (𝐴𝐵𝑀𝑛,𝑘), all samples with 𝑥𝑖 − 𝑚𝑛,𝑘 > 0 were replaced 
with 0 when performing Eq. 5.3. 
𝐴𝐴𝑀𝑛,𝑘𝑜𝑟 𝐴𝐵𝑀𝑛,𝑘  
= ∑(1.5 ∗ (𝑥𝑖 − 𝑚𝑛,𝑘) − 0.5 ∗ (𝑥𝑖−1 − 𝑚𝑛,𝑘))
𝑗
𝑖=2
 ∗ (𝑠𝑖 − 𝑠𝑖−1) 
Eq. 5.3 
where 𝑠𝑖 is the time at which the 𝑖th sample measurement is made in hours. Note that the 
calculation is a backwards looking summation beginning at 𝑠𝑖 = 2. If the sampling 
interval is constant, 𝑠𝑖 − 𝑠𝑖−1 can be replaced with 𝑠𝑖𝑛𝑡, yielding: 
𝐴𝐴𝑀𝑛,𝑘𝑜𝑟 𝐴𝐵𝑀𝑛,𝑘  = ∑(1.5 ∗ (𝑥𝑖 − 𝑚𝑛,𝑘) − 0.5 ∗ (𝑥𝑖−1 − 𝑚𝑛,𝑘))
𝑗
𝑖=2
 ∗ 𝑠𝑖𝑛𝑡) Eq. 5.4 
The total area away from the median (𝑇𝐴𝐴𝑀𝑛,𝑘) was calculated by adding the absolute 
values for 𝐴𝐴𝑀𝑛,𝑘 and  𝐴𝐵𝑀𝑛,𝑘 as seen in Eq. 5.5. 
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𝑇𝐴𝐴𝑀𝑛,𝑘 = |𝐴𝐴𝑀𝑛,𝑘| + |𝐴𝐵𝑀𝑛,𝑘| Eq. 5.4 
When calculating the MAD, AAM, ABM, and TAAM, the calculations could be 
completed using two different median values. These were: 
 𝑚𝑛,𝑛+1: The median value of data captured between two sequential timepoints.  
 𝑚1,𝐿: The median of data captured between the first and last timepoints. 
Use of different medians allowed the identification of culture where limited periods of 
operation were notably different from overall behaviour, e.g. values for area away from 
median and MAD calculated using 𝑚𝑛,𝑛+1 are notably different when compared to the 
same values calculated using  𝑚1,𝐿. 
Excluding perturbations lasting 6 hours or more (>25% of data points in a 24 hour 
window), 𝑚𝑛,𝑛+1 and 𝑚1,𝐿 for a perturbation should not notably differ. In the event of a 
shift in setpoint, the daily median will be notably different from the overall median for 
days on the minority side of the shift, e.g. a culture spends 3 days at pH setpoint A and 
12 days at pH setpoint B, assuming no major issues the overall median is B ± noise. 
Subsequently informative values calculated for the first 3 days using the overall median 
will be notably different than when using daily medians. 
The artificially generated dataset (P001 to P100) is re-used here to demonstrate how these 
informative values can be used to analyse online monitoring of pH for four cultures. The 
cultures demonstrate a range of behaviours (described in Table 36 and shown in Figure 
55) and lasting 11 days with online monitoring of pH (5 minutes sample 
interval x 264 h = 3168 measurements per culture). 
P001 was an ideal pH profile with random noise ± 0.005 (Figure 55A). P021 had random 
noise ± 0.005 with a high perturbation from 168 h to 172 h (Figure 55B). P031 had 
random noise ± 0.010 as well a high perturbation from 43 h to 48 h (Figure 55C). P041 
had random noise ± 0.005 and underwent a change in setpoint at 39 h (Figure 55D). For 
daily calculations, 𝑇1,2= 1 h and all other 𝑇𝑛,𝑛+1= 24 h. 
The shift in setpoint for P041 was apparent when the median values for each window of 
activity (𝑚𝑛,𝑛+1) were plotted (Figure 3A). The perturbations for P021 and P031 could 
not be identified at this point. 
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Calculations for 𝑀𝐴𝐷𝑛,𝑛+1 were completed for each window of activity using daily and 
overall medians (Figure 59B and Figure 59C). In Figure 59B, it can be seen that similar 
values were calculated for P001 and P021, which showed normal noise. For P031, MAD 
were higher than that of P001 or P021. 
For P041, values 𝑀𝐴𝐷𝑛,𝑛+1 calculated when using 𝑚𝑛,𝑛+1 were of a similar magnitude 
as for P001 and P021. However the shift in P041 was clearly identifiable when 𝑀𝐴𝐷𝑛,𝑛+1 
was calculated when using 𝑚1,𝐿(Figure 59C). This was the only culture where replacing 
𝑚𝑛,𝑛+1 in the calculation with 𝑚1,𝐿caused such a change in 𝑀𝐴𝐷𝑛,𝑛+1. 
While median and MAD calculations could be used to differentiate between high and low 
noise as well as normal and shift behaviours, it was not possible to differentiate between 
normal and perturbed behaviours. 
To differentiate between normal and perturbed behaviour, 𝐴𝐴𝑀𝑛,𝑘, 𝐴𝐵𝑀𝑛,𝑘, and 
𝑇𝐴𝐴𝑀𝑛,𝑘 were used. It can be seen in Figure 3D that there was an increase in 𝑇𝐴𝐴𝑀𝑛,𝑛+1 
for P021 for 𝑇7,8  (168 h to 192 h) and P031 for 𝑇2,3 (24 h to 48 h). This increase was seen 
when both 𝑚𝑛,𝑛+1 and 𝑚1,𝐿 are used, indicating that behaviour in these windows was 
unusual.  
Shift behaviour could also be identified using 𝐴𝐴𝑀𝑛,𝑘, 𝐴𝐵𝑀𝑛,𝑘, and 𝑇𝐴𝐴𝑀𝑛,𝑘. When 
using 𝑚𝑛,𝑛+1, a higher area was seen for P041 in the window 𝑇2,3 (24 h to 48 h). This 
value captured the shift in pH setpoint which occurred at 39 h. In Figure 59E where 𝑚1,𝐿 
was used, all area values calculated prior to 48 h are increased, indicating pre-shift and 
post-shift data. 
Culture pH Behaviour Noise Noise Range Event Time 
P001 Ideal Acceptable Setpoint ± 0.005 N/A 
P021 High Perturbation Acceptable Setpoint ± 0.005 168 h to 172 h 
P031 High Perturbation High Setpoint ± 0.010 43 h to 48 h 
P041 Setpoint Shift Acceptable Setpoint ± 0.005 39h 
Table 36. Summary of pH profiles compared.  
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Figure 59. Informative values calculated from artificially generated online monitoring data of pH 
for four theoretical cultures showing various behaviours and noise. P001: ideal, setpoint ± 0.005. 
P021: high perturbation, setpoint ± 0.005. P031: high perturbation, setpoint ± 0.010. P041: shift 
in setpoint, setpoint ± 0.005. 
A) 𝑚𝑛,𝑛+1 
B) 𝑀𝐴𝐷𝑛,𝑛+1 using 𝑚𝑛,𝑛+1  
C) 𝑀𝐴𝐷𝑛,𝑛+1using 𝑚1,𝐿  
D) 𝑇𝐴𝐴𝑀𝑛,𝑛+1 using 𝑚𝑛,𝑛+1 
E) 𝑇𝐴𝐴𝑀𝑛,𝑛+1 using 𝑚1,𝐿 
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A.4.2 Informative Values for ‘Dynamic’ Variables 
Dynamic variables are variables which are strongly dependent on culture performance, 
e.g. the flowrate of O2 into the bioreactor is determined by culture oxygen demands 
whereas pH level is affected by culture behaviour but is primarily dependent on pre-set 
operating setting points. Dynamic profiles were summarised using volumes of gas 
entering the bioreactor between sampling timepoints and when key events occurred. The 
key events for air, O2, and CO2 feeds are demonstrated with references in Figure 60. When 
the fermentation begins, O2 is provided through the air feed, which is increased until a 
capped value is reached (A). Once the air feed reaches the capped value, the O2 feed is 
activated to meet any further O2 demands (B). 
The O2 flowrate increases until the viable cell concentration reaches a maximum. At this 
point the O2 feed is at a peak value (C). As the number of viable cells in the culture 
decreases, the O2 demand also decreases. The O2 feed is reduced until it becomes 
effectively zero (D). At this point, the air feed begins to decrease (E). 
In some control arrangements, O2 and air could be considered a single mixed feed. As 
stated, air is increased to meet increasing demand for O2 until a capped value is reached. 
Further demands for O2 are met by increasing the proportion of O2 in the feed. The air 
feed is decreased so that the flowrate remains at the capped value. This creates a 
distinctive ‘dip’ in the air flow (F). 
In other controllers, air and O2 could be considered separate feeds. The air feed was 
maintained at the capped flowrate while the O2 flowrate increased and declined as 
necessary. Several additional events may be noted of interest: when the air feed reaches 
half of the capped flowrate (G), the time between the air flowrate capping and the O2 feed 
activating, the time the air feed was at the capped flowrate, the time the O2 feed was 
active, and the peak O2 flowrate. 
Due to the concentrated nature of feeds and bolus used, these additions could sometimes 
be identified by analysing the profiles of the variables intended to control pH, such as the 
CO2 profile. CO2 gas is an acidic gas used to correct pH in cultures when pH 
measured > pH setpoint by sparging. In Figure 60, distinct jumps in CO2 flowrate can be 
seen at H, I, and J. 
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A.4.3 Method 
Online monitoring data from 49 cultures performed in 10 L and 130 L bioreactors at 
Lonza’s Slough site were summarised as informative values. Informative values were 
calculated from inoculation to Day 10 using sampling times recorded in daily offline 
monitoring data. 
For fairer comparability with the previous analysis of data in its native state, 11 cultures 
were removed including all 130 L cultures. Due to mixed O2 gassing strategies and 
disparity in observations of key events for dynamic variables, informative values for air 
and O2 flowrates were restricted to volumes added between sampling timepoints. All 
informative values based on CO2 flowrate were removed as variables due to data loss and 
data validity issues related to transfer of data from datalogger to computer. 
Data were imported to Matlab for analysis with the Eigenvector PLS-Toolbox. Data were 
mean-centred and scaled to unit variance. A PCA model was created using random 
sampling (10 splits, 5 iterations) for cross-validation. A one PC model was recommended 
based on lowest RMSE during cross-validation. As in the previous analysis, two PCs were 
retained. The model captured 26.24% of variance in the dataset. 
 
Figure 60. Sample profiles from process data from the online monitoring of air, O2, and CO2 
flowrates for bioreactor culture A023. Key events described in the text are annotated A—J. 
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The informative values dataset was then extended to include the elapsed time at which 
sampling occurred, which was used when calculating the informative values. This 
extended dataset was mean-centred and scaled to unit variance. A PCA model was created 
using random sampling (10 splits, 5 iterations) for cross-validation. A one PC model was 
recommended based on lowest RMSE during cross-validation. As a single PC model 
would be difficult to visualise and interpret, two PCs were retained. The model captured 
27.14% of variance in the dataset. 
A.4.4 Results and Discussion 
As there was less than a 1% difference in variance captured by the two models created, 
the second model, where offline sampling times were included in the modelled dataset, 
was excluded from further analysis. 
Figure 61 and Figure 62 show the loadings for the final model. In Figure 61, the variables 
were coloured by the original variable from which the informative values were calculated 
(pH, temperature, DOT, air flowrate, O2 flowrate). In Figure 62, the variables were 
coloured by the type of informative value calculated. 
From the loading plots, it was concluded that the greatest sources of variation between 
cultures in the modelled dataset were DOT-based informative values. Two clusters of 
DOT-based informative values were observed in the upper-left and lower-right quadrants 
of Figure 61A. The upper-left quadrant cluster was comprised predominantly of three 
types of informative values describing DOT behaviour: 
1. Area Below Median (Using Daily Median) 
2. Area Below Median (Using Overall Median) 
3. Daily Median 
The lower-right quadrant comprised of six types of informative values describing DOT 
behaviour: 
1. Area Above Median (Using Daily Median) 
2. Area Above Median (Using Overall Median 
3. Total Area Away from Median (Using Daily Median) 
4. Total Area Away from Median (Using Overall Median) 
5. MAD (Using Daily Median) 
6. MAD (Using Overall Median)  
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Figure 61. Loading plots for a PC model created from informative values calculated from online 
monitoring data. Variables were coloured by the original variable from which the new informative 
value variables were calculated. Note that Figure 61B and Figure 61C were arranged to match the 
axes of Figure 61A. 
A) Loadings for PC1 and PC2. Two clusters of informative values calculated from DOT 
measurements were seen in the upper-left and lower-right quadrants. 
B) Loadings for PC2. PC2 behaviour appeared to marginally greater defined by temperature 
behaviours. As PC2 was retained primarily for improved visualisation of PC1, the lack 
of clearly structured behaviour captured by the PC was expected. 
C) Loadings for PC1. Informative values calculated from DOT had the greatest impact on 
overall behaviour captured in PC1. Air flowrate and O2 flowrate had a greater impact of 
captured PC1 behaviour from inoculation to Day 3 and from Day 4 to Day 6, respectively, 
than on other days during cultures.  
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Figure 62. Loading plots for a PC model created from informative values calculated from online 
monitoring data. Variables were coloured by the type of informative value calculated. Note that 
Figure 62B and Figure 62C are arranged to match the axes of Figure 62A. 
A) Loadings for PC1 and PC2. In Figure 61A, two clusters of informative values calculated 
from DOT measurements were observed in the upper-left and lower-right quadrants. Here 
it was observed that the cluster in the upper-left quadrant comprised of three main 
informative values for DOT: Area Below Median (Using Daily Median), Area Below 
Median (Using Overall Median), and Daily Median. The cluster in the lower-right 
quadrant comprised of Area Above Median (Using Daily Median), Area Above Median 
(Using Overall Median), Total Area Away from Median (Using Daily Median), Total 
Area Away from Median (Using Overall Median), MAD (Using Daily Median), and 
MAD (Using Overall Median). 
B) Loadings for PC2. As PC2 was retained primarily for improved visualisation of PC1, a 
lack of clearly structured behaviour captured by the PC was expected. However, strong 
clusters for both MAD-based informative values for temperature were observed. 
C) Loadings for PC1. Informative values calculated from DOT had the greatest impact on 
overall variance captured in PC1.  
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Air flowrate and O2 flowrate had a greater impact of captured PC1 behaviour from 
inoculation to Day 3 and from Day 4 to Day 6, respectively, than on other days during 
cultures. This was in keeping with what was known about air and O2 control strategies, 
i.e. the use of air flowrate cap and a supplementary O2 feed. From this, it can be surmised 
that the activation of the O2 feed on average occurred around Day 3/Day 4. 
Overall, the loading plot analysis demonstrated that informative values had captured 
expert knowledge and process understanding in a form appropriate for MVDA in keeping 
with the stated project aims. 
Figure 63 shows the scores for the final model. It was seen in Figure 63B that the cultures 
considered in the previous analysis with data in its native state, A006 and A47, both lie 
within the Q Residual limit and Hotelling T2 limit. A006 and A47 showed a greater 
difference in Hotelling T2 residual values than Q Residual value. 
A Hotelling T2 contribution analysis (Figure 63C) indicated that the majority of the 
difference in Hotelling T2 value was due to informative values summarising DOT 
behaviour. From this contribution analysis, it appeared that A006 had greater movement 
around the DOT setpoint, approximately 5 to 6 times greater movement in terms of 
area-based informative values and MAD. As these differences were observed when using 
both daily median DOT and the median DOT across the full culture duration under 
consideration, it was known that this 5 to 6 fold increase in movement was sustained 
through the majority of culture duration. For completeness, this was confirmed by a 
further drill down to the calculated informative values (Figure 63D). 
Additional differences observed in Figure 63C were the consistently higher contributions 
from air and O2 volumes for A006 than for A047. This indicated that higher volumes of 
air and O2 entered A006 than A047 throughout the majority of the culture duration under 
consideration. 
In comparison to the analysis of online monitoring in its native state, a lower percentage 
of dataset variance was captured when the same number of variables were retained 
(36.11% v. 26.29%). However use of informative values reduced in the number of 
variables to be analysed from 9580 to 360. This in addition to the context-rich nature of 
the informative values used led to improved identification of behaviours of interest and 
quantitative communication of those differences.  
 195 
 
 
Figure 63. Drill down analysis of cultures A006 and A047 in a PC model created from informative 
values calculated from online monitoring data. 
A) Score plot for PC1 (14.17%) and PC2 (12.07%) with 95% Hotelling T2 limit (-). 
B) Plot of values for Q residual (73.76%) against values for Hotelling T2 (26.29%). 
C) Comparison of Hotelling T2 contributions for A006 (blue) and A047 (red). The variables 
can be split into five ‘variable blocks’: pH (1 to 108), DOT (109 to 216), temperature 
(217 to 324), air (325 to 335), O2 (336 to 348). The greatest difference in contributions to 
Hotelling T2 appear to come from the DOT block. 
D) The calculated value for Area Above Daily Median for the sampling intervals Day 1 to 
Day 2, Day 2 to Day 3, Day 3 to Day 4 indicated greater degree of movement and a 
greater magnitude of movement around the daily median DOT for A006 than A047 over 
the 72 hours captured. From Day 2 to Day 4, the movement above the daily median for 
culture A006 was approximately three times that of culture A047.  
Variable Number 
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A.5 Additional Demonstration of Informative Values 
The previously created models were very comprehensive analyses of behaviour captured 
in online monitoring data, in that as they included many variables of interest (pH, 
temperature, DOT, etc.). While MVDA techniques can be used to create such 
comprehensive models, it may be desired to create simpler, more focussed models for a 
variety of reasons, e.g. variable-specific models for simpler interpretation. Such models 
and subsequent interpretation could also benefit through the use of informative values. 
Temperature-based informative values were calculated from inoculation to Day 10 using 
the sampling times recorded in daily offline monitoring data. A total of 44 cultures were 
included in the dataset, including two 130 L cultures, A043 and A046. 
Data were imported to Matlab for analysis with the Eigenvector PLS-Toolbox. Data were 
mean-centred and scaled to unit variance. A PCA model was created using random 
sampling (10 splits, 5 iterations) for cross-validation. A two PC model was retained that 
captured 60.68% of variance in the dataset. 
It was seen that two cultures were outside the 95% confidence interval for PC1. (Figure 
64A). These cultures were 130 L cultures – A043 and A046. Hotelling T2 and Q Residual 
values were also above the calculated limits for the model (Figure 64B). It was decided 
to focus on the behaviour of A043 for the purpose of this demonstration. 
Hotelling T2 contribution analysis of A043 (Figure 64C) did not indicate any particularly 
unusual values compared to other cultures in the dataset. All values were within one 
standard deviation of dataset means, hence the high Hotelling T2 calculated for A043 
appears to be due to a cumulative effect. Q Residual contribution analysis for A043 
(Figure 64D) revealed the separation was caused by unusually high contributions from 
the informative values listed in Table 37. 
Interval for Informative Value Informative Value 
Day 2 to Day 3 Area Below Median Using Daily Median 
Area Below Median Using Overall Median 
Day 3 to Day 4 Area Above Median Using Daily Median 
Area Below Median Using Daily Median 
Total Area Away from Median Using Daily Median 
Area Below Median Using Overall Median 
Total Area Away from Median Using Overall Median 
Day 5 to Day 6 MAD Using Daily Median 
Table 37. Informative values of interested identified through Q Residual contribution 
analysis.   
 197 
 
 
Figure 64. Results for a PCA model created using temperature-based informative value and drill 
down analysis for the indicated culture A043. 
A) Score plot for PC1 (46.31%) and PC2 (14.37%). 
B) Culture values for Hotelling T2 (60.68%) and Q Residual (39.32%) with calculated limits. 
It was observed that A043 had unusual Hotelling T2 and Q Residual values above the 
displayed limits. 
C) Hotelling T2 contribution analysis for culture A043. No informative values appeared to 
be of particular note as all informative values were within 1 standard deviation of the 
dataset mean. 
D) Q Residual contribution analysis for culture A043. Eight informative values of interested 
are indicated with the numerals. 
1. MAD Using Daily Median for Day 5 to Day 6 
2. Area Above Median Using Daily Median for Day 3 to Day 4 
3. Total Area Away from Median Using Daily Median for Day 2 to Day 3 
4. Area Below Median Using Daily Median for Day 3 to Day 4 
5. Total Area Away from Median Using Daily Median for Day 3 to Day 4 
6. Area Below Median Using Overall Median for Day 2 to Day 3 
7. Area Below Median Using Overall Median for Day 3 to Day 4 
8. Total Area Away from Median Using Overall Median for Day 3 to Day 4  
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Informative values of interested identified through Q Residual contribution analysis 
described behaviour for three offline sampling intervals: Day 2 to Day 3, Day 3 to Day 4, 
and Day 5 to Day 6. 
Unusual informative values for the offline sampling interval Day 2 to Day 3 were Area 
Below Median and the Total Area Away from Median when calculations were completed 
using either the median temperature for the sampling interval or the median temperature 
from inoculation to the Day 10 offline sampling. From this, it was known that an event 
had occurred with the following conditions: 
1. The event was restricted to the ~24 hours in question. 
2. The event did not last long enough to affect the median temperature or the median 
absolute distance for temperature for the ~24 hour block. 
3. The event increased area-based informative values in one direction only. 
From these conclusions, it was suggested that the recorded temperature measurement had 
dropped drastically for a short time. Referring back to the original data (Figure 65), it was 
revealed that errors had occurred in several readings which lead to the informative value 
calculator treating the readings as zero. Repeating the contribution analysis on A046 
showed a similar issue, indicating a recurring equipment fault for the 130L bioreactor 
control system. This was confirmed through discussion with members of the UK pilot 
team. 
This form of error can be easily hidden during visual analysis of raw data. When plotting 
the variable against time, missing data could be overlooked due to the graphing program 
rules in use, e.g. hold last known value or create a straight line connection to the next 
available value, or gaps being too small to notice amongst the 1000s of points. Through 
the use of informative values, this error was quickly captured and identified. 
The second interval of interest was Day 3 to Day 4. All area-based informative values 
were unusual, except for the Area Above Median from when the median temperature 
from inoculation to the Day 10 offline sampling was used to complete the calculation. 
Referring back to the original data showed generally lower readings for temperature 
during this interval however the typical movement around the median (measured by 
MAD) was relatively unaffected. While the general decrease was relatively small, it was 
sufficient to capture that the interval was unusual compared to activity of other days and 
draw the user’s attention to the transition. 
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The third interval of interest was Day 5 to Day 6. This interval contained the end of the 
general decrease in temperature. This ‘return to normal’ behaviour was captured in the 
MAD when using Daily Median. 
 
 
Figure 65. Original temperature measurements for online monitoring of culture A043. Figure 65A 
shows all measurements and it was observed that a shift in overall temperature measurements 
occurred and lasted approximately two days. Closer examination revealed missing data points 
(indicated by red markers at the temperature setpoint 36.5°C). Figure 65B shows a magnified 
view of measurements used to calculated informative values for the interval Day 2 to Day 3. When 
calculating informative values, these missing data points were treated as zero readings by the 
Excel-based calculator. This caused the increased values for Area Below Median and Total Area 
Away from Median, both when using the Daily Median and the Overall Median for culture 
temperature. Area Above Median was effectively unaffected.  
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A.6 Conclusions 
The control systems used in bioreactors are dependent on measurements from online 
monitoring systems. These systems can create thousands of data points per variable in a 
matter of days. However the time series created are frequently analysed qualitatively and 
subjectively on an individual basis. 
While statistical methods exist that can analyse high frequency online monitoring data 
with little to no human intervention, such analyses may be of limited use when 
considering non-major deviations and may prevent batch-to-batch comparisons of the 
data in its native form. Furthermore, it may benefit research and development or 
manufacturing departments to prioritise human interpretability over pure statistical 
power. 
Online monitoring data were converted from univariate time series to informative values 
that provide a balance between both quantitative and qualitative understanding and 
possess intuitive meaning for users. The developed informative values were used to 
differentiate between common online monitoring data behaviours encountered during 
cultures of mAb-producing cells. This was achieved through the analysis of an online 
monitoring dataset, where online monitoring data were first summarised with informative 
values and then analysed using PCA. Behaviours in online monitoring data were 
adequately captured to be identifiable in the resulting PCA model. Interpretability during 
contribution analysis was increased as the informative values selected were developed to 
have intuitive and appropriate contextual meaning for human understanding. These 
conclusions were supported by an additional demonstration using a PCA model to analyse 
only temperature-based informative values. 
The informative values presented were developed specifically for online monitoring data 
originating from the production of a mAb by a mammalian cell line and influenced by the 
verbal descriptions provided by scientists familiar with the process. Informative values 
could be developed for other high frequency process variables using similar logic. 
The third aim of the presented research was to enable the interrogation of online 
monitoring and offline monitoring datasets in a single, balanced dataset. Achievement of 
this aim was tested through the productivity and culture viability investigations described 
in Chapter 5 and Chapter 6 respectively. 
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Appendix B. Additional Tables and Figures 
Unique Code [SPE] (mL/L) 
ID Vessel number 
Cell  Inoc date 
Cell line Inoc time 
Experiment ID Post- Inoc volume (L) 
Experimental Conditions Stage and Round ID 
Process Working Cell Bank 
Table 38. Routine Meta Data Collected in Project A. 
 
 
Elapsed time (h) Glu (g/L) 
Elapsed time (days) Gluc (g/L) 
Bioreactor volume(L) Lac (g/L) 
Temp(°C) NH4+ (g/L) 
Bench pH Na+ (mmol/L) 
DOT (%) K+ (mmol/L) 
VCC (106/mL) Osmolality (mOsm/Kg) 
TCC  (106/mL) SF66 (g) 
IVC (106 cell h/mL) Gluc (g) 
Product (mg/L) SF66 (g/109 cell.hour) 
Nova pH Gluc Utilisation (g/109 cell.h) 
pO2 (mmHg) Viability (%) 
pCO2 (mmHg) Specific growth rate (h-1) 
Gln (g/L) Doubling time (h) 
Table 39. Routine Daily Monitoring Data Collected in Project A. 
 
 
d[Gluc]/d[Lac] Osmolality - Theoretical Osmo (mOsm/kg) 
d[K]/d[Na+] [K+]/[Na+] (mmol/mmol) 
[Na+] /pCO2 (mmol/mmHg) d[Gln]/d[Lac] 
[Na+]/[Lac] (mmol/g) Lac Production Rate (g/109 cell.h) 
d[Na+]/d[Lac] (mmol/g) Antibody Accumulation Rate (mg/109 cell.h) 
[Lac]/[NH4+] (g/g) NH4+ Accumulation Rate (g/109 cell.h) 
d[Lac]/d[NH4+] (g/g) Glu Utilisation Rate (g/109 cell.h) 
[Gln]/[NH4+] (g/g) K+ Utilisation (mmol/109 cell.h) 
d[Gln]/d[NH4+] (g/g) Na+ Accumulation Rate (g/109 cell.h) 
Theoretical Osmo (mOsm/kg) Bench pH - Nova pH 
Table 40. Additional Ratios and Rates Calculated for Stage 1 Extended DM Dataset.  
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Setpoint Variables Dynamic Control Variables 
pH Gradient Air Gradient 
pH R2 Air R2 
pH Mean Average Air Mean Average 
pH StDev Air StDev 
DOT Gradient O2 Gradient 
DOT R2 O2 R2 
DOT Mean Average O2 Mean Average 
DOT StDev O2 StDev 
Temp Gradient CO2 Gradient 
Temp R2 CO2 R2 
Temp Mean Average CO2 Mean Average 
Temp StDev CO2 StDev 
N2 Gradient 
 
N2 R2 
N2 Mean Average 
Ns StDev 
Table 41. Informative Values Version 1.0 Used in Stage 1. 
 
 
 
Setpoint Variables Dynamic Control Variables 
pH Median Volume of Air Added 
pH MAD Volume of Oxygen Added 
Area Above pH Median True Volume of Oxygen Added 
Area Below pH Median Volume CO2 Added 
Total Area Away from pH Median  
Temp Median 
Temp MAD 
Area Above Temp Median 
Area Below Temp Median 
Total Area Away from Temp Median 
DO Median 
DO MAD 
Area Above DO Median 
Area Below DO Median 
Total Area Away from DO Median 
Table 42. Subset of Informative Values Version 7.0 Used in Stage 2. 
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Figure 66. Comparison of schooling and age effects on performance in different tests to evaluate 
intelligence in students in grades 4 to 6 [164]. 
 
 Estimated Net Effect of 1 Year of  
Test Number and Name Age (A) Schooling (B) B/A (C) 
Verbal Tests 
1 Verbal Classification 0.12 0.23 1.9 
3 Verbal Analogies 0.14 0.27 1.9 
6 Vocabulary 0.19 0.40 2.1 
9 Verbal Oddities 0.05 0.35 7.0 
11 Arithmetic Problems 0.16 0.50 3.1 
12 Sentence Completion 0.18 0.41 2.3 
Numerical Tests 
7 Number Series 0.15 0.26 1.7 
Figural Tests 
2 Figure Classification 0.16 0.16 1.0 
4 Figure Analogies 0.22 0.14 0.6 
5 Matrices 0.13 0.27 2.1 
8 Figure Series 0.19 0.11 0.6 
10 Figural Oddities 0.09 0.20 2.2 
Table 43. Estimated effects of age and schooling on grade 4 to grade 6 student performance in 
standardised intelligence exams [164]. 
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Table 44. Correlations between Day 11 [Product] (mg/L) and events in air and oxygen profiles 
using Elapsed Time (h) and IVC as measures of progress.  
Factor  
Correlation with Day 11 [Product] 
Measurement All Cultures Control Cultures 
Reaches Half Air Cap Elapsed Time (h) -0.25 -0.38 
Reaches Half Air Cap IVC -0.11 -0.32 
Reaches Air Cap Elapsed Time (h) -0.37 -0.50 
Reaches Air Cap IVC -0.21 -0.52 
Ratio Cap to Half Cap Elapsed Time (h) -0.17 -0.14 
Ratio Cap to Half Cap IVC -0.22 -0.64 
Oxygen Feed On Elapsed Time (h) -0.44 -0.57 
Oxygen Feed On IVC -0.25 -0.79 
Oxygen Feed Peaks Elapsed Time (h) -0.12 -0.40 
Oxygen Feed Peaks IVC 0.23 -0.16 
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No Progression Variable 
 
Developed 04-Dec-2012 
11:54:30.09  
X-block: Project A Day by 
Day 475 by 32  
Num. LVs: 6 
CV: random samples w/ 10 
splits 10 iterations 
Model Performance Cal CV 
RMSE 
Bias 
R2 
107.68 
-8.83915e-012   
0.762318 
121.185 
1.11864 
0.713459 
Variables 
Temp (C) 
Radiometer pH 
DOT % 
Nova pH 
pO2 (mmHg) 
pCO2 (mmHg) 
Gln (g/L) 
Glu (mmol/L) 
Gluc (g/L) 
Lac (g/L) 
NH4 (mM) 
Na (mM) 
K (mM) 
Volume of Air Added 
Volume of Oxygen Added 
True Volume of Oxygen 
Added 
Volume CO2 Added 
pH Median 
pH MAD 
Area Above pH Median 
Area Below pH Median 
Total Area Away from pH 
Median 
Temp Median 
Temp MAD 
Area Above Temp Median 
Area Below Temp Median 
Total Area Away from Temp 
Median 
DO Median 
DO MAD 
Area Above DO Median 
Area Below DO Median 
Total Area Away from DO 
Median 
Percent Variance Captured by Regression Model 
   ---------X-Block----------   ---------Y-Block----------  
Comp   This   Total    This   Total  
----   -------   -------    -------   -------  
1  19.18   19.18    55.48   55.48  
2  7.38   26.56    12.71   68.19  
3  5.86   32.42    4.56   72.75  
4  5.11   37.53    2.21   74.96  
5  4.12   41.65    0.99   75.95  
6  3.91  45.55   0.28  76.23  
Table 45. Details for PLSR model created using no explicit progression variable during Chapter 
5.7.1  
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Elapsed Time 
 
Developed 04-Dec-2012 
12:11:34.43  
X-block: Project A Day by 
Day 475 by 33  
Num. LVs: 8  
CV: random samples w/ 10 
splits and 10 iterations  
Model Performance Cal CV 
RMSE 
Bias 
R2 
81.6259 
-2.10036e-011 
0.863422 
90.8876 
0.030923 
0.830859 
Variables 
Time 
Temp (C) 
Radiometer pH 
DOT % 
Nova pH 
pO2 (mmHg) 
pCO2 (mmHg) 
Gln (g/L) 
Glu (mmol/L) 
Gluc (g/L) 
Lac (g/L) 
NH4 (mM) 
Na (mM) 
K (mM) 
Volume of Air Added 
Volume of Oxygen Added 
True Volume of Oxygen 
Added 
Volume CO2 Added 
pH Median 
pH MAD 
Area Above pH Median 
Area Below pH Median 
Total Area Away from pH 
Median 
Temp Median 
Temp MAD 
Area Above Temp Median 
Area Below Temp Median 
Total Area Away from Temp 
Median 
DO Median 
DO MAD 
Area Above DO Median 
Area Below DO Median 
Total Area Away from DO 
Median 
Percent Variance Captured by Regression Model 
--------X-Block-----------   ----------Y-Block--------- 
Comp   This   Total    This   Total  
----   -------   -------    -------   -------  
1   20.97   20.97    59.87   59.87  
2   7.22   28.19    13.32   73.19  
3   5.74   33.93    5.60   78.78  
4   5.01   38.95    3.09   81.87  
5   4.05   43.00    1.75   83.62  
6   3.61   46.60    1.02   84.65  
7   3.02   49.62    0.99   85.63  
8   3.15   52.77    0.71   86.34  
Table 46. Details for PLSR model created using Elapsed Time (h) as an explicit progression 
variable during Chapter 5.7.1  
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IVC 
 
Developed 04-Dec-2012 
12:19:7.25  
X-block: Project A Day by 
Day 475 by 33 
Preprocessing: Autoscale  
Num. LVs: 8  
CV: random samples w/ 10 
splits and 10 iterations  
Model Performance Cal CV 
RMSE 
Bias 
R2 
40.63 
-3.95062e-012 
0.966162 
47.18 
0.253164 
0.95457 
Variables 
IVC 
Temp (C) 
Radiometer pH 
DOT % 
Nova pH 
pO2 (mmHg) 
pCO2 (mmHg) 
Gln (g/L) 
Glu (mmol/L) 
Gluc (g/L) 
Lac (g/L) 
NH4 (mM) 
Na (mM) 
K (mM) 
Volume of Air Added 
Volume of Oxygen Added 
True Volume of Oxygen 
Added 
Volume CO2 Added 
pH Median 
pH MAD 
Area Above pH Median 
Area Below pH Median 
Total Area Away from pH 
Median 
Temp Median 
Temp MAD 
Area Above Temp Median 
Area Below Temp Median 
Total Area Away from Temp 
Median 
DO Median 
DO MAD 
Area Above DO Median 
Area Below DO Median 
Total Area Away from DO 
Median 
Percent Variance Captured by Regression Model 
  ---------X-Block----------   ---------Y-Block----------  
Comp   This   Total    This   Total  
----   -------   -------    -------   -------  
1   20.59   20.59    64.50   64.50  
2  7.33   27.92    15.36   79.86  
3   5.59   33.52    6.61   86.48  
4   5.06   38.58    3.71   90.19  
5   4.06   42.64    2.36   92.55  
6   3.53   46.17    1.74   94.29  
7   2.89   49.06    1.61   95.90  
8   3.57   52.64    0.72   96.62  
Table 47. Details for PLSR model created using IVC as an explicit progression variable during 
Chapter 5.7.1 
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Model # 
Data Used Arrangement Alignment Include Variable Response 
Daily Monitoring Informative Values DbD Profile Natural Time IVC Time IVC Viability [Product] VCC 
1-3 X  X  X   X X 1 2 3 
4-6 X  X  X   X  4 5 6 
7-9 X  X  X    X 7 8 9 
10-12 X  X   X  X  10 11 12 
13-15 X  X   X    13 14 15 
16-18 X  X    X  X 16 17 18 
19-21 X  X    X   19 20 21 
22-24 X X X  X   X X 22 23 24 
25-27 X X X  X   X  25 26 27 
28-30 X X X  X    X 28 29 30 
31-33 X X X   X  X  31 32 33 
34-36 X X X   X    34 35 36 
37-39 X X X    X  X 37 38 39 
40-42 X X X    X   40 41 42 
Table 48. Dataset combinations, dataset arrangements, and variable selections test to evaluate impact of progression variable choice and dataset rigidity in analyses.  
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Model # 
Data Used Arrangement Alignment Include Variable Response 
Daily Monitoring Informative Values DbD Profile Natural Time IVC Time IVC Viability [Product] VCC 
43-45 X   X X   X X 43 44 45 
46-48 X   X X   X  46 47 48 
49-51 X   X X    X 49 50 51 
52-54 X   X  X  X  52 53 54 
55-57 X   X  X    55 56 57 
58-60 X   X   X  X 58 59 60 
61-63 X   X   X   61 62 63 
64-66 X X  X X   X X 64 65 66 
67-69 X X  X X   X  67 68 69 
70-72 X X  X X    X 70 71 72 
73-75 X X  X  X  X  73 74 75 
76-78 X X  X  X    76 77 78 
79-81 X X  X   X  X 79 80 81 
82-84 X X  X   X   82 83 84 
Table 49. Dataset combinations, dataset arrangements, and variable selections test to evaluate impact of progression variable choice and dataset rigidity in analyses 
(con’t). 
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Model Information [Product] Viability VCC 
Arrange. Align. 
Progression 
Variable 
Cal/Val LV R2 Cal R2 CV LV R2 Cal R2 CV LV R2 Cal R2 CV 
DbD IVC IVC All 5 0.933 0.928 3 0.579 0.536 3 0.952 0.947 
DbD None IVC All 3 0.876 0.850 3 0.808 0.766 2 0.859 0.836 
DbD IVC NOI All 3 0.832 0.816 3 0.443 0.387 4 0.940 0.933 
DbD None NOI All 2 0.700 0.658 3 0.643 0.576 2 0.863 0.842 
DbD Time NOI All 3 0.816 0.796 3 0.698 0.666 3 0.901 0.891 
DbD None Time All 3 0.802 0.764 3 0.740 0.681 2 0.858 0.834 
DbD Time Time All 3 0.857 0.844 3 0.780 0.756 3 0.900 0.888 
Profile IVC IVC All 2 0.681 0.315 1 0.417 0.125 1 0.656 0.460 
Profile None IVC All 3 0.948 0.724 2 0.923 0.784 2 0.929 0.856 
Profile IVC NOI All 2 0.670 0.294 1 0.415 0.109 2 0.757 0.529 
Profile None NOI All 3 0.930 0.613 1 0.737 0.589 2 0.937 0.834 
Profile Time NOI All 4 0.967 0.390 2 0.828 0.292 2 0.877 0.554 
Profile None Time All 3 0.931 0.634 3 0.939 0.647 1 0.775 0.519 
Profile Time Time All 4 0.967 0.422 2 0.828 0.342 2 0.877 0.559 
Table 50. Summary of PLSR Models and Results when Using Only Daily Monitoring Dataset  
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Model Information [Product] Viability VCC 
Arrange. Align. 
Progression 
Variable 
Cal/Val LV R2 Cal R2 CV LV R2 Cal R2 CV LV R2 Cal R2 CV 
DbD IVC IVC All 4 0.893 0.876 6 0.634 0.550 5 0.962 0.957 
DbD None IVC All 7 0.914 0.890 7 0.873 0.831 2 0.863 0.842 
DbD IVC NOI All 7 0.867 0.838 6 0.527 0.429 5 0.950 0.943 
DbD None NOI All 6 0.778 0.709 5 0.680 0.569 3 0.876 0.851 
DbD Time NOI All 3 0.796 0.753 3 0.695 0.623 3 0.903 0.884 
DbD None Time All 7 0.838 0.795 7 0.794 0.744 2 0.861 0.840 
DbD Time Time All 3 0.903 0.883 3 0.752 0.717 3 0.903 0.886 
Profile IVC IVC All 1 0.474 0.160 4 0.888 0.227 2 0.833 0.461 
Profile None IVC All 1 0.681 0.111 5 0.984 0.339 9 0.997 0.649 
Profile IVC NOI All 1 0.472 0.192 2 0.743 0.070 4 0.944 0.525 
Profile None NOI All 5 0.979 0.097 5 0.973 0.338 5 0.984 0.714 
Profile Time NOI All 4 0.950 0.042 4 0.945 0.037 5 0.975 0.064 
Profile None Time All 5 0.977 0.983 5 0.976 0.367 10 0.998 0.675 
Profile Time Time All 4 0.950 0.065 4 0.945 0.011 5 0.975 0.152 
Table 51. Summary of PLSR Models and Results when Using Integrated Daily Monitoring and Online Monitoring Dataset. 
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Informative 
Values Set 
Values for Steady State Profiles Values for Dynamic Profiles 
1 Averages, Standard Deviations, Slope, 
Coefficient of determination (R2) 
Averages, Standard Deviations, 
Slope, Coefficient of 
determination (R2) 
2 Averages, Standard Deviations, Slope, 
Coefficient of determination (R2) 
Times of key events (air and O2) 
3 Median, Median Absolute Distance Times of key events (air and O2) 
4 Median, Median Absolute Distance Times of key events (air and O2) 
Volumes added (air and O2) 
5 Median, Median Absolute Distance Times of key events (air and O2) 
Volumes added (air and O2) 
6 Median, Median Absolute Distance, 
Areas between reading and median 
(above, below, total) 
Times of key events (air and O2) 
Volumes added (air and O2) 
7 Median, Median Absolute Distance, 
Areas between reading and median 
(above, below, total) 
 
Times of key events (air, O2, and 
CO2) 
Volumes added (air, O2, and CO2) 
Table 52. Summary of Informative Value Datasets by Version 
 
Scaling 
Justification 
Used 
Type 
PCs 
Used* 
X Variance 
Captured (%) 
Autoscale 
Harvest Justified 
Data 2 25 
Single Variable Model PCs 1 19 
Inoculation 
Justified 
Data 5 45 
Single Variable Model PCs 1 25 
Peak VCC 
Centred 
Data 1 18 
Single Variable Model PCs 1 23 
Intrascale 
A 
Harvest Justified 
Data 5 45 
Single Variable Model PCs 1 26 
Inoculation 
Justified 
Data 4 38 
Single Variable Model PCs 1 20 
Peak VCC 
Centred 
Data 5 48 
Single Variable Model PCs 2 42 
Table 53. PCA and HPCA Models. *Number of PC used based on minimum RMSE during 
cross-validation. 
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Scaling Applied Justification Used Decline Limit (%/d) Latent Variables Used 
Variance Captured (%) 
Misclassified (%) 
X Y 
Autoscale 
Harvest Justified 
10 2 20 48 24 
20 2 19 50 22 
30 2 21 53 16 
40 2 20 53 14 
50 2 18 44 10 
60 2 17 31 12 
Inoculation Justified 
10 2 25 43 31 
20 3 31 48 26 
30 2 25 45 18 
40 2 24 43 15 
50 2 23 35 20 
60 2 23 27 32 
Peak VCC Centred 
10 2 24 37 26 
20 2 22 42 31 
30 2 24 45 21 
40 2 23 49 14 
50 3 30 47 15 
60 2 19 31 20 
Table 54. PLS-DA results for CHO process platform investigation using Analysis Pattern 1 and Autoscaling (i.e. mean-centred and scaled to unit variance) applied. 
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Scaling Applied Justification Used Decline Limit (%/d) Latent Variables Used 
Variance Captured (%) 
Misclassified (%) 
X Y 
Intrascale A 
Harvest Justified 
10 2 19 21 46 
20 2 24 34 30 
30 2 23 33 32 
40 2 22 31 34 
50 2 21 32 43 
60 2 21 30 38 
Inoculation Justified 
10 2 19 25 49 
20 2 21 37 37 
30 2 21 33 19 
40 2 20 31 40 
50 2 18 28 49 
60 2 18 30 49 
Peak VCC Centred 
10 2 16 20 51 
20 3 32 44 29 
30 2 28 27 37 
40 2 27 25 32 
50 2 18 31 37 
60 2 12 37 44 
Table 55. PLS-DA results for CHO process platform investigation using Analysis Pattern 1 and Intrascale A (two-step scaling process) applied. 
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Scaling Applied Justification Used Decline Limit (%/d) Latent Variables Used 
Variance Captured (%) 
Misclassified (%) 
X Y 
Autoscale 
Harvest Justified 
10 2 26 38 24 
20 4 44 44 26 
30 2 27 38 16 
40 2 26 38 15 
50 2 24 23 18 
60 2 22 12 37 
Inoculation Justified 
10 2 35 32 29 
20 2 34 29 29 
30 2 35 35 20 
40 3 41 37 18 
50 2 33 19 29 
60 2 33 13 37 
Peak VCC Centred 
10 2 31 29 26 
20 2 31 31 32 
30 2 33 35 22 
40 2 31 39 13 
50 2 28 27 21 
60 2 27 22 28 
Table 56. HPLS-DA results for CHO process platform investigation using Analysis Pattern 2 and Autoscaling (i.e. mean-centred and scaled to unit variance) applied. 
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Scaling Applied Justification Used Decline Limit (%/d) Latent Variables Used 
Variance Captured (%) 
Misclassified (%) 
X Y 
Intrascale A 
Harvest Justified 
10 2 24 10 52 
20 2 36 30 29 
30 2 36 25 29 
40 2 34 22 36 
50 2 33 16 39 
60 2 32 14 48 
Inoculation Justified 
10 2 24 12 49 
20 2 31 24 39 
30 2 31 20 40 
40 2 28 17 40 
50 2 26 10 53 
60 2 26 9 53 
Peak VCC Centred 
10 2 18 13 47 
20 2 38 22 31 
30 2 38 19 37 
40 2 38 19 33 
50 2 35 11 41 
60 2 30 11 40 
Table 57. HPLS-DA results for CHO process platform investigation using Analysis Pattern 2 and Intrascale A (two-step scaling process) applied. 
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Scaling 
Applied 
Justification 
Used 
Decline 
Limit 
(%/d) 
Leaves 
in Tree 
Misclassified 
(%) 
Top Node 
Autoscale 
Harvest 
Justified 
10 11 2 pCO2 PC2 
20 9 10 pH PC1 
30 11 5 Lac PC1 
40 11 1 pH PC1 
50 10 1 pH PC1 
60 10 2 Gln PC2 
70 6 1 Gln PC1 
Inoculation 
Justified 
10 11 5 Lac PC1 
20 18 4 pH PC1 
30 14 2 pH PC1 
40 6 4 pH PC1 
50 11 4 pH PC1 
60 10 5 Gluc PC1 
70 8 2 Gluc PC1 
Peak VCC 
Centred 
10 9 3 K PC1 
20 17 4 Lac PC1 
30 14 4 pH PC1 
40 8 4 pH PC1 
50 7 4 pH PC1 
60 5 4 Gln PC1 
70 2. 3 Gln PC1 
Intrascale 
A 
Harvest 
Justified 
10 13 5 Na PC1 
20 13 7 pH PC1 
30 10 7 pH PC1 
40 10 2 pH PC1 
50 11 1 Gln PC2 
60 9 3 Gln PC2 
70 3 2 Gln PC1 
Inoculation 
Justified 
10 13 2 Na PC1 
20 19 6 Lac PC1 
30 13 4 pH PC1 
40 11 2 pH PC1 
50 7 4 pH PC1 
60 7 6 Gln PC2 
70 7 1 Gln PC2 
Peak VCC 
Centred 
10 14 4 pH PC1 
20 19 7 pH PC1 
30 15 5 pH PC1 
40 9 6 pH PC1 
50 10 6 Lac PC1 
60 9 4 Gln PC1 
70 4 2 Gln PC2 
Table 58. Decision tree results for CHO process platform investigation using Analysis Pattern 2 
and Intrascale A (two step scaling process) applied.
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Scaling 
Applied 
Decline Limit 
(%/d) 
Leaves in 
Tree 
Misclassified (%) Top Node 
Autoscale 
10 11 2 PC1 Reading 7 
20 15 6 PC1 Reading 2 
30 12 4 PC1 Reading 2 
40 11 4 PC1 Reading 2 
50 12 1 PC1 Reading 2 
60 7 4 PC1 Reading 3 
70 6 2 PC1 Reading 1 
Intrascale A 
10 12 7 PC1 Reading 8 
20 13 13 PC1 Reading 10 
30 13 2 PC1 Reading 3 
40 10 4 PC1 Reading 3 
50 9 3 PC1 Reading 3 
60 7 2 PC1 Reading 11 
70 6 2 PC1 Reading 3 
Table 59. Decision tree results for CHO process platform investigation using Analysis Pattern 3 
and Intrascale A (two step scaling process) applied. 
 
